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ABSTRACT 
 
 
In the last decades, biomaterial science experienced enormous expansion because of its 
peculiar connections with other scientific, medical, and engineering disciplines, including 
molecular and cell biology, human physiology, and materials science. The continuous 
flow of knowledge among these fields, and the constant demand for new supplies and 
solutions is driving biomaterial science to be one of the most promising and intriguing 
scientific fields. In particular, two major applications of biomaterial science, that is tissue 
engineering and controlled drug delivery, attracted attention and dedication from many 
branches of academic and industrial entities. 
Tissue engineering is aimed at creating partial or complete bioartificial organs by 
exploiting the synergistic interactions of living cells and synthetic materials 
Controlled drug delivery technology also represents one of the most rapidly advancing 
areas of biomaterial science. With respect to conventional dosage forms, delivery systems 
offer several advantages, including improved efficacy, reduced toxicity, better patient 
compliance, and convenience. 
Recently, the combination of drug delivery and tissue engineering techniques has been 
proposed, to afford systems that not only constitute a supportive scaffold for cell 
proliferation, but also guide cell development and organization by progressive and 
controlled release of cell growth and differentiating factors. Aliphatic polyesters are 
generally considered to be well–suited for applications as polymer–based biomaterials 
due to their demonstrated biocompatibility and biodegradability, because of the wide 
range of properties that can be attained by careful modulation of their chemical structure.  
The present work was aimed at the development of bioactive polymeric materials to be 
used for the targeted delivery of proteic drug and for applications in the tissue engineering 
field. The proposed strategy was based on the design of special polymer classes whose 
structures and functionality could be easily modified by finely tuning the adopted 
synthetic procedures. Polymalolactonate and other polyesters containing side chain 
primary hydroxyl groups were chosen as promising materials for the proposed 
applications.  
Initially, polyesters containing pendant primary hydroxyl groups were synthesized by 
polyaddition of oxetanes and carboxylic anhydrides catalyzed by quaternary onium 
halides. The polyaddition of bis(oxetane) with different dicarboxylic acids in the presence 
of the same catalysts was also investigated. In all cases, the oxetane monomers contained 
one hydroxyl functionality either free or protected by a benzyl group. The yield and the 
 molecular weight of soluble polymer are good when aromatic anhydrides were used. In 
all other cases low conversions or no polymerization at all were obtained. 
On the other hand, readily available alcoholic derivatives were successfully employed to 
synthesize a series of ?,?’,?–trisubstituted ?–lactone monomers displaying a wide range 
of physical–chemical derivatives. The preparations were carried out according to 
established synthetic routes, in five steps starting from diethyl oxalpropionate. Final 
yields were related to the preparation method as well as to the nature of the monomer side 
chain, and were comprised in the 53–63% range as based on the precursor alcohol. The 
purity of all synthesized monomers and intermediates were assessed by chromatographic 
techniques whereas their structural features were confirmed by FT–IR and 1H–NMR 
spectroscopy. 
In the presence of catalytic amounts of quaternary ammonium salts, the synthesized 
functional lactones underwent anionic ring opening polymerization leading to the 
corresponding homopolymers and copolymers in fairly good yields. The prepared 
polymeric materials were extensively characterized by spectroscopic techniques, gel 
permeation chromatography, and thermal analysis. Thermogravimetric analysis evidenced 
materials stability up to 190–240 °C, the actual values being fairly dependent on the 
nature of pendant groups in the polymers. Preliminary biological tests performed on thin 
polymer films indicated that the polymer surface did not promote cell adhesion, although 
no significant toxic effect was detected. These data suggest that the synthesized, 
poly(alkyl malolactonate)s are better suited for drug delivery than for tissue engineering 
applications. 
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1. INTRODUCTION 
 
 
 
1.1. POLYMERIC BIOMATERIALS 
1.1.1. Polymeric biomaterials in tissue engineering and drug delivery 
 
Biomaterials are natural or synthetic materials that are applied in biological environments. 
Beside natural materials, such as collagen and cellulose, synthetic polymers are being 
increasingly designed and applied as biomaterials, due to the possibility of attaining a 
wide range of chemical, physical, and mechanical properties by structure modulation. 
They can be designed in order to have active interactions with the biological environment. 
This feature distinguishes biomaterials from inert materials applied in vivo. In the last 
decades, biomaterial science experienced enormous expansion because of its peculiar 
connections with other scientific, medical, and engineering disciplines, including 
molecular and cell biology, human physiology, and materials science. The continuous 
flow of knowledge among these fields, and the constant demand for new supplies and 
solutions is driving biomaterial science to be one of the most promising and intriguing 
scientific fields. In particular, two major applications of biomaterial science, that is tissue 
engineering and controlled drug delivery, attracted attention and dedication from many 
branches of academic and industrial entities. 
Tissue engineering is aimed at creating partial or complete bioartificial organs by 
exploiting the synergistic interactions of living cells and synthetic materials. At present, 
transplantation and reconstructive surgery, the most used therapies to address the loss and 
failure of organs and tissues, remain imperfect solutions. Tissue engineering could afford 
a valid alternative solution. The importance of this emerging discipline can be measured 
also by the market value of biotechnology companies involved in tissue regeneration, 
about 4 billion dollars in the US market only [Langer 1999]. The Food and Drug 
Administration Agency (FDA) currently is making tissue engineering a high priority area 
and it is working to develop explicit policies to deal with bioartificial products. Some 
tissue substitutes (for example skin and cartilage) are now in clinical phases of testing in 
humans or even commercially available [Mooney 1999]. Controlled drug delivery 
technology also represents one of the most rapidly advancing areas of biomaterial 
science. With respect to conventional dosage forms, delivery systems offer several 
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advantages, including improved efficacy, reduced toxicity, better patient compliance, and 
convenience. Synthetic polymers are often used as drug carriers, making nowadays 
feasible treatments that otherwise would not be possible. Although the introduction of the 
first clinical application of controlled release systems occurred less than 25 years ago, the 
sales of advanced drug delivery systems in the United States alone were about 14 billion 
dollars in 1997 [Uhrich 1999]. Recently, the combination of drug delivery and tissue 
engineering techniques has been proposed, to afford systems that not only constitute a 
supportive scaffold for cell proliferation, but also guide cell development and 
organization by progressive and controlled release of cell growth and differentiating 
factors [Saltzman 2002]. This concept, which could promote the formation of highly 
organized and complex tissues, is actually under investigation by the most distinguished 
research groups involved in biomaterial science. 
Nowadays, one of the most pursued tasks is the synthesis of biomimetic architectures, 
that is multifunctional molecules that assemble predictably and can be used to interact 
with specific biological ligands [Tu 2004]. The imitation of natural aggregating systems 
by biomaterials science requires a fundamental understanding of the forces that direct 
assembly, the chemical synthesis of complex building blocks with biological functions, 
and the application of the systems to biologically relevant problems. 
Bottom up design is the election approach for synthetic systems aimed at the emulation of 
cellular interfaces, normally by using self–assembling molecules, where the structure 
contains at least two distinct moieties, a biologically active portion and a fraction that 
directs the assembly. These systems use molecules capable of associating into 
supramolecular structures, which are encoded with an appropriate biologically–specific 
message, by binding with peptides, nucleotides, sugars, etc. Another molecular region 
must be included to direct the molecule assembly into a controlled supramolecular 
structure, such as micelles, vescicles, tubules, etc. These complex structures enhance the 
control over the spatial relationship among biofunctional groups and their local 
concentration, while allowing, for example, for encapsulation and targeting of drugs or 
other biologically relevant molecules. Amphiphilic molecules are capable of self–
assembling in supramolecular structures, which are often very difficult to predict, and 
which depend on physical parameters and chemical principles, such as intermolecular 
forces, thermodynamics of assembly, and surfactant number theory. The involved 
intermolecular forces are chiefly hydrophobic and electrostatic interactions, and hydrogen 
bonding. The assembly of block copolymers is thermodynamically favored by a total free 
energy decrease during the micellization process. Physical and chemical characteristics of 
the polymeric chains (head and tail groups, tail length, etc.) can be used in the surfactant 
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number theory to predict or control the morphology of the aggregate [Israelachvili 1999]. 
Polymer chemistry can provide interesting solutions, such as the synthesis of amphiphilic 
polymeric molecules that can self–assemble and conjugate to biological molecules with 
specific binding character, in analogy to viral architectures available in nature. Different 
strategies can be adopted, for example the synthesis of block copolymers using 
aminoacids (block–co–polypeptide) or the bioconjugation of the water soluble interface 
of block–copolymers with biologically active ligands (sugars, peptides, proteins etc.). 
1.1.2. The biological environment 
 
Many requirements must be satisfied in the design of biomaterials. In particular, 
investigation of the chemical and biological characteristics of the environment in which 
the material is expected to perform its action is of utmost importance. Indeed, this 
knowledge may allow for better understanding which are the main factors that determine 
the final performances of materials, thereby allowing for optimization of their design. 
The insoluble non–cellular material present among cells throughout the body of 
multicellular organisms is known as the extracellular matrix (ECM). This matrix is made 
up of a complex mixture of cell–secreted molecules and can be organized into different 
structures. It plays a major role in cell sustenance and proliferation, in terms of 
mechanical (support for cell anchorage, scaffolding of orderly tissue renewal), and 
chemical–biological control (determination of cell growth, shape, orientation, 
polarization, and differentiation, establishment of tissue microenvironment by 
sequestration, storage, and release of regulatory molecules) [Wolfe1993, Schoen 1996]. 
Although the extracellular matrix provides different functions, the eukaryotic ECM has 
some general features. Indeed, ECM structure generally contains long semi–crystalline 
fibers (hard domain) immersed in a soft flexible network affording resistance to stretch 
and compression. The fourteen types of collagen, a family of glycoproteins differing in 
molecular weight and in tertiary and quaternary structures, constitute the main fibrous 
component of the hard domain. Proteoglycans and exceptionally carbohydrates–rich 
glycoproteins are the main components of the flexible matrix of animal ECM. It is worth 
noting that the composition directly modulates all ECM characteristics, such as viscosity, 
strength, and mechanical resistance, which are finely tailored to the functions of the 
tissue. For instance, it constitutes a stiff and strong medium in bone tissue and a soft, 
transparent support in the cornea. 
ECM contains specific domains for modulating cell adhesion. Cells can be directly 
connected to the ECM backbone by interaction of specific receptors with glycoproteins 
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bound to ECM itself. Fibronectin, vitronectin, and laminin are connection glycoproteins 
that play a major role in the signaling and selective site recognition of cell adhesion. 
Integrins are cell membrane receptors that bind the connection proteins, allowing for the 
effective adhesion to ECM. Recognition of a connection protein by the integrin receptor 
results in non–covalent bonds among many regions of the two molecules. The first 
identified binding site was the RGD (arginine, glycine, aspartic acid) sequence present in 
fibronectin, vitronectin, and in a variety of other adhesion proteins [Massia 2001]. This 
tripeptide sequence is recognized by several integrins and it is among the most important 
structural motifs for cell binding. It is worth noting that integrin–RGD interactions 
critically depend on the secondary and tertiary structure of the protein region, which 
contains the tripeptide binding site [Hass 1994]. This mechanism allows for the 
modulation of ligand affinity by slight changes in the connection protein conformation, 
which in turn arise from environment changes. Because of their transmembrane 
localization, integrins play a major role in determining cell response to external signals by 
controlling and promoting fundamental cell functions, such as spreading, migration, 
growth, proliferation, and death. The study of these complex interactions, in terms of 
receptor analysis and adhesion mechanisms is of primary interest for understanding how 
to bind cellular substrates without damaging cells. 
From a tissue engineering perspective, a detailed analysis of ECM–cell interactions 
represents the starting point of every investigation. In fact, this knowledge is crucial for 
the realization of scaffolds that are proper substrates for cell survival, differentiation, and 
maintenance [Martins–Green 1997]. On the contrary, from a drug delivery point of view, 
the knowledge of the mechanism of cell adhesion afford the fundamental concepts to 
avoid cell adhesion, which could trigger inflammatory reactions and rejection, in order to 
design a long circulating, efficient, and non immunogenic release devices. 
In all cases, it is clear that the material surface has a primary function in determining the 
success of biomaterials, because it is the first one to interact with the body environment. 
1.1.3. Cell interactions with polymer surfaces 
 
In most cases, cell cultures are used to investigate the interactions of cells with polymers. 
Although in vitro experiments only partially reproduce the complex cellular responses 
that occur following material implantation, culture experiments guarantee for a degree of 
control and quantification that can not be obtained in vivo. The general approach involves 
deposition of cultured cells on the polymer surface followed by determination of some 
important biological parameters, mainly cell adhesion and spreading. Indeed, the growth 
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of most tissue cells such as fibroblasts [Saltzman 1997] require attachment to a solid 
surface, and the initial events that occur when a cell approaches a surface are of 
fundamental interest. 
In the perspective of complete tissue regeneration, cell migration and aggregation are two 
further important parameters to assess cell viability and functionality on a polymer 
surface. Many procedures allow for quantitative evaluation of the extent of cell adhesion 
and proliferation, making use of a variety of experimental techniques that measure 
different physical–chemical properties (i.e. radioactivity, fluorescence, enzyme activity) 
[Saltzman 1997]. 
1.1.3.1. Dependence of cell behavior on polymer structure 
So far, no general principle that would allow for the prediction of cell attachment to 
different polymer surfaces has been clearly identified [Saltzman 1997]. However, 
interesting relationships with some surface characteristics were proposed. Although many 
exceptions are reported, [van Wachem 1985, Altankov 1996, Saltzman 1997] cell 
adhesion is apparently maximized on surfaces with intermediate wettability (Fig. 1.1). 
Following this interpretation, some authors introduced the concept of “equilibrium water 
content” (EWC), and showed that cell adhesion is apparently related to this physical–
chemical parameter [Lydon 1985].However, other groups evidenced that cell adhesion 
strongly depends upon individual functional groups, rather than on general surface 
characteristics such as wettability[Saltzman 1997, Webb 2000]. 
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Figure 1.1. Correlation between cell adhesion and surface wettability. 
In almost all cases, cell adhesion was shown to be mediated by proteins [Yamamoto 
2000]. Indeed, cellular adhesion and other correlated functions are mediated in vivo by 
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ECM components. Similarly, in vitro most cells display adhesion, spreading, and growth 
only if the culture medium contains biological serum, consisting of many ingredients that 
are typical of natural ECM. This effect has been explained by considering that cell 
attachment may proceed by a four steps mechanism [Schakenraad 1996]: 
1) In a short time (seconds to minutes) a thin film of protein is adsorbed over the surface; 
2) Cells approach the surface driven by diffusive or active mechanisms. 
3) Cells recognize and adhere to the protein layer. 
4) Cells spread, because of continuing adhesion and cytoplasmic contractile meshwork 
activity. 
Considering the first step in more details, protein adsorption was found to be largely 
irreversible; this behavior is consistent with the hypothesis that each cell is linked to the 
protein surface by multiple bonds. Actually, the adsorption process is very complicated, 
and it has been proposed that it is made of two fast sequential phases [Andrade1986]. 
Initially, the protein reversibly interacts with only a limited number of surface sites. Later 
on, partial conformational changes occur, as a consequence of strong interactions with 
specific surface sites, resulting in a nearly irreversible protein–surface association 
[Horbeet 1996]. This strong adhesion literally blocks the structure and the position of the 
protein, avoiding its diffusion towards the material bulk [Horbeet 1996]. It is therefore 
clear that the process of adsorption depends on multiple factors. However, it was 
suggested that the general driving force is constituted by the entropy gain arising from the 
dehydration of the adsorbent surface and structural rearrangements of the protein 
molecule (hydrophobic effect) [Andrade1986]. Accordingly, surface wettability (or 
EWC) may be an important parameter for protein adsorption and hence for mediated cell 
adhesion, as reported by some authors , [van Wachem 1985, Altankov 1996, Saltzman 
1997]. However, the driving force leading to protein adsorption and hence to cell 
adhesion can be also strongly influenced by other specific factors (e.g.: functional groups 
on the surface). 
A further parameter involved in the protein adsorption process is the time–dependent 
selective enrichment of the surface in some specific moieties, as it was observed starting 
from protein nearly equimolar solution mixtures. Apparently, this form of competition, 
that is protein exchange, is in contrast with the irreversible nature of protein adsorption, 
since it is a typical property of multiple equilibriums. However, two possible explanations 
of this phenomenon were suggested [Andrade1986]: 
a) Adsorption is a kinetic process: proteins that undergo the conformational 
rearrangement faster are likely to be dominant in the surface phase. 
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b) Only small molecules (e.g. water) do not lead to protein desorption, since they cannot 
establish a large bond network with the surface: instead, a second protein may 
displace an already adsorbed one, provided that it can bind to a comparable number of 
surface sites with higher affinity. 
The latter process is likely to be the most effective. Indeed, if differences in protein 
concentrations in the bulk solution and a limited space on the surface phase are taken into 
account, the corresponding kinetic model is in agreement with a hierarchical adsorption 
process (Vroman Effect) [Andrade1986]. In this case, high concentration proteins 
dominate the surface at short times, whereas only the highest affinity proteins are 
adsorbed at long times. 
It is worth noting that, in absence of serum, cell attachment is theoretically linked only to 
solid–liquid interfacial free energy [Schakenraad 1996]. Serum–free culture experiments 
suggested that hydrophilic and charged surfaces promote adhesion [Wachem 1985]. 
Taking into account all these factors, it is clear that the peculiar properties of the surface 
play a major role in the organization of the absorbed protein layer, which specify the final 
cellular response. Therefore, surface analysis and surface engineering are actually two of 
the most interesting and promising fields for the achievement of high efficiency 
biomaterials. 
1.1.3.2. Development of active polymer surfaces 
Interactions of cells with the surrounding environment are based on the biological 
recognition of some molecular structures by specific membrane receptors. Therefore, one 
convenient methodology to improve the biological activity of polymer surfaces is the 
covalent or physical incorporation of adhesion–promoting moieties [Hubbel 1999]. 
Besides enhancing cell adhesion, this approach may be advantageous for achieving 
selectivity in cell cultures [Hubbel 1995]. Some studies involved modification of the 
polymer surface by either physical methods or immobilization of whole ECM 
components, such as collagen [Ikada 1994]. More extensive researches were addressed to 
the introduction of adhesion–promoting oligopeptides onto the biomaterial surface. These 
molecules try to mimic useful features of the ECM, being based on the primary structure 
of the receptor–binding site of proteins such as fibronectin and laminin. In most cases 
these short linear sequences show similar receptor specificity and affinity, as well as 
signaling of cellular response, compared to the whole protein [Hubbel 1999]. In addition, 
nearly all surface–immobilized adhesion peptides are usually available for binding to cell 
membrane receptors, and do not require a specific active conformation as it occurs in vivo 
[Hass 1994, Garcia 1999]. A good example consists in the bioactive adhesion–promoting 
RGD tripeptide from fibronectin. When this sequence was immobilized on a surface, 
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about 105 copies per cell were required to induce cell adhesion, spreading, focal contact 
formation, and cytoskeleton organization. 
Several biomaterial systems were explored and developed for displaying of adhesion 
promoting peptides [Hubbel 1995]. The immobilization problem was generally addressed 
by covalent binding onto the polymer surface [Shakesheff 1998]. So far, the RGD 
sequence is the most investigated adhesion oligopeptide for incorporation in polymers 
[Saltzman 1997]. This tripeptide is nearly ubiquitous in ECM proteins, and studies on the 
effect of soluble RGD in cell cultures indicated that in vitro it is indeed among the most 
involved sequences in cell adhesion [Pierschbacher1984]. Actually, RGD induced cell 
adhesion and spreading on otherwise non–adhesive or weakly adhesive polymers 
[Saltzman 1997]. In addition to cell–binding oligopeptides, a variety of other biologically 
active molecules were used to promote surface cell functions. Some studies showed that 
cell adhesion and growth can be enhanced by covalently bound amine groups [Kikuchi 
1992, Massia 1992]. Examples of polymeric matrices designed in order to carry free 
amino groups were also reported. Advantages can be taken from the free NH2 moiety 
itself or from further functionalization by using the NH2 group as a binding site. 
Saccharides proved useful as well, especially when specific receptors such as the 
asialoglycoprotein receptors of hepatocytes could be involved in cell immobilization and 
viability modulation [Saltzman 1997, Chiellini 2001]. 
1.1.3.3. Development of biomimetic polymer surfaces 
The positive interaction of a biomaterial and the in vivo environment can also mean that 
no recognition of the device as a foreign body occurs, therefore avoiding the ensuing 
inflammatory and rejection processes. This concept, which will be further developed to 
afford the more general definition of biocompatibility (§ 1.2.1) can be now limited to a 
surface point of view. 
In principle, every kind of material can be applied as biomaterial, taking therefore 
advantages from its bulk properties, if its surface characteristics do not let it to be 
identified as non–autologous moiety (stealth surface). This concept is particularly 
important when only special classes of synthetic materials possess the needed properties 
that can afford highly specific performances. Drug delivery systems represent an 
interesting example of this concept, and the present discussion will be limited to these 
systems. 
The presence of stealth surface can guarantee a better performance of release devices 
(micro and nanospheres), especially in parenteral drug delivery systems [Gref 1995]. 
Indeed, there has been an increasing interest in the development of stealth nanoparticles 
as long circulating drug carrier systems [Gref 1994]. The main method to obtain stealth 
INTRODUCTION 
 9
nanoparticles consists in the exposition of hydrophilic, flexible, and non ionic 
poly(ethylene glycol) (PEG) surface that acts as a protecting shield. Due to the high 
hydrophilicity of the materials, once applied in a biological environment, the PEG surface 
is immediately covered by a thin water film, which hides the particle itself. Actually, it is 
supposed that it appears like a giant water drop, therefore eluding the host immune 
system (antiopsonizing effect). 
Two main techniques are usually applied to obtain a PEG exposing surface. In the first 
method, already formed and drug–loaded particles are enveloped by a polymeric PEG 
cover. The second technique consists in the development of PEG–containing synthetic 
materials that under particular conditions are self–assembled to afford organized 
structures. Even if some examples of the post–coating method were reported [Hawley 
1995], the second approach is the most used, because of the intrinsic difficulty of bonding 
a PEG cover on the particle surface without altering its structure. The self–assembly 
capacity is based on the formation of particular structures by suitably designed materials, 
because of thermodynamically favorable interactions [Thomasin 1998a]. Usually, 
amphiphilic block copolymers are used. The hydrophilic domains of these materials are 
constituted by PEG segments, whereas the hydrophobic part is endowed of the desired 
bulk properties [Peracchia 1997, Yo 1999]. Once in contact with strongly dipolar 
solvents, the material undergoes structural self–assembly to expose hydrophilic domains 
to the polar environment, while the hydrophobic block is confined in the particle core 
[Thomasin 1998b]. 
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1.2. BIODEGRADABLE POLYMERIC MATERIALS FOR BIOMEDICAL APPLICATIONS 
1.2.1. Biocompatibility and hemocompatibility 
 
The fundamental characteristic of biomaterials is their capability of interacting with 
organic tissues and biological fluids without triggering secondary alterations or damaging 
processes of the living organism where they are placed. More stringently, when 
biomaterials are in contact with body tissues, they must not cause toxic, inflammatory, or 
tumoral responses (biocompatibility) and their interactions with blood must not elicit 
coagulative or cell–disruptive activities (hemocompatibility). Very often, structural 
modification of the biomaterial within the living organism is an essential feature for its 
medical use. For example, biodegradability is required whenever the body is not able to 
eliminate naturally the polymer matrix after its function expired. Furthermore, 
biodegradable materials are very useful whenever complex surgical removal of the 
implanted medical device is needed at the end of its action. Indeed, biodegradable 
polymers are currently employed in the biomedical and pharmaceutical fields to realize 
prostheses, resorbable sutures, and drug delivery devices [Kimura 1993]. 
Most of the polymers used in biomedical applications are chemically degraded by 
hydrolysis or oxidation [Acemoglu 2004]. Chemical biodegradation is affected by the 
chemical structure, which is responsible for functional group stability, reactivity, 
hydrophilicity, and swelling behavior. Physical and mechanical properties also affect the 
degradation process. Degradation by hydrolysis is a fast process, often accompanied by a 
substantial decrease of pH; its rate can be tuned by choosing the appropriate molecular 
weight and the suitable combination of monomeric units. Oxidation is a slower process, 
due to the consumption of stoichiometric amounts of oxidizing agents, which interests 
mainly soft segments and positions alpha to oxygen atoms. Regardless of the chemical 
mechanism, biodegradation is characterized by two surface–related phenomena, that is 
bulk and surface erosion. In bulk erosion, degradation proceeds throughout the polymer 
matrix with an immediate drop of molecular weight, while mass loss occurs more slowly. 
On the contrary, surface erosion is characterized by a fast mass loss while the molecular 
weight of the residual mass remains almost constant until complete degradation. A 
specific degradation process fits better with a specific application (drug delivery systems, 
scaffolds, etc.) 
The overall elimination process of biodegradable matrices is made of two steps, 
degradation and adsorption [Kimura 1993]. Degradation is promoted by hydrolytic or 
enzymatic scission of linkages along the macromolecular backbone. This process always 
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leads to a decrease of the polymer molecular weight accompanied by the contemporary 
formation of low molecular weight products. However, biodegradation occurs only by 
enzymatic catalytic activity; the simple physical degradative action of biological fluids on 
the material is called bioerosion. Adsorption of the degradation products involves the 
metabolic pathways of cells. Care has to be taken to avoid negative interactions of the 
degradation molecules with tissues and the immune system. 
Biodegradability and bioerodibility are a consequence of the chemical architecture of the 
polymer chains and their interactions with a biological environment. There are some 
well–established relations between macromolecular structure and biodegradability [Swift 
1993], which may be summarized in the following general statements: 
– Natural polymers are biodegradable. 
– The biodegradability of chemically modified natural polymers depends upon their 
modification degree. 
– Polymers containing only carbon atoms in the main chain and having molecular 
weight over 500 Daltons are not biodegradable. 
– The biodegradability of polymers with etheroatoms in the main chain depends upon 
the nature of functional group (ester > ether > amide > carbamide), molecular weight, 
morphology (amorphous > semicrystalline), and hydrophilicity. 
– Water solubility alone does not impart biodegradability. 
– Biodegradable polymers have some homology with natural polymers. 
The last statement indicates that the attack of macromolecular compounds by natural 
enzymes occurs with high, but not complete selectivity. Therefore, chemical research on 
biodegradable polymers is involved in developing synthetic or partially–synthetic 
materials that mimic natural structures. 
1.2.2. Bioerodible and biodegradable biomaterials 
 
Degradable polymers are classified in bioerodible and biodegradable, according to their 
degradation characteristics. A bioerodible polymer is defined as a water–insoluble 
material which is converted, under physiological conditions, into a water–soluble 
material, regardless of the specific erosion process (physical or chemical) [Heller, 1987; 
SaintPierre, 1987; Chiellini, 1996 a,b]. Instead, a biodegradable polymer is defined as a 
material which may undergo a degradation pathway by the direct action of a biological 
agent, as an enzyme or a microorganism [Kohn, 1996b]. The final step of both bioerosion 
and biodegradation is always bioabsorption or biomineralization, meaning that the 
polymer degradation products are removed by cellular activity in biological environment. 
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Clearly, short–term medical applications requiring only a temporary presence of 
polymeric materials take advantage from the use of degradable and bioresorbable 
polymers. One good example is provided by implanted degradable polymers, which do 
not need to be removed at the end of their function, as required by conventional non–
degradable materials. Indeed, in the last few years degradable polymers allowed for the 
successful biomedical utilization of a number of polymeric devices, such as sutures, drug 
delivery systems, temporary vascular grafts and stents [Kohn, 1996b; Chiellini, 2001a,b]. 
From a tissue engineering perspective, bioerodible/biodegradable materials seem well–
suited for the production of systems promoting tissue regeneration, especially as synthetic 
components of scaffolds which have to be replaced by excreted autologous ECM as cell 
proliferation occurs [Pachence, 1997; Langer, 1999a]. 
As every polymer used for biomedical applications, degradable biomaterials must possess 
adequate mechanical properties as well as manufacturing feasibility, including 
commercial availability at a convenient cost and the capability to be molded into the final 
product design. In addition, degradable materials must fulfill more stringent requirements 
in terms of their biocompatibility than non–degradable materials, since the potential 
toxicity of the degradation products and subsequent metabolites has to be carefully 
considered. The practical consequence of this consideration is that only a limited number 
of synthetic, degradable polymers has been so far approved by the FDA and other 
pharmaceutical authorities for use in clinical studies involving humans [Kohn, 1996b]. 
Nonetheless, materials research has led to the development of some polymeric structures 
that may find practical biomedical applications in the next future. Representative example 
of the most interesting polymers, out of the dozens suggested as degradable biomaterials, 
are discussed in the following. 
1.2.3. Polyhydroxyacids 
 
Most degradable polymers for biomedical use, including some promising systems for 
tissue engineering, are synthesized from naturally occurring hydroxyacids, such as 
glyceric, glycolic, lactic, and ?–caproic acid [Cima 1991;Vert, 1992; Chiellini, 1993, 
1995; Freed, 1994; Harris, 1998; Ulrich, 1999]. The synthetic pathway for the production 
of polyhydroxyacids usually involves ring–opening polymerization (ROP) of a cyclic 
lactone monomer by means of an efficient metal–complex initiator (Scheme 1.1). If the 
polymer is tailored for in vivo application, stannous octoate is generally used since it has 
FDA approval as food stabilizer [Ulrich, 1999]. 
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Under physiological conditions, the ester bonds of polyhydroxyacids are cleaved by an 
hydrolytic mechanism. Actually, bioerosion occurs until the molecular weight is less than 
5 kDa, then cellular biodegradation takes over. The degradation rate is determined mainly 
by the starting molecular weight, exposed surface area, crystallinity, and, in the case of 
copolymers, chemical composition. Bioabsorption of the final degradation products may 
involve inflammatory cells, such as macrophages, lymphocytes, and neutrophiles. 
Although polyhydroxyacids have a limited range of mechanical properties, they can be 
formed into different shapes by standard processing techniques, and the production of 
suitable structures for many different applications is well documented [Langer,1995; 
Harris, 1998; Ulrich, 1999]. 
Scheme 1.1. Ring opening polymerization of cyclic monomers. 
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1.2.3.1. Poly(glycolic acid), poly(lactic acid), and copolymers of glycolic acid and 
lactic acid 
Poly(glycolic acid) (PGA), poly(lactic acid) (PLA) and glycolic acid/lactic acid 
copolymers (PLGA) are currently the most widely investigated and medically employed 
synthetic bioerodible polymers [Kohn, 1996b; Pachence, 2000]. These polyesters differ 
considerably in their physical, chemical, and mechanical properties, because of their 
different chemical structures (Table 1.1). PGA is the simplest aliphatic polyester and it is 
characterized by extensive semi–crystallinity in the solid state and high melting point; its 
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solubility in organic solvent is quite low. PGA was early recognized as good material for 
biomedical applications and PGA sutures (Dexon™) have been commercially available 
since 1970. However, PGA polymers quickly loose their mechanical strength when tested 
in vivo, because their high hydrophilicity favors a fast bioerosion process. 
In order to extend the possible applications of PGA while avoiding some of its 
drawbacks, several investigations focused on the development of PLA homopolymers and 
copolymers with PGA. Indeed, the presence of methyl side chains makes PLA more 
hydrophobic and more resistant to hydrolysis than PGA [Reed, 1981]. In addition, the 
asymmetric ?–carbon present in the lactic acid molecule allows for the modulation of 
PLA physical–chemical characteristics. Polymerization of racemic monomer mixtures 
affords atactic stereocopolymers (D,L–PLA) that display loss of crystallinity, improved 
solubility in organic solvents, and lowered stiffness as compared with isotactic 
semicrystalline polymers (L–PLA and D–PLA) generated from the enantiomerically pure 
monomer. Intermediate characteristics are obtained by suitable selection of the optical 
purity of the monomer mixture. Crystallinity is also very important for practical 
application. Amorphous D,L–PLA is usually considered when a homogeneous matrix is 
required, as in the case of drug delivery systems [Ulrich, 1999]. On the other hand, 
isotactic PLA is preferred for biological applications where high mechanical strength and 
toughness are necessary, such as sutures and orthopedic devices [Pachence,2000 ]. 
Generally, L–PLA is more frequently employed than D–PLA, since hydrolysis of L–PLA 
yields L–lactic acid, a natural metabolite. 
 
 
Table 1.1. Properties of PLA homopolymers in dependence of the stereochemical 
structure.a
 
 Polymer MW Tg Tm Tensile Tensile  Elongation 
     strength modulus Yield Break 
  (kDa) (°C) (°C) (MPa) (MPa) (%) (%) 
 PGA 50 35 210 n.r. n.r. n.r. n.r. 
 L–PLA 50 54 170 28 1200 3.7 6.0 
 L–PLA 100 58 159 50 2700 2.6 3.3 
 L–PLA 300 59 178 48 3000 1.8 2.0 
 D,L–PLA 107 51 – 29 1900 4.0 6.0 
 D,L–PLA 107 53 – 35 2400 3.5 5.0 
a Data from Kohn (1996), n.r. = not reported. 
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Lactic acid/glycolic acid copolymers have become the most used materials for biomedical 
applications, especially drug delivery devices. Apparently, there is no linear relationship 
between the chemical composition of PLGA and the corresponding physical–chemical 
features. Copolymers display low or no crystallinity and a noteworthy increase of the 
hydrolysis rate [Vert, 1994]. Due to polyester degradation, the increased local acidity can 
lead in a low percentage of cases to severe noninfectious inflammatory responses and 
consequent surgery intervention [Bostman, 1991]. Blending of basic salts was 
investigated as a technique to control the pH in the local environment of PLGA implants 
[Agrawal, 1997]. 
1.2.3.2. Poly(?–caprolactone) 
Biomedical utilization of poly(?–caprolactone) (PCL) became a real possibility after its 
appearance on the commercial market as a potentially degradable packaging material. It 
was later demonstrated that PCL can be degraded under physiological conditions by the 
same hydrolytic mechanism as other hydroxyl acids [Woodward, 1985]. Compared with 
PGA or PLA, bioerosion of PCL is significantly slower. PCL is currently regarded as a 
non–toxic, tissue–compatible material [Pitt, 1990]. The fairly long aliphatic backbone 
imparts to PCL some properties unknown among the other aliphatic polyesters, such as 
very low glass transition (Tg ? –60 °C), moderate melting temperature (Tm ? 60 °C), high 
solubility in organic solvent, noteworthy thermal stability (up to 350 °C), and capability 
to form monophasic blends with a wide range of other polymers [Pachence, 1997]. The 
high permeability of PCL matrices, which are always in the rubbery state at physiological 
temperature, has been exploited for the production of effective drug delivery systems 
[Pitt, 1990]. 
1.2.3.3. Poly(3–hydroxyalkanoate)s 
Poly(3–hydroxyalkanoate)s (PHAs) are bioerodible polymers that can be obtained by 
microbial synthesis [Miller,1987]. Poly(3–hydroxybutyrate) (PHB), poly(3–
hydroxyvalerate) (PHV), and copolymers of 3–hydroxybutyric acid with 3–
hydroxyvaleric acid (PHBV) are the most common PHAs (Scheme 1.2). 
PHB is a highly hydrophobic, crystalline, and brittle material with degradation times in 
the order of years under physiological conditions [Miller,1987]. The final degradation 
product of PHB is (R)–3–hydroxybutyric acid, a normal constituent of human blood, 
which is readily metabolized. To obtain more flexible and degradable materials, different 
PHBV copolymers were synthesized, and some of them are now commercially available 
under the trade name Biopol™. Biomedical applications of these materials are currently 
under investigation [Pachence,2000].  
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Scheme 1.2. Microbial synthesis of poly(hydroxyalkanoate)s 
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1.2.4. Polyorthoesters 
 
Polyorthoesters are a family of synthetic bioerodible polymers whose peculiar 
characteristics have been investigated for several years. Devices made of polyorthoesters 
can be formulated in such a way that the polymeric matrix undergoes surface erosion 
without crumbling into pieces. This property was exploited to realize drug delivery 
formulates with strictly zero–order release kinetics [Heller,1990; Roskos, 1995]. 
Research on polyorthoesters focused on the synthesis of polymers by addition of polyols 
to diketene acetals. The main examples are polymers obtained by addition of 3,9–
diethylidene–2,4,8,10–tetraoxaspiro[5,5]undecane (DETOSU) to a diol [Heller,1980]. 
These materials contain acid–labile orthoester bonds that are readily hydrolyzed in 
aqueous environment to form pentaerythritol dipropionate and diols as breakdown 
products (Scheme 1.3). Pentaerythritol dipropionate is further hydrolyzed to 
pentaerythritol and propionic acid. 
Acid–catalyzed hydrolysis of these polymers can be controlled by blending with either 
acidic or basic additives. For example, bioerosion can be limited to the surface by using 
basic additives, which in bulk stabilize the matrix, whereas they diffuse out of the surface 
region. Recently, new polyorthoester structures were designed to avoid the need of 
additives and to achieve a better control over the release rate [Ng,1997]. The possibility 
of controlling the mechanical properties by changing the diol nature and monomer ratios 
is a useful feature of DETOSU systems [Heller,1990]. Indeed, the glass transition 
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temperature of polymers consisting of stiff cyclic diol units and of flexible aliphatic units 
can be varied between 20 and 100 °C by increasing the proportion of the rigid diol. 
Crosslinked materials having different characteristics were obtained by adjusting the 
diol/triol ratio in the reacting mixtures [Heller,1992]. Processability tests were carried out 
on some polyorthoesters [Pachence,1997]. 
Scheme 1.3. Synthesis and hydrolysis mechanism of polyorthoesters 
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1.2.5. Polyanhydrides and their modifications 
 
Polyanhydrides are among the most reactive and hydrolitically unstable polymers 
currently used as biomaterials. Their high degradation rate is an advantage for many 
applications, such as drug delivery [Mathiowitz,1997]. In fact, hydrophobic 
polyanhydrides are believed to undergo predominantly surface erosion, due to the high 
water lability of anhydride bonds on the surface and the bulk hydrophobicity, which 
prevents water penetration. As for polyorthoesters, this phenomenon allows for the 
maintenance of the matrix structural integrity and nearly zero–order degradation kinetics. 
Polyanhydrides are mostly prepared by melt condensation polymerization. In the first 
step, mixed anhydride prepolymers are formed from dicarboxylic acids and acetic 
anhydride. Then, the final polymer is obtained by heating the prepolymer under vacuum. 
The most widely investigated polyanhydrides are based on sebacic acid (PSA), 1,3–di(p–
carboxyphenoxy)propane (PCPP), and 1,6–di(p–carboxyphenoxy)hexane (PCPH) 
(Scheme 1.4) [Ulrich,1999]. Variation of polymer composition and hydrophobicity allows 
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for the modulation of the degradation rate [Leong,1985]. Generally, aliphatic–aromatic 
copolyanhydrides are of practical value, since they display intermediate degradation rates. 
Scheme 1.4. Typical structures of polyanhydrides. 
O
O
O
O
O
O O
O
n
x
n
PSA x = 3, PCPP
x = 6, PCPH  
The in vivo biocompatibility of polyanhydrides is well established [Laurencin,1990]. 
Indeed, PSA–PCPP copolymers have been already approved by FDA for phase III 
clinical trials, as a part of toxicity evaluation studies of drug delivery devices for the 
intracranial release of an antitumor agent [Brem,1995]. Some modifications of the 
macromolecular structure of polyanhydrides were attempted to improve their mechanical 
or degradation properties. For instance, amino acids were incorporated into the backbone, 
thus generating polymers with increased mechanical resistance without losing the typical 
surface bioerosion feature. Dicarboxyl monomers carrying pendant polyester groups were 
also polymerized to afford polymers showing two–steps degradation profiles. 
1.2.6. Poly(?–aminoacid)s and “pseudo” poly(?–aminoacid)s 
 
Since proteins are composed of ?–aminoacids, it was an obvious idea to explore the 
possible use of poly(?–aminoacid)s in biomedical applications [Anderson,1985]. Poly(?–
aminoacid)s have several advantages as biomaterials. For example, their side chains may 
contain reactive functional groups that can be exploited for the physical–chemical 
modification of the polymer or for the attachment of other agents, such as drugs 
[Kohn,1984]. In addition, backbone degradation of these polymers is accompanied by the 
release of naturally occurring ?–aminoacids that show very low systemic toxicity. 
Poly(?–aminoacid)s are usually prepared by ring opening polymerization of the 
corresponding N–carboxyanhydrides, which in turn can be obtained by reaction of ?–
aminoacids with phosgene (Scheme 1.5). However, N–carboxyanhydrides are rather 
expensive and difficult to handle for their high reactivity and moisture sensitivity. 
Other severe drawbacks limit the number of practical applications of poly(?–aminoacid)s. 
For instance, adequate modulation of chain degradation cannot be achieved by adjusting 
the polymer chemical structure, since the amide bond is hydrolitically stable under 
physiological conditions. Amide hydrolysis must rely upon enzyme action for bond 
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cleavage.64 In addition, antigenicity of polymers containing three or more ?–aminoacids 
rules out the biomedical use of macromolecules with variable internal composition.63 So 
far, only homopolymers, predominantly of glutamic and aspartic acids, were tested as 
possible biodegradable materials for use in vivo [Pachence, 1997; Ulrich,1999].  
Scheme 1.5. Synthesis of poly(?–aminoacid)s. 
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A general approach to circumvent the problems associated with conventional poly(?–
aminoacid)s is to replace some peptide bonds in the polymer backbone with more labile 
linkages, such as ester, iminocarbonate, urethane, and carbonate bonds. The resulting 
polymers are named “pseudo” poly(?–aminoacid)s. Polycarbonates and poly(imino-
carbonate)s, derived from the polymerization of desaminotyrosyl tyrosine alkyl esters 
(DHT), are the most investigated “pseudo” poly(?–aminoacid)s (Scheme 1.6) [Li, 1990; 
Ertel,1994]. Pseudo poly(?–amino acid)s show improved physical–mechanical properties 
and degradation rate dependent upon the nature of the introduced hydrolysable bond 
[Ertel,1994]. Other tests evidenced the high biocompatibility of these materials 
[Silver,1992]. 
Scheme 1.6. Chemical structure of common “pseudo” poly(?–aminoacid)s. 
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1.2.7. Polyphosphazenes 
 
Polyphosphazenes are inorganic polymers of particular interest for biomedical 
applications because of their unique inorganic phosphorous–nitrogen backbone and 
remarkable synthetic versatility [Allcock,1990; Scopelianos,1994]. 
Biomedical polyphosphazenes are generally synthesized by molecular substitution of 
polydichlorophosphazene with biocompatible alcohols, amines, and ?–aminoacids 
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(Scheme 1.7) [Allcock,1990; Scopelianos,1994]. These materials degrade hydrolytically 
to nontoxic products such as phosphate and ammonia, with the contemporary release of 
the side group. Differently from the previously described biomaterials, the properties and 
degradation kinetics of poly(phosphazene)s can be modulated by changing the side–chain 
structure rather than the polymer backbone [Allcock,1990]. 
Scheme 1.7. Chemical structure of common poly(phosphazene)s 
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1.3. PHARMACOLOGICAL APPLICATIONS 
 
Controlled release represents an invaluable scientific and practical tool for improving 
performance and safety of drugs. This technology entails designing the material/drug/site 
of action system in such a way that barriers surrounding the drug act with efficacy and 
drug safety at the optimum time and the needed rate. Advances in polymer science have 
led to the development of several novel drug delivery systems. A proper consideration of 
surface and bulk properties can aid in designing polymeric systems for various drug 
delivery applications [Kost,1994]. 
Prosthetics or biomedical devices are objects, which serve as body replacement parts for 
humans and other animals or as tools for implantation of such parts. Implanted 
biomedical devices are surgically inserted into the living body by a physician. Such 
implants are intended to function in the body for some time in order to perform a specific 
task. Medical devices may replace a damaged part of anatomy; simulate a missing part; 
correct a deformity; aid in tissue healing; rectify the mode of operation of a diseased 
organ; or aid in diagnosis [Szycher 2004]. 
Prosthetics and biomedical devices are composed of biocompatible materials, or 
biomaterials. In the early 1930s the only biomaterials were wood, glass, and metals. 
These were used mostly in surgical instruments, paracorporeal devices, and disposable 
products. The advent of synthetic polymers and biocompatible metals in the latter part of 
the twentieth century has changed the entire character of health care delivery. Polymers, 
metals, and ceramics originally designed for commodity applications have been adapted 
for prostheses, opening the way for implantable pacemakers, vascular grafts, 
diagnostic/therapeutic catheters, and a variety of other orthopedic devices. The term 
prosthesis encompasses both external and internal devices. This chapter concentrates on 
implantable prostheses. 
1.3.1. Drug delivery technology 
 
Controlled drug release devices have the overall goal to maintain the drug level in the 
therapeutic range (zero–order release kinetics) and to target delivery to specific tissues, 
thus lowering systemic exposure and side effects. 
Drug delivery technology mainly concerns the preparation of pharmaceutical multi–
component formulates in order to maximize the therapeutic efficacy of drugs. Indeed, 
conventional administration of drugs is often characterized by a pulsed regime and 
extended body distribution, which in turn may elicit negative effects at systemic level. 
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This problem became more severe with the introduction of protein and peptide drugs 
from recombinant DNA, whose extremely high biological activity is seldom restricted to 
a specific region of the human organism. Drug delivery systems offer many advantages 
over conventional dosage forms, including improved activity, high patient compliance 
and convenience, and reduced toxicity. Hence, drug delivery systems can have an 
incredible impact on nearly every branch of modern medicine. In 1997, the drug delivery 
market reached over 13 billions US$ in the United States alone [Langer 1998]. 
Four general characteristics of drug delivery systems can be identified: 
1) Ability to incorporate the drug without damaging it. 
2) Tunable release kinetics. 
3) Long in vivo stability. 
4) Capability of targeting specific organs or tissues. 
Although all of them are related to the nature of the materials that constitute the delivery 
system, it is convenient to attribute the first two and the last two to bulk and surface 
properties of the formulation, respectively. Therefore, the success of a drug delivery 
system relies upon the possibility of properly engineering both the bulk and the surface 
properties of the materials to be used, which represent a demanding issue. Often, 
compromises must be accepted, as in the case of liposomes that are still the most widely 
applied carriers for drug delivery. Indeed, liposomes allow for high drug loading and 
tunable release patterns, but they display several disadvantages when in vivo stability and 
targeting are considered, on account of their difficult surface functionalization. Polymeric 
materials, whose physical–chemical characteristics are highly tunable, and which are now 
available in forms ready for further processing or functionalization (functional polymers), 
very likely represent the best suited class of materials for drug delivery applications. 
Accordingly, in the last 25 years the studies on polymeric carriers of drugs became 
prominent. First generation drug delivery devices were based on drug incapsulation in a 
non–degradable polymer matrix, from which the drug could diffuse. The release kinetics 
was, therefore, completely dependent on the diffusive behavior of the drug through the 
matrix [Langer 1998]. In second generation systems, the polymer plays an active role; it 
permits a selective release of the incorporated drug at a specific site (drug targeting). 
Moreover, thanks to in vivo biodegradability, the release kinetic profile can be precisely 
modulated [Uhrich 1999]. The first category of release systems consists in simple 
devices, but it cannot be applied to particular cases, like for example protein delivery. On 
the other hand, the second generation systems are characterized by high selectivity and 
efficacy, but it needs a careful control of the macromolecular structure of the matrix. A 
brief overview of the most applied delivery systems is reported by following. 
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1.3.1.1. Diffusion controlled delivery systems 
Diffusion controlled release systems are generally non degradable and made up of 
polymer materials [Langer 1981, Uhrich 1999], such as: ethylene–vinyl acetate 
copolymers, ethylene–vinyl alcohol copolymers, polymers of 2–hydroxyethyl 
methacrylate (HEMA) and, generally, polymethacrylates. In these systems, the drug 
diffuses through the polymer matrix or membrane because of a thermodynamic driving 
force, due to the different concentration of the drug inside and outside the device. Two 
different classes of release devices can be identified, that is monolithic systems (or matrix 
systems) and membrane devices (or reservoir systems). 
1.3.1.1.1. Monolithic systems 
The matrix consists of hydrophobic or viscous hydrophilic polymer in which the solid 
drug is dispersed (Fig. 1.2). Generally, the drug is sparingly soluble in the polymer 
matrix. These release devices are cheap and readily available, since they are obtained 
simply by mixing the polymer matrix and the drug. Device shape is later obtained by 
extrusion. The release mechanism is based on the drug diffusion through the matrix, to 
reach the device surface and then be released. This process takes place until the higher 
concentration of the drug in the core of the systems affords a constant flux of drug 
molecules. In this dissolution–diffusion process, the interface between the drug reservoir 
and the release moiety progressively moves towards the core of the device. 
time = 0 time = t
Drug 
dispersed 
in the 
matrix
Drug 
released from 
the matrix
 
Figure 1.2. Schematic representation of monolythic systems. 
It is worth noting that in these systems the release rate decreases with the square root of 
time. Therefore, the release kinetics is not properly zero–order, even if a decrease in the 
release rate at long times is satisfying for most the applications. 
1.3.1.1.2. Membrane systems 
These devices are not as simple as matrix systems, but they offer a better control of the 
release characteristics. In membrane systems the drug is surrounded by a polymer film 
(Fig. 1.3), whose porosity is not homogeneous, and which determines the drug release 
rate [Theeuwes 1991] 
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Figure 1.3. Schematic representation of membrane systems. 
The drug may be a dry powder, dispersed in a liquid or entrapped in a solid polymer 
matrix. The membrane can be a polymer film made up of one component or a mixture of 
polymers, a micro or macro porous film, or a heterogeneous matrix in which hydrophilic 
polymer particles are dispersed in a hydrophobic polymer matrix. The membrane and the 
active core can be assembled using different technologies: drug and solid membrane 
lamination into films; drug covering with a volatile solution of the polymer; drug 
microencapsulation; tubular membrane loading with the dissolved or dispersed drug; drug 
loading in membrane capsules. In these systems, the dependency of the diffusion 
coefficient through the membrane on the position is exploited to make up for the decrease 
of the release rate due to the lower concentration gradient. The obtained release profile is 
therefore close to that of zero–order kinetics. 
1.3.1.2. Degradable delivery systems 
In delivery systems based on degradation, the drug is loaded in a bioerodible or 
biodegradable polymer matrix. The release takes place because of a combination of 
factors, such as matrix degradation and drug diffusion [Heller, 1978, Couvreur, 1993]. As 
in the case of non–degradable systems, the drug can be encapsulated in a polymer 
membrane (membrane systems) or dispersed in the polymer matrix (monolithic systems). 
In ideal systems, the degradations occurs only at the surface of the device, affording a 
progressive delivery of the drug (Fig. 1.4). 
time = 0 time = t
Drug 
dispersed 
in the  
polymer 
matrix
Released 
drug
 
Figure 1.4. Schematic representation of degradable delivery systems. 
However, swelling phenomena and/or internal degradation usually take place, thus 
making the kinetics more complex. An almost constant release profile can be achieved 
over long periods by fine modulation of the geometric, chemical, degradation, and 
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porosity characteristics of the device. Moreover, this kind of release system can be 
formulated in different shapes, i. e. cylinders, sticks, microcapsules, microspheres, films, 
fibers, and needles. 
It is convenient to classify biodegradable release systems according to the mechanism 
responsible for matrix degradation and hence of drug delivery. Three main types of 
polymer matrix can be identified. 
1) Bioerodible crosslinked matrix. In this case water–soluble polymers are crosslinked to 
give non soluble networks. By hydrolytic or enzymatic cleavage of crosslinks, soluble 
macromolecules are formed, and the release of the incorporated drug is achieved. 
2) Water insoluble matrix. Water solubility and hence drug release is achieved by 
ionization, hydrolysis, or protonation of the polymer side chains. 
3) Bioerodible/biodegradable matrix. Hydrolytic cleavage of main chain bonds of water 
insoluble polymers affords medium–low molecular weight, water–soluble fragments. 
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1.4 TISSUE ENGINEERING 
1.4.1. Introduction to tissue engineering  
 
The loss or failure of an organ or tissue is one of the most frequent, serious, and costly 
problems in human health care. Transplantation and reconstructive surgery, the currently 
most used therapies to address it, contributed to save and improve countless lives. Still, 
they remain imperfect solutions. For instance, transplantation is critically limited by 
donor shortage, which is increasing every year (Fig. 1.5), and by the need of immuno–
suppressants to avoid wear or rejection of the implants. 
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Figure 1.5. Comparison between organ demand and availability in Italy from 1994 to 
1999 (source: AIDO, Italy). 
In addition, moderate expectations have been set on transplantation of purely artificial 
devices, which are not able to perform all functions of a real organ and that may represent 
only a temporary solution. Even limited surgical reconstruction may result in long–term 
problems such as cancer insurgence. Such drawbacks have led to the development of a 
new type of research, called tissue engineering, which attempts to create partial or 
complete bioartificial organs by exploiting the synergistic interactions of living cells and 
synthetic materials. Tissue engineering is an interdisciplinary approach, since it is meant 
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to apply different knowledge for restoring, maintaining or improving tissue functions 
[Langer, 1993; Kohn, 1996a; Vacanti, 1997]. Indeed, the noteworthy results in molecular 
biology, human physiology, and materials science in the last few years make tissue 
regeneration and replacement a real possibility. The importance of this emerging 
discipline can be measured also by the market value of biotechnology companies 
involved in tissue regeneration, that is about 4 billion dollars in the US market only 
[Langer, 1999a]. The Food and Drug Administration Agency (FDA) is currently making 
tissue engineering a priority area and it is working to develop clear–cut policies to deal 
with bioartificial products. Some tissue substitutes are now in the first clinical phases of 
experiment in humans or even commercially available [Mooney, 1999; Naughton, 1999; 
Parenteau, 1999]. 
However, inducing tissue regeneration is not an easy task. Many different parameters 
must be taken into account, mainly the functional specialization of the organ or tissue to 
be replaced. Indeed, the success of tissue engineering rests on the ability to direct specific 
cell types to multiply, migrate, and express normal physiological behaviors, in order to 
yield a cellular organization that performs the functions of the selected tissue. To 
accomplish this ambitious goal, tissue–engineering scientists focused on two general 
strategies, namely: 
1) placement of cells within or onto matrices, which can be obtained from natural 
materials and synthetic polymers, or blends of the two different components;  
2) use of tissue–inducing substances, such as growth factors, specifically delivered to 
their targets either in vitro or in vivo. 
These two approaches are complementary, and the success of future tissue engineering 
applications is likely to be dependent on the developing of fully integrated techniques 
[Caplan, 2000]. 
1.4.2. Polymer scaffolds to guide tissue formation 
 
Most tissues undergo constant remodeling due to attrition and renewal of constituent 
cells. Indeed, partial tissue regeneration is genomically programmed as a function of the 
developmental stage and the age of the organism [Caplan, 2000]. Biological studies about 
this intrinsic ability of the cell toward organization and morphogenesis evidenced two 
important characteristics: 
❍ isolated cells tend to reform appropriate tissue structure in vitro if the external 
conditions are favorable; for example, capillary cells form tubular structures when 
cultured in vitro on an appropriate substrate [Folkman, 1980]; 
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❍ although isolated cells have the capacity to form tissue structures in vitro, they do so 
only to a limited degree when transplanted as a suspension into mature tissues in 
vivo. In fact, such cells cannot rely upon any intrinsic organization and do not have 
any template to guide their restructuring. 
These observations led to the development of a new cell transplantation strategy, which 
can be defined neomorphogenesis [Langer, 1995, 1999a,b; Hubbell, 1995a]. In this 
approach, isolated cells are cultured onto a polymeric three–dimensional structure that 
should provide a suitable template to guide cell reorganization and growth. Once 
implanted, the polymer scaffold would maintain the cells alive by allowing plasma 
diffusion and vascularisation of the matrix (Fig. 1.6). 
 
Figure 1.6. Neomorphogenetic approach to tissue engineering [Langer, 1993]. 
This strategy extends the usual procedure entailing the multiplication of isolated cells in 
culture, and appears extremely promising for its versatility. In fact, once the 
developmental rules for a given organ are fully known, it might be theoretically formed 
from a small sample of starter cells and a suitable geometry of the matrix where they are 
cultured. Vascularisation could be a natural host response to the implant or could be 
artificially induced by release of angiogenic factors (see § 1.3.3). In the first case, the 
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polymer scaffold is also seeded with endothelial cells, whose proliferation in vivo affords 
new vessels able to grow outward the matrix and merge with already existing blood 
vessels (Fig. 1.7a). In the latter case, the growth of vessels from surrounding tissues 
inward the scaffold is promoted by the release of growth factors from the polymer matrix 
(Fig. 1.7b). In addition, the use of a biodegradable polymer may allow for cell 
organization into the desired tissue to proceed along with the demolition of the support 
matrix, thus avoiding problems related to the long permanence of the exogenous 
structure. 
 
Figure 1.7. Vascularisation of a polymeric scaffold for cells [Mooney, 1999]. 
However, guided neomorphogenesis can be achieved only if some important challenges 
are addressed [Langer, 1995; Kohn, 1996a]. First of all, the support material has to be 
fully biocompatible and easily engineered into the desired 3D shape. Then, isolated tissue 
cells must be successfully seeded onto the polymer matrix and implanted in vivo either 
after cell adhesion, or after being cultured for some time in vitro. Finally, in vivo the 
scaffolded cells must effectively organize into an integrated complex structure displaying 
recovered biological functions. 
Tissues not requiring extensive vascularisation are likely to be the first to be successfully 
regenerated in a proper shape. Indeed, considerable advancements in skin and cartilage 
transplantation have been carried out in the last few years [Langer, 1995; Vacanti, 1997; 
Parenteau, 1999]. For example, studies on animals have shown that new cartilage can be 
grown in the shapes of ear, nose, and other recognizable forms and then re–grafted in vivo 
[Vunjak–Novakovic, 1998]. Actually, there is an acute need of skin and cartilage 
transplantation, since skin cancer, severe burns, and damaged joints affect more than one 
million people per year in the U.S. alone. The challenges ahead of tissue engineering 
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comprise the realization of more complex organs, for which the vascularization problem 
must be overcome. Nonetheless, some important preliminary results were obtained while 
trying to fabricate organs such as liver, kidney, and heart [Kaufmann, 1994; Langer, 
1995, 2000]. 
1.4.3. Growth factor delivery in tissue engineering 
 
The biological research on developing embryos showed that soluble signaling proteins 
execute critical functions during the formation of specialized tissues. These proteins, 
called growth factors, operate in a complex, concentration–dependent way on receptors 
exposed on the surface of target cells. When these polypeptides are provided to adult 
organisms, they often encourage regeneration or repair of organs damaged by disease or 
trauma [Saltzman, 1996]. For instance, bone morphogenetic proteins (BMP), which help 
healing serious bone detachments, were tested in experiments in vivo on humans, with 
results comparable to the ordinary bone transplants [Mooney, 1999]. Therefore, growth 
factors can possibly be used as powerful protein drugs to elicit tissue renewal in vivo. 
This strategy is strongly promoted by recent developments in biotechnology, since large 
scale manufacturing of highly purified proteins is becoming possible. Also, the fast–
advancing knowledge of embryo development and differentiation will surely provide new 
more effective growth factors in the next few years [Saltzman, 1996]. 
However, conventional routes of drug administration proved usually unsuccessful in the 
case of growth factors. In fact, in vivo these large proteins display short half–life, slow 
tissue diffusion coefficients, and high toxicity at systemic level. Drug delivery techniques 
provide one way of enhancing their in vivo efficacy [Babensee, 2000]. In this approach, 
the protein is encapsulated within a biocompatible polymer matrix, micro–nanospheres, 
or gel. Then, the device is either implanted at the desired tissue where it releases the 
soluble factor directly into the surrounding space, or targeted to the tissue cells by 
specific moieties displayed onto the surface. A steady release must be obtained in order to 
match the rate of protein adsorption with the application time. 
Controlled–release formulates have been designed in a variety of geometry and 
configurations, and have been fabricated from diverse types of natural and synthetic 
polymers [Ulrich, 1999]. Degradable polymers allow for significant advantages over non–
degradable matrices aimed at protein delivery. Indeed, for their large dimensions, proteins 
have small diffusion coefficients in solids and degradation of the matrix provides an 
alternative and more efficient way for their release. In addition, conversion of the delivery 
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device to small molecules improves removal from the body by physiological excretion or 
participation into metabolic pathways. 
Growth factors can greatly improve the functionality of tissue engineering devices, 
especially inducing angiogenesis and cell proliferation, as a result of synergistic effects 
[Babensee, 2000]. The neomorphogenetic approach allows for the design of two delivery 
systems releasing growth factors during cell engraftment [Saltzman, 1996]. One 
possibility is to incorporate the protein directly into the scaffold: as the polymer matrix is 
biodegraded, the growth factor would be released to induce tissue regeneration in a 
modulated way. Alternatively, a delivery device containing growth factors can be placed 
internally to the scaffold, thus providing an independent way to tune up the release 
kinetics. A further possibility, allowed by recent developments in molecular biology, may 
be the co–transplantation of engineered cells secreting growth factors, within the device 
1.4.4. Importance of stem cells in tissue engineering 
 
Cell availability is a critical factor for the success of tissue engineering regardless the 
approach to tissue regeneration that is to be followed. Therefore, cell source and cell 
preservation are important issues, and they must be considered from ethical, safety and 
efficacy perspective [Langer, 1999a]. 
Ordinary somatic cells used for tissue engineering studies are often excellent for research 
purposes, but they display severe shortcomings if they are considered for the realization 
of practical healing devices in humans. New experimental techniques may lead to 
improved results in the next future, but immunitary rejection of allogenic or xenogenic 
cells remains the most important problem to address, since the use of autologous cells is 
impossible in the vast majority of cases. As described (§ 1.1.3), encapsulation systems 
represent a sound way to avoid the destructive reaction of the immunitary system. 
However, the scenario has changed dramatically in 1998, when J. A. Thomson of the 
University of Wisconsin published an important study to describe for the first time 
durable cultures of human stem cells [Thomson, 1998]. Stem cells are embryo cells that 
are committed to differentiate and generate all kinds of cell types and tissues during the 
fetal development.  
The idea of using stem cells for tissue engineering applications is not new. Indeed, 
experiments were carried out on mouse stem cells to determine which physiological 
factors make them switch between different cellular lines [Rathjen, 1998]. For example, 
retinoic acid can stimulate them to produce neurons. Other simple chemicals were shown 
to lead to selective differentiation, probably by activating a set of genes and inhibiting 
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others and so leading to different cellular pathways [Pedersen, 1999]. Nowadays the 
problems to establish a reliable human stem cell culture have been overcome, and 
researches similar to that performed in mice gave first important results. It was 
demonstrated that human stem cells formed a wide variety of recognizable tissues when 
transplanted under the skin of mice [Thomson, 1998]. Clearly, strong improvements 
toward effective replacement of entire human organs may come from stem cells seeded in 
suitable scaffolds followed by their guided proliferation. Generation of large and 
organized tissues is likely to be more effective starting from stem cells rather than 
somatic cells, the latter having unmodifiable genetic banks only partially committed to 
tissue renewal. 
A further striking possibility allowed by stem cells is represented by the use of totally 
autologous cells that do not have unfavorable interactions with the host immunitary 
system. This may be realized by a combination of stem cell technology and cloning 
techniques, which is supposed to be developed in the next few years [Pedersen, 1999]. In 
this approach, the nucleus of a somatic (non–reproductive) cell would be transferred into 
an unfertilized egg, which would be afterwards activated and cultured until the blastocyst 
stage. Then, the embryos would be used to produce stem cells that are genetically 
identical to a patient’s own cells. In this perspective, serious ethical requirements are 
overcome, as it is well known that embryonic stem cells may provide a source of 
medically useful tissue not possessing the potential of an intact embryo, and thus human 
cloning cannot occur. 
INTRODUCTION 
 33
1.5. POLYESTERS FROM MALIC ACID AS CONVENIENT BIODEGRADABLE MATERIALS 
FOR BIOMEDICAL APPLICATIONS 
1.5.1. Introduction 
 
Polyesters constitute a large qualified family of degradable materials for bio–applications, 
with the additional advantage that several monomeric precursors can be provided by 
natural sources. Indeed, PGA, PLA, and PLGA copolymers have attained a unique 
position in the biomedical field because of their biocompatibility and tuneable mechanical 
properties. Nonetheless, some drawbacks remain to be addressed, particularly in the 
perspective of tissue engineering applications. For example, the hydrophobic character of 
their backbone can be modulated only slightly, a factor which may prevent the matching 
of the materials degradation rate with the biological process to be sustained. In addition, 
widely used polyesters do not possess reactive sites in the chain, which may allow for 
convenient conjugation with bioactive molecules.  
Only recently, in the effort of producing new polymeric materials with high biological 
activity, a number of functional and more hydrophilic degradable polyesters started to be 
investigated [in't–Veld, 1992]. The PLA–lysine copolymer developed by Langer's group 
[Barrera, 1993, 1995; Cook, 1997; Langer, 1999b, 2000] was one of the first examples of 
functionalized PLA, almost immediately followed by the report on modifications of other 
polyhydroxyacids of biomedical interest [Cook, 1997]. However, these preparations often 
involved many synthetic steps in order to modify the physical–chemical properties of the 
polymer chain [Cook, 1997; in't–Veld, 1992] 
A more convenient option is represented by the synthesis of hydrophilic polyesters from 
naturally occurring molecules that intrinsically bear functional groups. Poly(malic acid) 
(PMLA), a polyester containing side–chain carboxyl groups and a stereogenic center in 
the repeating unit, belong to this class. PMLA seems an extremely good candidate to act 
as degradable, tailor–made, synthetic polymeric material for biomedical applications. 
1.5.2. Poly(alkyl malolactonate)s 
 
PMLA may exist with alternative ester linkages of ? or ? type (Scheme 1.8), which can 
be prepared either by direct polycondensation of malic acid [poly(?–malic acid)], or by 
ring opening polymerization of a substituted ?–lactone [poly(?–malic acid) or 
polymalolactonate]. Linear macromolecules with adequate molecular weight were 
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synthesized only by adopting the second synthetic methodology [Cammas, 1996] and 
poly(?–malic acid) is the unique form of PMLA which will be considered further. 
PMLA is a water–soluble polyelectrolyte (pK1/2= 4.4), which appears to be non–toxic 
(LD50 3.3 g/kg in mice), completely bioresorbable, and non–immunogenic when injected 
intramuscularly or intravenously in mammalians [Braud, 1982, 1985]. PMLA was found 
to degrade both in vitro and in vivo at physiological pH to yield only malic acid [Fournie, 
1990, 1992]. In addition, the L–form of malic acid is an important metabolite of the 
cellular Krebs cycle. Natural production of isotactic poly(L–malic acid) can be carried out 
by different microorganism such as Penicillium cyclopium, [Shimada, 1969] Physarum 
polycephalum [Fischer, 1989], and Aureobasidium SP–A [Nagata, 1993]. 
Scheme 1.8. Different forms of poly(malic acid). 
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The lateral carboxylic function of PLMA was exploited for the preparation of many 
materials (polymalolactonates) with variable physical–chemical characteristics, either by 
direct copolymerization of monomers bearing different side ester groups, or by post–
modification of PMLA [Arnold, 1986; Bouteault, 1995; Leboucher–Durand, 1996, 
Moine, 1997; Barbaud, 1999; Cammas, 1999; Cammas–Marion, 2000]. The control of the 
chain stereoregularity allowed for a further modulation of some materials properties, such 
as crystallinity, water solubility, and degradation rate [Guerin, 1985; Arnold, 1986; 
Braud, 1988]. Indeed, it was shown that the introduction of chiral centers in the side 
chains greatly enhances the conformational organization and chiroptical features of 
stereoregular PMLA [Bouteault, 1995]. Thus, PMLA and its derivatives were 
investigated for a number of biomedical applications, such as micro/nanoparticles for 
drug delivery [Stolnik, 1994; Cammas, 1999; Cammas–Marion, 2000a–b], biologically 
active polymers [Leboucher–Durand, 1996; Cammas–Marion, 2000a], polyelectrolyte 
colloidal dispersions [Rossignol, 1999], and pH–sensitive networks [Moine, 1997; Moine, 
1998]. Interestingly, copolymers of malic acid and lactic acid, and their RGD–conjugates 
were prepared by a similar approach to that developed by Langer [Kimura, 1988, 1993; 
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Yamaoka, 1999]. These materials showed improved surface cell adhesion as well as 
composition tunable degradability [Yamaoka, 1999]. 
1.5.2.1. Structure and synthetic methodologies of malic ?–lactone monomers 
The common structural features of malic monomeric precursors are a four–member cyclic 
ester (?–lactone), a secondary ester group as lateral chain, and an asymmetric carbon 
atom in the ring (Scheme 1.9). The only efficient technique developed so far for the 
preparation of malic ?–lactones involves the intramolecular displacement (SN2i) of a good 
leaving group by action of a deprotonated carboxylic function. This process generally 
occurs with inversion of the stereochemical configuration of the asymmetric lactone atom 
[Bartlett, 1951]. Depending on the nature of reactants, two general procedures are 
available. 
Scheme 1.9. Typical structure of malic ?–lactone monomers. 
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In the aspartic acid route (Scheme 1.10, steps Ia–IIIa), the precursor of the ?–lactone is a 
monoester of bromosuccinic acid. This compound is synthesized in two steps from 
aspartic acid.  
At first, the amino group is converted to a bromine atom (Ia), then the bromosuccinic acid 
is dehydrated to give the corresponding anhydride, which in turn is opened by reaction 
with the hydroxyl group of an alcohol molecule (IIa). Actually, this step leads to two 
different ester isomers, because of the incomplete chemical selectivity of the ring–
opening reaction; only the 2–bromo–substituted alkyl succinate can undergo the 
intramolecular displacement reaction necessary to form the lactone (IIIa). 
In the malic acid route (Scheme 1.10, steps Ia–IIIa), complete regioselectivity in the 
formation of the monoester precursor is accomplished by the stronger inductive action of 
the ?–trifluoroacetic group of the anhydride in the ring opening reaction (IIa). In this 
case, malic acid is the starting material for the synthesis. A Mitsunobu reaction allows for 
the internal cyclization (IIIa) to give the four–ring ?–lactone structure, according to a 
mechanism involving the selective activation of the hydroxyl group in the malic 
monoester. Despite the more complicated synthetic scheme, the malic acid route was 
introduced to overcome some loss of optical purity registered in the aspartic acid 
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procedure. Indeed, the stereoselectivity of the final intramolecular displacement in the 
latter synthetic route was found to depend critically on the reaction temperature, whereas 
in the malic acid procedure the stereoregularity of the final ?–lactone depends only on the 
enantiopurity of the starting malic acid. 
Scheme 1.10. Aspartic acid and malic acid routes to the synthesis of malic ?–lactones 
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These two procedures allow for a large spectrum of physical–chemical features of malic 
?–lactones only by changing the structure of the side ester group. However, the reactivity 
of secondary, tertiary, and hindered primary alcohols towards activated carboxylic 
functions is rather low, and the anhydride–opening step of both routes gives poor yields 
in these cases. Such a lack of reactivity prevents the introduction of many interesting 
natural and synthetic residues whose high biological activity is often accompanied by a 
complex molecular structure. This problem was overcome by the introduction of the 
benzyl moiety as protecting group of the lateral carboxylic function. According to this 
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strategy, benzyl malolactonate is formed by one of the previous procedures and the 
benzyl chain is cleaved by catalytic hydrogenation, which does not affect the labile ester 
bond in the ring. The free carboxyl group is then exploited for the attachment of an 
alcohol by using a coupling agent, typically dicyclohexylcarbodiimide (Scheme 1.11). 
Scheme 1.11. Synthesis of malic ?–lactones via deprotection of benzylmalolactonate. 
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1.5.2.2. Polymerization of malic ?–lactones 
Polymerization of lactones is generally carried out by anionic ring–opening 
polymerization, which can display a living character. “Living” polymers take their name 
from the fact that they resume their growth whenever monomer is added to the system, 
and if the monomer is different from the previously used one, a block copolymer results. 
The characteristics of lactone ring–opening polymerization depend essentially on the size 
of the cycle and the nature of initiator [Spassky, 1991]. The polymerization process is 
thermodynamically controlled by the enthalpy of chain formation, which is proportional 
in modulus to the angle strain in the monomer cycle [Sawada, 1970]. Qualitatively, angle 
strain in three and four atom ring systems is large; it becomes small in five and six–
member rings and then increases again. Indeed, anionic polymerization of ?–lactones is 
strongly favored. 
The chemical structure of the initiator determines the regioselectivity of the ring–opening 
process. Weak nucleophiles, such as carboxylate salts and organic bases give 
preferentially O–alkyl scission, whereas O–acyl scission is obtained by using strong 
nucleophiles, like alkaline alkoxides (Scheme 1.12). It is worth noting that the 
propagating active centers in the polymerization are ion pairs with some contribution 
from free ions. Carboxylic salts are good initiator for ?–lactones [Spassky, 1991]. The 
best results in the polymerization of alkyl malolactonate monomers were obtained by 
using tetraethylammonium benzoate, a weak carboxylic salt whose counter–ion structure 
does not allow for the formation of tight ion–pairs in organic media [Lenz, 1986]. 
Interestingly, the inversion of configuration at the ?–carbon involved in the O–alkyl 
scission mechanism was clearly demonstrated starting from chiral monomers. 
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Scheme 1.12. Regioselectivity of the ring–opening process. 
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In an anionic living polymerization, the final molecular weight of the polymer is 
theoretically set by the monomer–initiator ratio; a lower value is typically due to the 
presence of chain transfer processes. Experiments on the ring opening polymerization of 
benzyl malolactonate in different conditions showed a deviation from the ideal kinetic 
behavior after approximately 40 % of monomer conversion. The active chain transfer 
mechanism was found to involve the abstraction of one ?–hydrogen by a carboxylate 
group, leading to a stable, highly conjugated structure (Scheme 1.13). 
Apparently, this side reaction affects the polymerization of every ?–lactone and its 
incidence depends on both the nature and localization of the substituting groups in the 
molecule. Indeed, molecular weights close to the theoretical ones were found for the 
polymerization of ?–methyl–?–propyl–?–propiolactone, a monomer devoid of ?–
hydrogen atoms. 
Scheme 1.13. Main chain transfer mechanism. 
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1.5.2.3. Synthesis of poly(malic acid) 
The selective introduction of different alkyl groups as side chains and the modulation of 
the monomer enantiomeric purity allowed for the preparation of a large family of 
functional polymers, copolymers, and stereocopolymers of malic ?–lactone monomers 
[poly(alkyl malolactonate)s]. However, direct polymerization of malic acid ?–lactone to 
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give PMLA homopolymer leads only to branched oligomers, since the lateral carboxyl 
group strongly interferes with the polymerization process [Vert, 1979]. Therefore, high 
molecular weight linear PMLA has been synthesized by a two–step procedure, involving 
the preparation of poly(benzyl malolactonate) followed by hydrogenolytic deprotection 
(Scheme 1.14). Worth to noting, partial cleavage of benzyl groups has been adopted as a 
useful method to obtain polymers with tunable degree of hydrophilicity and unusual 
physical–chemical properties. In fact, it was demonstrated that partial hydrogenolysis 
yields copolymers with preferential blocky structures, as result of a complex reaction 
pattern [Braud, 1983; Caron, 1990; Guerin, 1992]. The amphiphilic behavior of these 
block copolymers was found to promote aggregation in water, a characteristic that may be 
exploited for the preparation of biomedical devices such as micro/nanospheres. 
Scheme 1.14. Synthesis of poly(malic acid). 
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2. AIM OF THE WORK 
 
 
The present thesis stems from a long–standing research activity on the synthesis, 
characterization, and application of polymeric materials in the biomedical and 
pharmaceutical fields [Chiellini, 1990, 1992, 1993, 1995, 1996a,b, 1998, 2001a,b; 
Bizzarri, 1999, 2000, 2001] and follows the guidelines suggested by Prof. E. Chiellini. 
Specifically, the research project is aimed at the development of bioactive polymeric 
materials whose characteristics can be exploited in tissue engineering and drug delivery 
applications. This objective will be pursued by investigating the synthesis of polyesters 
containing side–chain reactive moieties by ring opening polymerization of suitable cyclic 
esters. 
In this respect, polyesters with pendant primary hydroxyl groups are promising materials 
for the formulation of targeted drug delivery systems. Such polyesters can be obtained by 
alternating ring opening polymerization of oxetanes with carboxylic anhydrides, and of 
bis(oxetane)s with dicarboxylic acids. On the other hand, polyesters containing tailored 
side chains can be obtained also starting from a special class of ?–lactones, namely 
(R,S)–4–alkyloxycarbonyl–3,3–dimethyl–2–oxetanones, whose structures can be easily 
modified by optimized synthetic procedures, thus helping the development of structurally 
and functionally controlled material properties. Indeed, the presence of two alkyl 
substituents in 3–position can minimize the incidence of chain transfer reactions in the 
ring opening polymerization of ?,??,??trisubstituted ??lactones thus allowing for a better 
control of the molecular weight. Moreover, the functionality and hence the properties of 
aliphatic polyesters can be tailored by incorporation of suitable substituents in beta 
position to the lactone group. 
In particular, benzyl, butyl, allyl, and cholesteryl alcohols have been chosen as starting 
compounds for the synthesis of ??lactonates. The benzyl group represents a protecting 
agent of the carboxylic moiety. After catalytic hydrogenolysis, the resulting free 
carboxylic groups can be exploited for linking bioactive and targeting molecules. On the 
other hand, pendant allyl groups can be modified to give not only free carboxylic acids 
but also epoxides and diols. Side chain hydrophobic butyl esters allows for modulating 
the polylactonate hydrophilic–hydrophobic balance. Finally, a malic ?–lactone with a 
pendant polycyclic structure will be synthesized starting from cholesterol, a polycylic 
terpene largely diffused in the cellular membrane where it is known to play structural as 
well regulatory roles.  
Accordingly, the research work will entail the following specific objectives:  
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1) Acquisition and preparation of oxetanes and bis(oxetane)s containing pendant 
hydroxyl groups either free or protected by benzyl groups.  
2) Synthesis of polyesters with pendant primary hydroxyl groups by alternating ring 
opening polymerization of the above functional oxetanes and of bis(oxetane)s with 
different carboxylic anhydrides and dicarboxylic acids, respectively. 
3) Synthesis of a variety of ?,??,?–trisubstituted ?–lactones starting from diethyl 
oxalpropionate and benzyl, butyl, allyl, and cholesteryl alcohol. 
4) Preparation of functional polyesters and copolyesters by ring–opening polymerization 
of the synthesized ?,??,?–trisubstituted ?–lactones. The polyester structural features 
will be tailored either by copolymerization with different cyclic monomers or by 
deprotection of side–chain allyl and benzyl ester groups. 
5) Thorough physical–chemical characterization of the prepared monomers and 
polymers. Preliminary assessment of the polyester toxicity will be also performed, in 
the perspective of their application in the biomedical field.  
 
 
 
  
3. GLOSSARY 
 
 
 
Nickname Formula 
AdpAc 
O
OH
O
HO
 
Adipic acid 
AllDML O
H3C
CH3
O
*
O O
 
(R,S)–4–Allyloxycarbonyl–3,3–dimethyl–2–oxetanone 
AllOH 
OH
 
Allyl alcohol 
AS1 
O O
OH
O
O
 
Poly((3–methyloxetan–3–yl)methanol–succinic 
anhydride) 
BEAP9 
O O
O O
O
 
Poly(2–benzyloxymethyl–3–methyloxetane–co–
phthalic anhydride 
BENEDETTA CERBAI – PHD THESIS 
 44 
Nickname Formula 
BMMO O O
 
3–(Benzyloxymethyl)–3–methyloxetane 
BOMT 
O
OO
O
O O
 
Bis((3–methyloxetan–3–yl)methyl) terephthalate 
BOPAIP 
O
O
O
O
HO
O
O
HO O (CH2)4
O
O
O
O
O
OH
O
0.2
O O
0.8
OH
O
 
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate 
with 80:20 adipic acid/isophthalic acid mixture 
BOPATP 
O
O
O
O
HO
O
O
HO O (CH2)4
O
O
O
O
O
OH
O
OH
O
O
O
0.8
0.2
 
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate 
with 80:20 adipic acid/terephthalic acid mixture 
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Nickname Formula 
BOPCI 
O
O
O
O
HO
O
O
HO O
O  
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate–
1,4–cyclohexanedicarboxylic acid 
BOPITA 
O
O
O
O
HO
O
O
HO O
O  
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate–
itaconic acid 
BOPPA 
O
O
O
O
HO
O
O
HO O (CH2)4
O  
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate–
adipic acid) 
BOPPS 
O
O
O
O
HO
O
O
HO O (CH2)8
O  
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate–
sebacic acid) 
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Nickname Formula 
BOPSU 
O
O
O
O
HO
O
O
HO O (CH2)2
O  
Poly(bis((3–methyloxetan–3–yl)methyl) terephthalate–
succinic acid) 
BuDML O
H3C
CH3
O
*
O O
 
(R,S)–4–Butyloxycarbonyl–3,3–dimethyl–2–oxetanone 
BuOH OH  
1–Butanol 
BzCl Cl  
Benzyl chloride 
BzDML 
O
H3C
CH3
O
*
O O
 
(R,S)–4–Benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone 
BzOH 
OH
 
Benzyl alcohol 
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Nickname Formula 
ChDML 
O
H3C
CH3
O
*
O O
H
H
H  
(R,S)–4–Cholesteryloxycarbonyl–3,3–dimethyl–2–
oxetanone 
ChOH 
HO
H
H
H
 
Cholesterol 
cHxAc 
O
OH
O
HO
 
1,4–Cyclohexane–dicarboxylic acid 
DIAD 
N
NO
O
O
O
 
(E)–diisopropyl diazene–1,2–dicarboxylate 
DOP 
O
EtOOC
COOEt
CH3
 
Diethyl oxalpropionate 
iPTAc 
O
OH
O
HO
 
Isophthalic acid 
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Nickname Formula 
ItcAc 
O
HO
O
OH
 
Itaconic acid 
LLact 
O
O
O
O  
(3S,6S)–3,6–Dimethyl–1,4–dioxane–2,5–dione 
(L–lactide) 
MOM 
O
OH
 
(3–Methyloxetan–3–yl)methanol 
(3–methyl–3–hydroxymethyloxetane) 
NaBH4 
H
B
H
HH Na+
–
 
Sodium borohydride 
Oxa 
OH
HOOC
COOH
H3C CH3
*
 
3,3–Dimethylmalic acid 
Oxam 
O
EtOOC
COOEt
 
Diethyl 3,3–dimethyl–2–ketosuccinate 
Oxam–All 
*
OH O
O
O
HO
 
(R,S)–4–(Allyloxy)–2–hydroxy–3,3–dimethyl–4–
oxobutanoic acid 
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Nickname Formula 
Oxam–Bu 
*
OH O
O
O
HO
 
(R,S)–4–Butoxy–2–hydroxy–3,3–dimethyl–4–
oxobutanoic acid 
Oxam–Bz 
*
OH O
O
O
HO
 
(R,S)–4–(Benzyloxy)–2–hydroxy–3,3–dimethyl–4–
oxobutanoic acid 
Oxamc 
O
O
O
TFAO
*
 
2–O–trifluoroacetyl–3,3–dimethylmalic anhydride 
Oxam–Ch 
*
OH
H3C CH3
O
O
HO
O
H
H
H
 
(R,S)–4–(Cholesteryloxy)–2–hydroxy–3,3–dimethyl–
4–oxobutanoate acid 
Oxamo 
*
OH
EtOOC
COOEt
 
Diethyl 3,3–dimethylmalate 
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Nickname Formula 
pAl 
*O
H3C CH3
O
O O
 
Poly((R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–
oxetanone) 
PAn 
O
O
O
 
Phthalic anhydride 
PAn 
O
O
O
 
Phthalic anhydride 
pBu 
*O
O
O O
 
Poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone) 
pBuBz 
*O
O
O O
*O
O
O O
 
Poly(butyl (R,S)–3,3–dimethylmalate–co–benzyl 
(R,S)–3,3–dimethylmalate) 
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Nickname Formula 
pBz 
*O
O
O O
 
Poly((R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone) 
pBzPL 
*O
O
*O
O
O O
 
Poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 
Pd(PPh3)4 
PPh3
Pd
PPh3
PPh3Ph3P
 
Palladium tetrakistriphenylphosphine
 
PL 
O
O
 
?–Propiolactone 
PPh3 
P
 
Triphenylphosphine 
pPL 
O
O  
Polypropiolactone 
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Nickname Formula 
Py 
N  
Pyridine 
Pyrr 
N H
 
Pyrrolidine 
SAn OO O
 
Succinic anhydride 
SebAc 
O
OH
O
HO
 
Sebacic Acid 
SnOct2 
Sn2+
O
O- O-O
 
Stannous 2–ethylhexanoate 
SucAc 
O
OH
O
HO
 
Succinic acid 
TBAB N+
Br–
 
Tetrabutylammonium bromide 
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Nickname Formula 
TBABs N+
HSO4
–
 
Tetrabutylammonium bisulfate 
TBABz N+
O
-O
 
Tetrabutylammonium benzoate 
TBPB P+
Br–
 
Tetrabutylphosphonium bromide 
TEABz 
N+
O
-O
 
Tetraethylammonium benzoate 
TFFA 
O
F
F
F
O
O
F
F
F
 
Trifluoroacetic anhydride 
THF O  
Tetrahydrofuran 
TMU 
O
NN
 
Tetramethylurea 
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Nickname Formula 
TPPB 
P+ Br–
 
Tetraphenylphosphonium bromide 
tPTAc 
O
OHHO
O
 
Terephthalic acid 
tPTCl 
O
ClCl
O
 
Terephthaloyl chloride 
TsCl 
S
O
O
Cl
 
Tosyl chloride 
?–HBuL 
OO
HO
 
?–Hydroxybutyrolactone 
?–BL O
O
 
?–Butyrolactone 
?–CL 
O
O  
?–Caprolactone 
 
  
4. EXPERIMENTAL PART 
 
 
 
4.1. MATERIALS AND METHODS 
4.1.1. Solvents 
4.1.1.1. Acetone 
The commercial product (Carlo Erba) was refluxed for 8 hours on KMNO4 under dry 
nitrogen atmosphere and then distilled. The collected product was further refluxed for 4 h 
on K2CO3 and finally distilled, collecting the fraction having b.p. 56 °C/25. 
4.1.1 2. Dichloromethane 
The commercial product (J. T. Baker) was refluxed for 8 hours on CaH2 under dry 
nitrogen atmosphere and then distilled, collecting the fraction having b.p. 40 °C. 
4.1.1.3. Ethanol 
The commercial product (Aldrich) was refluxed for 4 hours over CaH2 under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 78 °C. 
4.1.1.4. Pyridine (Py) 
The commercial product (Aldrich) was refluxed for 8 hours on KOH under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 115 °C. 
4.1.1.5. Tetrahydrofuran (THF) 
The commercial product (Carlo Erba) was refluxed for 4 hours over CaH2 under dry 
nitrogen atmosphere and then distilled, collecting the fraction having b.p. 65 °C. 
4.1.1.6. Tetramethylurea (TMU) 
The commercial product (Aldrich) was used as received. 
4.1.2. Reagents 
4.1.2.1. Adipic acid (AdpAc) 
The commercial product (Aldrich) was purified by crystallization from hot water, and 
then dried overnight under vacuum at room temperature. 
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4.1.2.2. Allyl alcohol (AllOH) 
The commercial product (Aldrich) was refluxed for 4 hours over CaH2 under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 96–98 °C. 
4.1.2.3. Amberlyst–15 (SO3H) 
The commercial product (Aldrich) was used as received. 
4.1.2.4. Benzyl alcohol (BzOH) 
The commercial product (Aldrich) was refluxed for 8 hours over CaH2 under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 90–95 °C/25 mbar. 
4.1.2.5. Benzyl chloride (BzCl) 
The commercial product (Aldrich) was used as received 
4.1.2.6. Butyl alcohol (BuOH) 
The commercial product (Aldrich) was refluxed for 4 hours over CaH2 under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 116–118 °C. 
4.1.2.7. ?–Butyrolactone (?–BL) 
The commercial product (Aldrich) was refluxed for 8 hours on CaH2 under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 70°C/40 mbar. 
4.1.2.8. ?–Caprolactone (?–CL) 
The commercial product (Aldrich) was refluxed for 8 hours on CaH2 under dry nitrogen 
atmosphere and then distilled, collecting the fraction having b.p. 65–70°C/25 mbar. 
4.1.2.9. Cholesterol (ChOH) 
The commercial product (Aldrich) was used as received. 
4.1.2.10. 1,4–Cyclohexanedicarboxylic acid (cHxAc) 
The commercial product (Aldrich) was used as received. 
4.1.2.11. Diethyl oxalpropionate (DOP) 
The commercial product (Aldrich) was used as received. 
4.1.2.12. Diisopropylazodicarboxylate (Diisopropyl diazene–1,2–dicarboxylate , DIAD) 
The commercial product (Aldrich) was used as received. 
4.1.2.13. (3S,6S)–3,6–Dimethyl–1,4–dioxane–2,5–dione (L–lattide, LLact) 
The commercial product (Aldrich) was used as received. 
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4.1.2.14. ?–Hydroxybutyrolactone (?–HBuL) 
The commercial product (Aldrich) was used as received. 
4.1.2.15. Iodomethane 
The commercial product (Aldrich) was used as received. 
4.1.2.16. Isophthalic acid (iPTAc) 
The commercial product (Aldrich) was used as received. 
4.1.2.17. Itaconic acid (ItcAc) 
The commercial product (Aldrich) was used as received. 
4.1.2.18. (3–Methyloxetan–3–yl)methanol (MOM) 
The commercial product (Aldrich) was used as received. 
4.1.2.19. Palladium/C 
The commercial product (Aldrich) was used as received. 
4.1.2.20. Palladium tetrakistriphenylphosphine (Pd(PPh3)4) 
The commercial product (Aldrich) was used as received. 
4.1.2.21. Phthalic anhydride (PAn) 
The commercial product (Aldrich) was purified by crystallization from methanol, and 
then dried overnight under vacuum at room temperature. 
4.1.2.22. ?–Propiolactone (PL) 
The commercial product (ABCR) was distilled under dry nitrogen atmosphere, collecting 
the fraction having b.p. 65–70 °C/25 mbar. 
4.1.2.23. Pyrrolidine (Pyrr) 
The commercial product (Aldrich) was used as received. 
4.1.2.24. Sebacic Acid (SebAc) 
The commercial product (Aldrich) was used as received. 
4.1.2.25. Sodium boroidride (NaBH4) 
The commercial product (Aldrich) was used as received. 
4.1.2.26. Stannous 2–ethylhexanoate (SnOct2) 
The commercial product (Aldrich) was used as received and manipulated under inert 
atmosphere. 
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4.1.2.27. Succinic acid (SucAc) 
The commercial product (Aldrich) was purified by crystallization from water, and then 
dried overnight under vacuum at room temperature. 
4.1.2.28. Succinic anhydride (SAn) 
The commercial product (Aldrich) was purified by crystallization from methanol, and 
then dried overnight under vacuum at room temperature. 
4.1.2.29. Terephthalic acid (tPTAc) 
The commercial product (Aldrich) was used as received. 
4.1.2.30. Terephthaloyl chloride (tPTCl) 
The commercial product (Aldrich) was used as received. 
4.1.2.31. Tetrabutylammonium benzoate (TBABz) 
The commercial product (Aldrich) was used as received. 
4.1.2.32. Tetrabutylammonium bisulphate (TBABs) 
The commercial product (Aldrich) was used as received. 
4.1.2.33. Tetrabutylammonium bromide (TBAB) 
The commercial product (Aldrich) was used as received. 
4.1.2.34. Tetraethylammonium benzoate (TEABz) 
The commercial product (Aldrich) was used as received. 
4.1.2.35. Tetrabutylphosphonium bromide (TBPB) 
The commercial product (Aldrich) was used as received. 
4.1.2.36. Tetraphenylphosphonium bromide (TPPB) 
The commercial product (Aldrich) was used as received. 
4.1.2.37. Tosyl chloride (TsCl) 
The commercial product (Aldrich) was used as received. 
4.1.2.38. Triethylamine 
The commercial product (Aldrich) was used as received. 
4.1.2.39. Trifluoroacetic anhydride (TFA) 
The commercial product (Aldrich) was used as received 
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4.1.2.40. Triphenylphosphine (PPh3) 
The commercial product (Aldrich) was purified by crystallization from ethanol, and then 
dried overnight under vacuum at room temperature. 
4.1.3. Methods 
4.1.3.1. Thin Layer Chromatography (TLC) 
TLC was performed on silica gel 60 F254 (Merck) and spots were detected either by 
fluorescence emission (excitation at 254 nm) or by iodine staining. Spot associated to 
lactone compounds were detected also by hydroxamic acid staining [Stahl, 1969]. 
4.1.3.2. Flash Chromatography 
Flash chromatography was performed on Merck Silica Gel 60 (230–400 mesh). Height of 
the silica layer was always 20 cm, while column diameter depended upon load and 
separation degree as detected on TLC plates with the same eluent mixture. Optimal flow 
rate was around 18–20 ml/min. 
4.1.3.3. Liquid Chromatography 
Liquid chromatography was performed on Merck Silica Gel 60 (70–230 mesh). Optimal 
flow rate was around 7–8 ml/min. 
4.1.3.4. Thermal gravimetric analysis 
Thermal gravimetric analysis (TGA) measurements were carried out on 10–12 mg 
samples in the 30–700 °C range under nitrogen atmosphere at 10 °C/min heating rate, 
using a HiRes TGA 2950 Thermogravimetric Analyzer TA instrument. 
4.1.3.5. Differential scanning calorimetry 
Differential scanning calorimetry (DSC) analyses were performed under nitrogen 
atmosphere at the flow rate of 30 mL/min on 5–10 mg samples using either a Mettler 
DSC 30 or a 2920 TA instrument. Glass transition temperatures were measured from the 
inflection point of the thermograms relevant to the second heating cycle. Indium and 
gallium samples were used as calibration standards. 
4.1.3.6. Infrared spectroscopy 
Infrared spectra (FT–IR) were recorded on liquid films, KBr pellets, and polymer cast 
films by a Perkin Elmer Spectrum One spectrometer. In a few cases, FT–IR spectra of 
powdered polymers were recorded by using a Bio–Rad 575C FT–IR Spectrometer 
equipped with Golden Gate Single Reflection ATR Specac tool. 
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4.1.3.7. Nuclear Magnetic Resonance 
Nuclear Magnetic Resonance (NMR) spectra were recorded on 10% (w/v) solutions in 
perdeuterated solvents at 25 °C, by using or a Varian Gemini 200 spectrometer and 
tetramethylsilane (TMS) as internal standard. 
4.1.3.8. Size exclusion chromatography 
Size exclusion chromatography (SEC) analyses were performed in chloroform by using a 
Jasco PU–1580 HPLC pump equipped with two 300x7.5 PL Mixed–D columns, Jasco 
830–RI refractive index detector and Perkin Elmer LC–75 spectrophotometric detector. 
Monodispersed polystyrene samples were used as calibration standards. 
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4.2. MONOMERS 
4.2.1. Synthesis of monomer precursors 
4.2.1.1. Synthesis of diethyl 3,3–dimethyl–2–ketosuccinate (Oxam) 
A solution of 60 g (55.9 mL, 0.30 moles) diethyl oxalpropionate and 82 g (0.60 moles) 
potassium carbonate in 200 mL of dry acetone was placed under dry nitrogen atmosphere 
in a 500 mL two–necked round–bottom flask, equipped with mechanical stirrer, reflux 
condenser, and dropping funnel. 105.3 g (46.2 mL, 0.74 moles) iodomethane was added, 
and the mixture was stirred for 8 hours at reflux temperature. Acetone was evaporated, 
200 mL dichloromethane was added and the solution was dried under vacuum. The 
residue was dissolved in 100 mL dichloromethane and extracted with 200 mL of water. 
The water phase was extracted with 100 mL of dichloromethane. The combined organic 
phases were washed with 5% hydrochloric acid (3x50 mL), and with water (2x50 mL). 
The organic layer was dried over sodium sulfate, filtered, and finally concentrated under 
vacuum to give 57.6 g (90 % yield, b.p. 100°C/ 0.4 mbar) of glc–pure colourless liquid 
that was characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.1 and 4.2). 
FT–IR (cast film): ?  = 2986–2850 (? aliphatic CH), 1731 (? C=O), 1467 (? CH2), 1387 
(? CH3) and 1259–1047 cm–1 (? C–O–C). 
1H–NMR (200 MHz, CDCl3,): ?  = 1.05–1.35 (2t, 6 H; CH3CH2), 1.40 (s, 6 H; CH3C) and 
4.15–4.3 ppm (2q, 4 H; OCH2). 
4.2.1.2. Synthesis of diethyl 3,3–dimethylmalate (Oxamo) 
A solution of 57.6 g (0.27 moles) diethyl 3,3–dimethyl–2–ketosuccinate in 550 mL 
tetrahydrofuran was placed in a 2 L 3–necked round–bottom flask, equipped with 
magnetic stirrer, reflux condenser, and dropping funnel. The solution was cooled at 0–5 
°C, then 9.83 g (0.27 moles) NaBH4 in 200 mL water was added under stirring. The 
stirring was continued for 1 hour at 0–5 °C, then 500 mL of acetic acid and 200 mL of 
water were added. The mixture was extracted with ethyl acetate (4x200 mL). The 
combined organic phases were washed with water, dried over sodium sulfate, filtered, and 
the solvent was removed under vacuum to give 36.5 g (62% yield) of glc–pure colourless 
liquid that was characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.3 and 4.4). 
FT–IR (cast film): ?  = 3500 (? OH), 2982–2850 (? aliphatic CH), 1734 (? C=O), 1467 
(? CH2), 1389 (? CH3) and 1260–1096 cm–1 (? C–O–C). 
1H–NMR (200 MHz, CDCl3): ?  = 1.15 (s, 6 H; CH3C), 1.25 (t, 6 H; CH3CH2), 4.05– 4.20 
(m, 4 H; OCH2), 4.38 (s, 1 H; CHCOH) and 6.40–6.65 ppm (bs, 1H; OH). 
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Figure 4.1.  FT–IR spectrum of diethyl 3,3–dimethyl–2–ketosuccinate. 
 
 
Figure 4.2.  1H–NMR spectrum of diethyl 3,3–dimethyl–2–ketosuccinate in CDCl3. 
4.2.1.3. Synthesis of 3,3–dimethylmalic acid (Oxa) 
A solution of 36.5 g (0.17 moles) diethyl 3,3–dimethylmalate, in 480 mL dioxane/water 
(1:1) was placed in 1 L 3–necked round–bottom flask, equipped with magnetic stirrer, 
reflux condenser, and dropping funnel. 124 mL of 20% KOH in water were added, and 
the mixture was refluxed for 16 hours. After cooling at room temperature, the solution 
was eluted with water over a column of Amberlyst–15 (acid form). The solvents were 
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removed under reduced pressure to give the crude diacid that was generally used without 
any further purification. Only once, the crude diacid was recrystallized from 
CH3CN/CHCl3 to give 20.7 g (75% yield) of colourless solid (m.p. 95–100 °C) that was 
characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.5 and 4.6). 
 
Figure 4.3.  FT–IR spectrum of diethyl 3,3–dimethylmalate. 
 
 
 
 
Figure 4.4. 1H–NMR spectrum of diethyl 3,3–dimethylmalate in CDCl3 . 
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FT–IR (KBr pellets): ?  = 3700–3500 (?OH acid), and 3500–3200 cm–1 (?OH alcohol). 
1H–NMR (200 MHz, acetone–d6): ? = 1.18 (s, 3 H; CH3C), 1.24 (s, 3 H; CH3C), 4.38 (s, 1 
H; CHC–OH) and 6.85 ppm (sl, 3 H, OH). 
 
 
 
Figure 4.5.  FT–IR spectrum of 3,3–dimethylmalic acid. 
 
 
 
 
Figure 4.6.  1H–NMR spectrum of 3,3–dimethylmalic acid in acetone–d6. 
EXPERIMENTAL 
 65
4.2.1.4. Synthesis of 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride (Oxamc) 
Crude 3,3–dimethylmalic acid 6.26 g (40 mmoles) was placed under dry nitrogen 
atmosphere in a 50 mL 3–necked round–bottom flask, equipped with magnetic stirrer, 
reflux condenser, and dropping funnel. The flask was cooled at 0 °C, then 12.9 mL (87 
mmoles) trifluoroacetic anhydride was added. The mixture was stirred for 30 min at 0 °C 
and for 3 hours at room temperatur. The volatile products were removed under vacuum to 
give 9.27 g (97% yield) of cyclic anhydride that was characterized by 1H–NMR 
spectroscopy (Fig. 4.7). 
1H–NMR (200 MHz, acetone–d6): ? = 1.45 (s, 3 H; CH3C), 1.65 (s, 3 H; CH3C) and 6.45 
ppm (s, 1 H; CHC–O). 
 
Figure 4.7. 1H–NMR spectrum of 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride in 
acetone– d6. 
4.2.1.5. Synthesis of (R,S)–4–(allyloxy)–2–hydroxy–3,3–dimethyl–4–oxobutanoic acid 
(Oxam–All) 
A mixture of 2.0 g (8.3 mmoles) 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride and 
3.9 mL (57 mmoles) allyl alcohol was placed under dry nitrogen atmosphere in a two–
necked round–bottom flask, equipped with magnetic stirrer and reflux condenser. The 
mixture was stirred at room temperature for 12 hours, then the crude product was washed 
with 3x100 mL 5% NaHCO3 solution and 3x100 mL ethyl acetate. The aqueous phase 
was acidified to pH 2 with 5% hydrochloric acid and then extracted with 3x100 mL ethyl 
acetate. The collected organic phases were dried over sodium sulphate, filtered, and the 
solvent was removed under vacuum to give 2.0 g (67 % yield) of a white solid that was 
characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.8 and 4.9). 
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FT–IR (cast film): ?  = 3600–2500 (? COOH), 3088 (? vinyl CH), 2985–2850 
(? aliphatic CH), 1731 (? C=O), 1650 (? C=C), 1467 (? CH2), 1369 (? CH3), 1270–1093 
(? C–O–C), 989 and 937 cm–1 (? vinyl CH). 
1H–NMR (200 MHz, CDCl3): ? = 1.20 (s, 3 H; CH3C), 1.35 (s, 3 H; CH3C), 4.45 (s, 1 H; 
CHC–OH) , 4.75 (d, 2 H; CH2CH=CH2), 5.2–5.4 (m, 2 H; CH2CH=CH2) and 5.8–6.0 
ppm (m, 1 H; CH2CH=CH2). 
 
Figure 4.8. FT–IR spectrum of (R,S)–4–(allyloxy)–2–hydroxy–3,3–dimethyl–4–oxo–
butanoic acid. 
 
Figure 4.9. 1H–NMR spectrum of (R,S)–4–(allyloxy)–2–hydroxy–3,3–dimethyl–4–oxo–
butanoic acid in CDCl3. 
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4.2.1.6. Synthesis of (R,S)–4–(butoxy)–2–hydroxy–3,3–dimethyl–4–oxobutanoic acid 
(Oxam–Bu) 
A mixture of 2.64 g (11.0 mmoles) 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride 
and 8.0 mL (87 mmoles) butyl alcohol was placed under dry nitrogen atmosphere in a 
two–necked round–bottom flask, equipped with magnetic stirrer and reflux condenser. 
The mixture was stirred at room temperature for 12 hours, and the crude product was 
washed with 3x100 mL 5% NaHCO3 solution and 3x100 mL ethyl acetate. The aqueous 
phases was acidified to pH 2 with 5% hydrochloric acid and then extracted with 3x100 
mL ethyl acetate. The collected organic phases were dried over sodium sulphate, filtered, 
and the solvent was removed under vacuum to give 2.0 g (yield 84 %) of a white solid 
that was characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.10 and 4.11). 
FT–IR (cast film): ?  = 3600–2500 (? COOH), 2985–2850 (? aliphatic CH), 1731 (? 
C=O), 1469 (? CH2), 1397 (? CH3) and 1276–1095 cm–1 (? C–O–C). 
1H–NMR (200 MHz, CDCl3): ? = 0.95 (t, 3 H; CH3CH2), 1.15 (s, 3 H; CH3C), 1.25 (s, 3 
H; CH3C), 1.25–1,45 (m, 2 H; CH2CH3), 1.55–1.70 (m, 2 H; CH2CH2CH2), 4.25 (t, 2 H; 
OCH2CH2) and 4.4 ppm (s, 1 H; CHC–OH). 
 
Figure 4.10.  FT–IR spectrum of (R,S)–4–(butoxy)–2–hydroxy–3,3–dimethyl–4–oxo–
butanoic acid. 
4.2.1.7. Synthesis of (R,S)–4–(benzyloxy)–2–hydroxy–3,3–dimethyl–4–oxobutanoic 
acid (Oxam–Bz) 
A mixture of 9.27 g (38.6 mmoles) 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride 
and 28.0 mL (280 mmoles) butyl alcohol was placed under dry nitrogen atmosphere in a 
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two–necked round–bottom flask, equipped with magnetic stirrer and reflux condenser. 
The mixture was stirred at room temperature for 12 hours then the crude product was 
washed with 3x100 mL 5% NaHCO3 solution and 3x100 mL ethyl acetate. The aqueous 
phases was acidified to pH 2 with 5% hydrochloric acid and then extracted with 3x100 
mL ethyl acetate. The collected organic phases were dried over sodium sulphate, filtered, 
and the solvent was removed under vacuum to give 2.0 g (yield 65 %) of a white solid 
that was characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.12 and 4.13). 
FT–IR (cast film): ?  = 3600–2500 (? COOH), 3089, 3067 and 3034 (? aromatic CH), 
2985–2850 (? aliphatic CH), 1735 (? C=O), 1497 (? C=C), 1460 (? CH2), 1391 and 1375 
(? CH3), 1265–1093 (? C–O–C), 751 and 699 cm–1 (? aromatic CH). 
1H–NMR (200 MHz, CDCl3): ? = 1.15 (s, 3 H; CH3C), 1.25 (s, 3 H; CH3C), 4.45 (s, 1 H; 
CHC–OH), 5.25 (s, 2H; CH2Ph) and 7.4 ppm (s, 5H; Ph–H). 
 
Figure 4.11. 1H–NMR spectrum of (R,S)–4–(butoxy)–2–hydroxy–3,3–dimethyl–4–oxo–
butanoic acid in CDCl3. 
4.2.1.8. Synthesis of (R,S)–4–(cholesteryloxy)–2–hydroxy–3,3–dimethyl–4–oxobuta-
noic acid (Oxam–Ch) 
A solution of 1.46 g (6.1 mmoles) 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride and 
2.37 g (6.1 mmoles) cholesterol in 10 mL of anhydrous CH2Cl2 was placed under dry 
nitrogen atmosphere in a two–necked round–bottom flask, equipped with magnetic stirrer 
and reflux condenser. The mixture was stirred at room temperature for 12 hours, then the 
crude product was washed with 3x100 mL 5% NaHCO3 solution and 3x100 mL CH2Cl2. 
The aqueous phases was acidified at pH 2 with 5% HCl and then extracted with 3x100 
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mL ethyl acetate. The collected organic phases were dried over sodium sulphate, filtered, 
and the solvent was removed under vacuum to give 1.05 g (30% yield) of a white solid 
that was characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.14 and 4.15). 
FT–IR (cast film): ?  = 3600–2500 (? COOH), 2985–2850 (? aliphatic CH), 1731 (? 
C=O), 1469 (? CH2), 1397 (? CH3) and 1276–1095 cm–1 (? C–O–C). 
 
 
Figure 4.12. FT–IR spectrum of (R,S)–4–(benzyloxy)–2–hydroxy–3,3–dimethyl–4–
oxobutanoic acid. 
 
Figure 4.13. 1H–NMR spectrum of (R,S)–4–(benzyloxy)–2–hydroxy–3,3–dimethyl–4–
oxobutanoic acid in CDCl3. 
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 Figure 4.14 . FT–IR spectrum of (R,S)–4–(cholesteryloxy)–2–hydroxy–3,3–dimethyl–4–
oxobutanoic acid. 
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Figure 4.15. 1H–NMR spectrum of (R,S)–4–(cholesteryloxy)–2–hydroxy–3,3–dimethyl–
4–oxobutanoic acid in CDCl3. 
 
1H–NMR (200 MHz, CDCl3): ? = 0.68 (s, 3H; Chol–CH3CCHCHCH3), 0.85–2.04 (38 H; 
Chol–H), 1.15 (s, 3 H; CH3C), 1.25 (s, 3 H; CH3C), 2.33–2.39 (m, 2H; Chol–CHCH2C=), 
3.55–3.62 (dd, 1H; CH2C=O), 3.74–3.82 (dd, 1H; CH2C=O), 4.45 (s, 1 H; CHC–OH), 
4.70–4.80 (m, 1H; Chol–CHO), 4.81–4.84 (dd, 1H; O=CCH2CHO), and 5.39–5.41 ppm 
(m, 1H; Chol–CH=). 
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4.2.2. Synthesis of ? ,??,?–trisubstituted ?–lactones 
4.2.2.1. Synthesis of (R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone (AllDML) 
A solution of 1.08 g (5.3 mmoles) OxamAl and 1.38 g (5.3 mmoles) triphenylphosphine 
in 17 mL of dry tetrahydrofuran was placed was placed under dry nitrogen atmosphere in 
a 50 mL 3–necked round–bottom flask, equipped with magnetic stirrer, reflux condenser, 
and dropping funnel. The solution was cooled at 0 °C, then a solution of 1.07 g (1.04 mL; 
5.3 mmoles) diisopropylazodicarboxylate in 3.5 mL of anhydrous tetrahydrofuran was 
added. The stirring was continued at 0–5 °C for 30 min and at room temperature for 12 
hours. After removal of most solvent under reduced pressure, the oily residue was 
triturated with diethyl ether and the precipitate was filtered off. The filtrate was purified 
by flash chromatography over silica gel with 2:1 ciclohexane–ethyl acetate to give 0.51 g 
(53% yield) of glc pure colourless liquid that was characterized by FT–IR, 1H–NMR, and 
13C–NMR spectroscopy (Figs. 4.16–4.18). 
FT–IR (liquid film): ?  = 3084 and 3060 (? unsatured CH), 3000–2850 (? aliphatic CH), 
1841 (? lactone C=O), 1750 (? ester C=O), 1658 (? C=C), 1448 (? CH2), 1382 (? CH3), 
1275–1030 (? C–O–C), 991 and 938 cm–1 (? vinyl CH). 
1H–NMR (200 MHz, CDCl3): ? = 1.25 (s, 3 H; CH3C), 1.45 (s, 3 H; CH3C), 4.65 (s, 1 H; 
OOC–CHC–O), 4.75 (d, 2 H; –CH2–CH=CH2), 5.25 (m, 2 H; –CH2–CH=CH2) and 5.90 
ppm (m, 1 H; –CH2–CH=CH2). 
13C–NMR (200 MHz, CDCl3): ? = 17.63 (CH3), 22.03 (CH3), 58.04 (C–CH3), 66.52 (O–
CH2–CH=), 120.25 (CH2=), 131.00 (CH=), 167.10 (C=O lactone) and 172.83 ppm (C=O 
ester). 
4.2.2.2. Synthesis of (R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–oxetanone (BuDML) 
A solution of 1.90 g (5.3 mmoles) OxamBu and 2.27 g (5.3 mmoles) triphenylphosphine 
in 28 mL of dry tetrahydrofuran was placed was placed under dry nitrogen atmosphere in 
a 50 mL 3–necked round–bottom flask, equipped with magnetic stirrer, reflux condenser, 
and dropping funnel. The solution was cooled at 0 °C, then a solution of 1.76 g (1.04 mL; 
5.3 mmoles) diisopropylazodicarboxylate in 3.5 mL of anhydrous tetrahydrofuran was 
added. The stirring was continued at 0–5 °C for 30 min and at room temperature for 12 
hours. After removal of most solvent under reduced pressure, the oily residue was 
triturated with diethyl ether and the precipitate was filtered off. The filtrate was purified 
by flash chromatography over silica gel with 2:1 ciclohexane–ethyl acetate to give 0.51 g 
(47% yield) of glc pure colourless liquid that was characterized by FT–IR, 1H–NMR, and 
13C–NMR spectroscopy (Figs. 4.19–4.21). 
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FT–IR (liquid film): ?  = 3000–2850 (? aliphatic CH), 1843 (? lactone C=O), 1755 
(? ester C=O), 1464 (? CH2), 1387 (? CH3), and 1212–1031 cm–1 (? C–O–C). 
1H–NMR (200 MHz, CDCl3): ? = 0.8–1.0 (t, 3 H; CH3CH2), 1.30 (s, 3 H; CH3C), 1.30–
1.50 (m, 2 H; CH2CH3), 1.55 (s, 3 H; CH3C), 1.60–1.80 (m, 2H; CH2CH2O), 4.25 (t, 2H; 
CH2O) and 4,65 ppm (s, 1 H; CH). 
13C–NMR (200 MHz, CDCl3): ? = 13.68 (CH3CH2), 17.60 (CH3–C), 19.09 (CH3CH2), 
22.03 (CH3–C), 30.57 (CH2CH2O), 57.83 (C–CH3), 65.88 (CH2O), 167.45 (C=O lactone) 
and 172.93 ppm (C=O ester). 
 
Figure 4.16. FT–IR spectrum of (R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone. 
 
Figure 4.17. 1H–NMR spectrum of (R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone 
in CDCl3. 
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Figure 4.18. 13C–NMR spectrum of (R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–
oxetanone in CDCl3. 
 
 
 
 
 
 
 
 
 
Figure 4.19. FT–IR spectrum of (R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–oxetanone. 
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Figure 4.20. 1H–NMR spectrum of (R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone in CDCl3. 
 
Figure 4.21. 13C–NMR spectrum of (R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone in CDCl3. 
4.2.2.3. Synthesis of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone (BzDML) 
Procedure 1 – A solution of 2.61 g (10.37 mmoles) OxamBz in 52 mL of anhydrous 
pyridine was placed under dry nitrogen atmosphere in 100 mL 3–necked round–bottom 
flask, equipped with magnetic stirrer, reflux condenser, and dropping funnel. After 
cooling at 0–5°C, 4.0 g (20.98 mmoles) tosyl chloride was added. The mixture was 
thoroughly shaken and then kept overnight in refrigerator. The reaction mixture was 
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poured over crushed ice and extracted with 3x100 mL diethyl ether and .The collected 
organic phases were washed with 100 mL of 5% NaHCO3 dried over sodium sulphate, 
filtered, and concentrated under vacuum to give 0.39 g (yield 16 %) of colourless liquid 
that was characterized by FT–IR and 1H–NMR spectroscopy. 
Procedure 2 – A solution of 3.20 g (5.3 mmoles) OxamBz and 3.31 g (5.3 mmoles) 
triphenylphosphine in 40 mL of dry tetrahydrofuran was placed was placed under dry 
nitrogen atmosphere in a 50 mL 3–necked round–bottom flask, equipped with magnetic 
stirrer, reflux condenser, and dropping funnel. The solution was cooled at 0 °C, then a 
solution of 2.56 g (1.04 mL; 5.3 mmoles) diisopropylazodicarboxylate in 3.5 mL of 
anhydrous tetrahydrofuran was added. The stirring was continued at 0–5 °C for 30 min 
and at room temperature for 12 hours. After removal of most solvent under reduced 
pressure, the oily residue was triturated with diethyl ether and the precipitate was filtered 
off. The filtrate was purified by flash chromatography over silica gel with 2:1 
ciclohexane–ethyl acetate to give 0.51 g (57% yield) of glc pure colourless liquid that was 
characterized by FT–IR, 1H–NMR, and 13C–NMR spectroscopy (Figs. 4.22–4.24). 
FT–IR (liquid film): ?  = 3091, 3067, and 3035 (? aromatic CH), 3000–2850 (? aliphatic 
CH), 1841 (? lactone C=O), 1757 (? ester C=O), 1610, 1588, and 1499 (? C=C), 1458 (? 
CH2), 1385 (? CH3), 1286–1026 (? C–O–C), 753 and 700 cm–1 (? CH phenyl). 
1H–NMR (200 MHz, acetone d6): ? = 1.20 (s, 3 H; CH3C), 1.45 (s, 3 H; CH3C), 4.65 (s, 1 
H; OOC–CHC–O), 5.2 (s, 2 H; CH2Ph) and 7,4 ppm (s, 5 H; Ph–H). 
13C–NMR (acetone d6, 200 MHz): ? = 16.15 (CH3–C), 20.25 (CH3–C), 56.83 (C–CH3), 
66.23 (CH2O), 76.03 (CH–O), 127.80 (CH phenyl ortho and para), 128.00 CH phenyl 
meta), 134.68 (C phenyl quaternary), 166.48 (C=O lactone) and 17216 ppm (C=O ester). 
 
Figure 4.22. FT–IR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone. 
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Figure 4.23. 1H–NMR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone in acetone d6. 
 
Figure 4.24. 13C–NMR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone in acetone d6. 
4.2.2.4. Synthesis of (R,S)–4–cholesteryloxycarbonyl–3,3–dimethyl–2–oxetanone 
(ChDML) 
A solution of 1.0 g (5.3 mmoles) OxamCl and 0.47 g (5.3 mmoles) triphenylphosphine in 
50 mL of dry tetrahydrofuran was placed was placed under dry nitrogen atmosphere in a 
100 mL 3–necked round–bottom flask, equipped with magnetic stirrer, reflux condenser, 
and dropping funnel. The solution was cooled at 0 °C, then a solution of 0.36 g (1.04 mL; 
5.3 mmoles) diisopropylazodicarboxylate in 3.5 mL of anhydrous tetrahydrofuran was 
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added. The stirring was continued at 0–5 °C for 30 min and at room temperature for 12 
hours. After removal of most solvent under reduced pressure, the oily residue was 
triturated with diethyl ether and the precipitate was filtered off. The filtrate was purified 
by flash chromatography over silica gel with 2:1 ciclohexane–ethyl acetate to give 0.51 g 
(63% yield) of glc pure colourless liquid that was characterized by FT–IR and 1H–NMR 
spectroscopy (Figs. 4.25 and 4.26). 
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Figure 4.25. FT–IR spectrum of (R,S)–4–cholesteryloxycarbonyl–3,3–dimethyl–2–
oxetanone. 
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Figure 4.26. 1H–NMR spectrum of (R,S)–4–cholesteryloxycarbonyl–3,3–dimethyl–2–
oxetanone in acetone d6. 
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FT–IR (cast film): ?  = 3000–2850 (? aliphatic CH), 1841 (? lactone C=O), 1757 (? ester 
C=O), 1469 (? CH2), 1397 (? CH3) and 1276–1095 cm–1 (? C–O–C). cartaceo 
1H–NMR (200 MHz, acetone d6): ? = 0.68 (s, 3H; Chol–CH3CCHCHCH3), 0.85–2.04 
(38 H; Chol–H), 1.15 (s, 3 H; CH3C), 1.25 (s, 3 H; CH3C),1.20 (s, 3 H; CH3C), 1.45 (s, 3 
H; CH3C), 2.33–2.39 (m, 2H; Chol–CHCH2C=), 3.55–3.62 (dd, 1H; CH2C=O), 3.74–3.82 
(dd, 1H; CH2C=O), 4.45 (s, 1 H; CHC–OH), 4.65 (s, 1 H; OOC–CHC–O), 4.70–4.80 (m, 
1H; Chol–CHO), 4.81–4.84 (dd, 1H; O=CCH2CHO), and 5.39–5.41 ppm (m, 1H; chol–
CH=). 
4.2.3. Synthesis of 3–methyloxetane derivatives 
4.2.3.1. Synthesis of 3–(benzyloxymethyl)–3–methyloxetane (BMMO) 
A solution of 6.0 g (5.85 mL 58 mmoles) 3–methyl–3–oxetanemethanol, 1.0 g (3.0 
mmoles) tetrabutylammonium bisulphate and 11.7 mL of 50% KOH water solution was 
placed in a 100 mL flask, equipped with magnetic stirrer, reflux condenser, and dropping 
funnel. The mixture was heated at 40 °C then 7.56 mL (65.6 mmoles) of benzyl chloride 
was slowly added under constant stirring. The stirring was continued for 4 hours at 40°C. 
After cooling at room temperature, the reaction product was dissolved in 100 mL diethyl 
ether and washed with 200 mL of water. Distillation at reduced pressure gave 10.8 g 
(99% yield) of colourless liquid having b.p. 105–106 °C at 0.3–0.4 mbar) that was 
analyzed by glc and characterized by
 1H–NMR spectroscopy (Figs. 4.27 and 4.28). 
1H–NMR (200 MHz, CDCl3): ? = 1.35 (s, 3 H; CH3C), 3.56 (s, 2 H; CH2–OBz), 4.31–
4.61 (m, 8 H; CH2 of oxetane ring and CH2Ph) and 7.4 ppm (s, 5H; Ph–H). 
8 6 4 2 0 
Figure 4.27. 1H–NMR spectrum of 3–(benzyloxymethyl)–3–methyloxetane. 
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Figure 4.28. 13C–NMR spectrum of 3–(benzyloxymethyl)–3–methyloxetane in CDCl3. 
4.2.3.2. Synthesis of bis((3–methyloxetan–3–yl)methyl) terephthalate (BOMT) 
A solution of 17.9 g (175 mmoles) 3–methyl–3–oxetanemethanol and 26.6 g (262 
mmoles) triethylamine in 140 mL of anhydrous tetrahydrofuran was placed under dry 
nitrogen atmosphere in a 500 mL 3–necks round–bottom flask, equipped with mechanical 
stirrer, reflux condenser, and dropping funnel. The solution was cooled at 0 °C, then a 
solution of 17.8 g (87.5 mmoles) terephthaloyl chloride in 200 mL of water was added. 
The stirring was continued for 3 hours at 0–5 °C. The precipitate was filtered off and the 
filtrate was evaporated under reduced pressure. Crystallization from methyl ethyl 
ketone/n–hexane afforded 26.4 g (45% yield) of white crystals having m.p 123–124 °C 
that was characterized by 1H–NMR. (Fig. 4.29). 
FT–IR (liquid film): ?  = 1710 (? C=O), 1280–1253 (? C–O ester ) and 985 cm–1 (? C–O 
oxetane). 
 1H–NMR (200 MHz, DMSO–d6): ? = 1.40 (s, 6 H; CH3), 4.30– 4.55 (m, 12 H; CH2), 
4.65 and 8,07 ppm (s, 4 H; Ph–H). 
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Figure 4.29. 1H–NMR spectrum of bis((3–methyloxetan–3–yl)methyl) terephthalate in 
DMSO–d6. 
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4.3. SYNTHESIS OF POLYMERS 
 
4.3.1. Homopolymerization of ?–lactones 
 
Polymerization experiments of ?–lactones were performed according to common 
procedures. Data relevant to the different runs are summarized in Table 4.1 whereas 
typical experiments are described in some detail by following. 
 
Table 4.1. Homopolymerization of ?–lactones. 
Run Monomer Catalyst a Solvent Temp. Duration Yield 
 (Type) (g) (Type) (μl) (Type) (mL) (°C) (days) (%) 
pAl AllDML 0.58 TEABz 16.5 none – 40 5 71 
pBu BuDML 0.67 TEABz 17.6 none – 42 6 67 
pBz1 BzDML 0.78 TEABz 17.5 none – 40 7 70 
pCOL1 ChDML 0.50 TEABz 5.0 none – 40 7 0 
pPL1 PL 0.50 TEABz 36.5 none – 42 3 90 
pPL2 PL 0.50 TEABz 36.5 none – 25 7 15 
pPL3 PL 0.50 TEABz b 36.5 none – 40 7 90 
pBL1 ?–BL 0.50 TEABz 30.5 none – 40 9 0 
pHBu1 ?–HBuL 0.50 TEABz 25.7 none – 40 8 0 
pCL1 ?–CL 1.00 TEABz 46.0 none – 40 7 0 
pCL2 ?–CL 1.00 TEABz 4.1 none – 80 4 0 
pPL PL 0.50 TBABz 2.0 mg c none – 40 6 80 
pPL4 PL 0.50 TEABz 36.5 THF d 1 25 7 33 
pPL5 PL 0.50 TEABz 36.5 THF d 1 40 e 3 52 
pPL6 PL 0.50 TBAB 2.0 mg c THF 1 25 7 50 
pPL7 PL 0.50 TBAB 2.0 mg c THF 1 40 e 7 50 
pPL8 PL 0.50 TBAB 2.0 mg c THF 1 40 e 6 58 
pCOL2 ChDML 0.50 TEABz 5.0 THF 2 40 e 7 0 
pCOL3 ChDML 0.50 TEABz 5.0 THF 2 65 7 0 
pBL2 ?–BL 0.50 SnOct2 9.5 none – 100 1 0 
pBL3 ?–BL 0.50 SnOct2 9.5 none – 130 1 0 
pHBu2 ?–HBuL 0.50 SnOct2 8.0 none – 100 1 0 
pHBu3 ?–HBuL 0.50 SnOct2 8.0 none – 130 1 0 
pDDI2 LLact 0.50 SnOct2 6.7 none – 100 1 0 
pDDI3 LLact 0.50 SnOct2 6.7 none – 130 1 0 
pPL2 PL 0.50 SnOct2 11.3 none – 100 1 60 
pBz2 BzDML 0.50 SnOct2 3.5 none – 100 1 0 
pBz3 BzDML 0.50 SnOct2 3.5 none – 130 1 0 
a As 0.19 M ethanol solution, unless otherwise stated. b The catalyst ethanol solution was not evaporated 
before monomer addition. c The catalyst was added as dry crystals. d Containing 20% ethanol. e The solution 
was stirred for 1h at 25 °C. 
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4.3.1.1. Poly((R,S)–4–Allyloxycarbonyl–3,3–dimethyl–2–oxetanone) 
Run pAl: (R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone (0.578 g, 3.14 mmoles) 
was placed under nitrogen atmosphere in a 10 mL schlenck whose bottom was previously 
coated with tetraethylammonium benzoate by vacuum evaporation of 16.5 μl of 0.19 M 
quaternary ammonium salt solution in ethanol. The mixture was kept under stirring at 40 
°C until disappearance of 1848 cm–1 band in the FT–IR spectrum of the reaction product. 
The polymerization reaction was stopped by addition of one drop of acetic acid. The 
polymeric product was dissolved in dichloromethane and purified by double precipitation 
into a tenfold excess of cyclohexane. The coagulated polymer was dried under vacuum up 
to constant weight to give 0.412 g (71% yield) of colourless product that was 
characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.30 and 4.31). 
FT–IR (cast film): ? = 3088 and 3021 (? unsatured CH), 2988–2750 (? aliphatic CH), 
1746 (? C=O), 1649 (? C=C), 1469 (? CH2), 1394 and 1373 (? CH3), 1262–1056 (? C–O–
C), 991 and 938 cm–1 (? vinyl CH). 
1H–NMR (200 MHz, CDCl3): ? = 1.20 (3 H; CH3C), 1.45 (3 H; CH3C), 4.65 (H; CH–O), 
5.2 (2 H; CH2Ph) and 7.4 ppm (5 H; Ph–H).  
 
4.3.1.2. Poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–oxetanone) 
Run pBu: Starting from 0.67 g (3.14 mmoles) (R,S)–4–butyloxycarbonyl–3,3–dimethyl–
2–oxetanone and 17.6 μl of 0.19 M tetraethylammonium benzoate ethanol solution, the 
above procedure afforded 0.40 g (67% yield) of colourless product that was characterized 
by FT–IR, 1H–NMR, and 13C–NMR spectroscopy (Figs. 4.32–4.34). 
FT–IR (cast film): ?  = 2962–2876 (? aliphatic CH), 1746 (? C=O), 1467 (? CH2), 1393 
(? CH3) and 1261–1060 cm–1 (? C–O–C). 
1H–NMR (200 MHz, CDCl3): ? = 0.8–1 (3H; CH3CH2–CH2–CH2), 1.30–1.50 (6 H; 
CH3C), 1.30–1.50 (2 H; CH2CH3), 1.60–1.80 (2 H; CH2CH2–O) 4.25 (2 H; –CH2–O) and 
5.4 ppm (1 H; CH–O). 
13C–NMR (200 MHz, CDCl3): 13.70 (CH3CH2), 19.06 (CH3CH2), 20.1–22.7 (CH3–C and 
CH3CH2), 30.51 (CH2CH2O), 45.27 (CH3–C–CH3), 65.47 (CH2O), 76.10 (CH–O), 167.61 
(C=O ester main chain) and 173,06 ppm (C=O ester side chain). 
4.3.1.3. Poly((R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone) 
Run pBz1: Starting from 0.78 g (3.14 mmoles) (R,S)–4–benzyloxycarbonyl–3,3–
dimethyl–2–oxetanone and 17.5 μl of 0.19 M tetraethylammonium benzoate ethanol 
solution, the above procedure afforded 0.55 g (70% yield) of colourless product that was 
characterized by FT–IR, 1H–NMR, and 13C–NMR spectroscopy (Figs. 4.35–4.37). 
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Figure 4.30. FT–IR spectrum of poly((R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetan-
one). 
 
 
 
 
 
 
 
 
 
Figure 4.31. 1H–NMR spectrum of poly((R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–
oxetanone)in CDCl3 
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Figure 4.32. FT–IR spectrum of poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–oxeta-
none). 
 
 
 
 
 
 
 
 
 
Figure 4.33. 1H–NMR spectrum of poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone) in CDCl3. 
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Figure 4.34. 13C–NMR spectrum of poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone) in CDCl3. 
 
 
 
 
 
 
 
 
 
Figure 4.35. FT–IR spectrum of poly((R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone). 
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Figure 4.36. 1H–NMR spectrum of poly((R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone) in acetone–d6. 
 
Figure 4.37. 13C–NMR spectrum of poly((R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone)in acetone–d6. 
 
FT–IR (cast film): ?  = 3067 and 3035 (? aromatic CH), 2986–2888 (? aliphatic CH), 
1656 (? C=O ester), 1611, 1588 and 1498 (? C=C), 1463 (? CH2), 1385 (? CH3), 1260–
1054 (? C–O–C), 747 and 700 cm–1 (? CH phenyl). 
1H–NMR (200 MHz, CDCl3): ? = 1.0–1.3 (6 H; CH3C), 5–5.1 (2 H; CH2Ph), 5.3–5.4 (1 
H; CHO) and 7.2–7.4 ppm (2 H; Ph–H). 
13C–NMR (200 MHz, acetone–d6): 19,48–20,85 (CH3–C), 44,12 (C–CH3), 75,26 (CH2–
O), 77,53 (CH–O), 167,59 and 167,70 (C=O ester main chain), 172,18 and 172,36 ppm 
(C=O ester side chain). 
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4.3.1.4. Poly(propiolactone) 
Run pPL1: Starting from 0.50 g (6.9 mmoles) propiolactone and 36.5 μl of 0.19 M 
tetraethylammonium benzoate ethanol solution, the above procedure afforded 0.45 g 
(90% yield) of colourless product that was characterized by FT–IR, 1H–NMR, and 13C–
NMR spectroscopy (Figs. 4.38–4.40). 
FT–IR (cast film): ?  = 2969–2852 (? aliphatic CH), 1732 (? ester C=O), 1461 (? CH2), 
and cm–11265–1075 (? C–O–C). 
1H–NMR (200 MHz, CDCl3): ? = 1.20 (s, 3 H; CH3C), 1.45 (s, 3H; CH3C), 4.65 (s, 1 H; 
OOC–CHC–O), 5.2 (s, 2H; CH2Ph) and 7.4 ppm (s, 5H; Ph–H). 
 
Figure 4.38. FT–IR spectrum of poly(propiolactone). 
 
Figure 4.39.  1H–NMR spectrum of poly(propiolactone) in CDCl3. 
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Figure 4.40.  13C–NMR spectrum of poly(propiolactone) in CDCl3. 
13C–NMR (200 MHz CDCl3,): ? = 33.64 (CH2C=O), 60.14 (OCH2CH2) and 170.35 ppm 
(CH2C=O). 
Run pPL2: ??propiolactone (0.50 g, 6.9 mmoles) was placed under nitrogen atmosphere 
in a 10 mL schlenck, than SnOct2 (11.3 μl, 34.9. μmol) was added. The mixture was kept 
under stirring at 100 °C for 24 h. The polymeric product was dissolved in 
dichloromethane and purified by double precipitation into a tenfold excess of methanol. 
The coagulated polymer was dried under vacuum up to constant weight to give 0.30 g 
(60% yield) of colourless product that was characterized by FT–IR, 1H–NMR, and 13C–
NMR spectroscopy. 
4.3.2. Copolymerization of ?–lactones 
 
Copolymerization experiments of ?–lactones were performed according to common 
procedures. Data relevant to the different runs are summarized in Table 4.2 whereas 
typical experiments are described in some detail by following. 
Table 4.2. Copolymerization of ?–lactones monomers by using TEABz as catalyst. 
Run Monomer 1 Monomer 2 Catalyst Temp. Duration Yield 
 (Type) (g) (Type) (g) (μl) (°C) (days) (%) 
pBuBz BzDML 0.25 LatBut 0.86 28.3 40 10 28 
pBzPL80 BzDML 0.45 PL 0.56 50.5 42 5 90 
pBzPL95 BzDML 0.20 PL 1.16 89.5 40 3 66 
pPLCL20 ?–CL 0.26 PL 0.14 13.2 42 7 0 
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4.3.2.1. Poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–oxetanone–co–(R,S)–4–
benzyloxycarbonyl–3,3–dimethyl–2–oxetanone) 
Run pBuBz: 0.25 g (3.14 mmoles) (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone and 0.86 g (3.14 mmoles) (R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone were placed under nitrogen atmosphere in a 10 mL schlenck whose bottom 
was previously coated with tetraethylammonium benzoate (TEAB) by vacuum 
evaporation of 28.3 μl of 0.19 M quaternary ammonium salt solution in ethanol. The 
mixture was kept under stirring at 38–42 °C until disappearance of 1848 cm–1 band in the 
FT–IR spectrum of the reaction product. The polymerization reaction was stopped by 
addition of one drop of acetic acid. The polymeric product was dissolved in 
dichloromethane and purified by double precipitation into a tenfold excess of 
cyclohexane. The coagulated polymer was dried under vacuum up to constant weight to 
give 0.31 g (28% yield) of colourless product that was characterized by FT–IR, 1H–NMR, 
and 13C–NMR spectroscopy (Figs. 4.41–4.43). 
FT–IR (cast film): ?  = 3091, 3066, and 3034 (? aromatic CH), 2971–2856 (? aliphatic 
CH), 1740 (? ester C=O), 1611, 1588, and 1499 (? C=C), 1461 (? CH2), 1389 and 1377 
(? CH3), 1261–1074 (? C–O–C), 749 and 702 cm–1 (? CH phenyl). 
1H–NMR (200 MHz, CDCl3): ? = 0.9 (CH3CH2), 1.3 (CH3C and CH2CH3), 1.6 
(CH2CH2O), 4.25 (CH2CH2O), 5.1 (CH2O benzyl), 5.3 (CH–O) and 7,3 ppm (Ph–H). 
 
 
 
Figure 4.41. FT–IR spectrum of poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone–co–(R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone). 
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Figure 4.42.  1H–NMR spectrum of poly((R,S)–4–butyloxycarbonyl–3,3–dimethyl–2–
oxetanone–co(R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone) in 
CDCl3. 
 
Figure 4.43.  13C–NMR spectrum of poly(butyl (R,S)–3,3–dimethylmalate–co–benzyl 
(R,S)–3,3–dimethylmalate) in CDCl3. 
 
 
13C–NMR (200 MHz, CDCl3): 12.33 (CH3CH2), 18.05 (CH3CH2), 19.2–20.9 (CH3–C), 
29.6 (CH2CH2O), 44.24 (CH3–C–CH), 64.26 and 64.31 (CH2CH2O), 66.11 and 66.24 
(CH2O benzyl), 75.34 and 75.53 (CH–O), 127.68 (CH phenyl), 134.66 (C quaternary 
phenyl), 166.44 (C=O ester main chain), 171.89 (C=O benzyl ester) and 172.03 ppm 
(C=O butyl ester). 
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4.3.2.2. Poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetan–
one) 80:20 
Run pBzPL80: Starting from 0.45 g (3.14 mmoles) (R,S)–4–benzyloxycarbonyl–3,3–
dimethyl–2–oxetanone, 0.56 g (3.14 mmoles) ?–propiolactone, and 50.5 μl of 0.19 M 
tetraethylammonium benzoate ethanol solution, the above procedure afforded 0.91 g 
(90% yield) of colourless product that was characterized by FT–IR, 1H–NMR, and 13C–
NMR spectroscopy (Figs. 4.44–4.46). 
 
Figure 4.44. FT–IR spectrum of poly(propiolattone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 80:20 in CDCl3. 
 
Figure 4.45. 1H–NMR spectrum of poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 80:20 in CDCl3. 
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Figure 4.46. 13C–NMR spectrum of poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 80:20 in CDCl3. 
 
FT–IR (cast film): ?  = 3089 and 3066 (? aromatic CH), 2968–2850 (? aliphatic CH), 
1734 (? ester C=O), 1461 (? CH2), 1263–1070 (? C–O–C), 756 and 703 cm–1 (? phenyl 
CH). 
1H–NMR (200 MHz, CDCl3): ? = 1.2 (CH3C), 2.6 (CH2C=O PL), 4.3 (CH2O PL), 5.2 
(CH2Ph), 5.3 (CHO), and 7.3 ppm (Ph–H). 
13C–NMR (CDCl3, 200 MHz): 20.94 and 21.53 (CH3–C), 33.62 (CH2–C=O PL), 45.02 
(CH–O), 60.10 (CH2–O PL), 67.55 (CH2–O benzyl), 128.09 and 128.68 (CH phenyl), 
134.87 (C phenyl quaternary ), 165.97 and 167.61 (C=O ML), 170.41 (C=O PL), 173.91 
ppm (C=O benzyl ester). 
4.3.2.3. Poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetan-
one) 95:5 
Run pBzPL95: Starting from 0.20 g (3.14 mmoles) (R,S)–4–benzyloxycarbonyl–3,3–
dimethyl–2–oxetanone, 1.16 g (3.14 mmoles) ?–propiolactone, and 89.5 μl of 0.19 M 
tetraethylammonium benzoate ethanol solution, the above procedure afforded 0.90 g 
(66% yield) of colourless product that was characterized by FT–IR, 1H–NMR, and 13C–
NMR spectroscopy (Figs. 4.47–4.49). 
FT–IR (cast film): ?  = 3063 and 3035 (? aromatic CH), 2962–2877 (? aliphatic CH), 
1747 (? ester C=O), 1611, 1588, and 1499 (? C=C), 1466 (? CH2), 1390 (? CH2), 1262–
1058 (? C–O–C), 747 and 701 cm–1 (? CH phenyl). 
1H–NMR (200 MHz, CDCl3): ? = 1.2 (CH3C), 2.6 (CH2C=O PL), 4.3 (CH2O PL), 5.2 
(CH2Ph), 5.3 (CHO), and 7.3 ppm (Ph–H). 
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13C–NMR (200 MHz, acetone–d6): ? = 2.33 (CH3CH2), 18.05 (CH3–C), 19.2–20.9 (CH3–
C), 44.24 (CH2CH2O), 64.26 and 64.31 (C–C=O), 66.11 and 66.24 (CH2O), 127.68 (CH 
phenyl), 134,66 (C phenyl quaternary), 166.44 (C=O ester main chain), 171.89 (C=O 
benzyl ester) and 172.03 ppm (C=O butyl ester). 
 
 
Figure 4.47. FT–IR spectrum of poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 95:5. 
 
 
 
Figure 4.48. 1H–NMR spectrum of poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 95:5 in CDCl3. 
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Figure 4.49. 13C–NMR spectrum of poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–
3,3–dimethyl–2–oxetanone) 95:5 in acetone–d6. 
4.3.3. Polymerization of oxetanes with cyclic anhydrides 
 
Polymerization experiments of oxetanes with cyclic anhydrides were performed 
according to common procedures. Data relevant to the different runs are summarized in 
Table 4.3, whereas a few typical experiments are described by following. 
4.3.3.1. Polymerization of 3–methyl–3–oxetanemethanol with succinic anhydride 
Run AS1: A mixture of 500 mg (4.89 mmoles) of 3–methyl–3–oxetanemethanol, 490 mg 
(4.89 mmoles) of succinic anhydride, and 205 mg (0.489 mmoles) of tetraphenyl-
phosphonium bromide was placed under dry nitrogen atmosphere in a glass vial, 
equipped with magnetic stirrer and connected to a condenser trap. The vial was cooled, 
degassed under vacuum, and sealed; the reaction mixture was kept under stirring at 130 
°C for 24 hours. The orange–brown solid product resulted insoluble in water and in the 
common organic solvents. 
4.3.3.2. Polymerization of 2–(benzyloxymethyl)–3–methyloxetane with phthalic 
anhydride 
Run BEAP9: A mixture of 1.3 g (6.7 mmoles) of 2–benzyloxymethyl–3–methyloxetane, 
1.0 g (6.7 mmoles) of phthalic anhydride, and 0.28 g (0.67 mmoles) of tetraphenyl-
phosphonium bromide was placed under dry argon atmosphere in a glass vial, equipped 
with magnetic stirrer and connected to a condenser trap. The vial was cooled, degassed 
under vacuum, and sealed; the reaction mixture was kept under stirring at 130 °C for 24 
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hours. After cooling at room temperature, the crude product was dissolved in 5 mL THF, 
coagulated in a large excess of 1:10 EtOH/n–hexane, and finally dried to constant weigh 
to give 1.41 g (60% yield) that was characterized by FT–IR and
 1H–NMR spectroscopy 
(Figs. 4.50 and 4.51). 
FT–IR (cast film): ?  = 3063 and 3035 (? aromatic CH), 2986–2888 (? aliphatic CH), 
1725 (? C=O ester), 1598 and 1498 (? C=C), 1463 (? CH2), 1385 (? CH3), 1260–1054 (? 
C–O–C), 747 and 700 cm–1 (? CH phenyl). 
1H–NMR (200 MHz, CDCl3): ? = 1.05 (3H; CH3C), 3.20 (2H; CH2OBz), 4.2–4.6 (6 H; 
CH2Ph and CH2 main chain ) and 7.2–7.4 ppm (9 H; Ph–H). 
Table 4.3. Copolymerization of oxetanes with cyclic anhydrides.a 
Run Oxetanes Anhydride Catalyst Temp. Duration Yield 
 (Type) (g) (Type) (g) (Type) (g) (°C) (days) (%) 
AS1 MOM 0.50 SAn 0.49 TPPB 0.21 130 1 95 
BEAS2 BMMO 1.50 SAn 0.78 TPPB 0.33 130 1 0 
BEAS3 BMMO 0.96 SAn 0.50 TBPB 0.17 60 0.2 0 
BEAS4 BMMO 0.96 SAn 0.50 TBPB 0.17 100 1 0 
AP1 MOM 1.0 PAn 1.45 TPPB 0.41 130 24 42 
BEAP2 BMMO 2.0 PAn 1.54 TPPB 0.44 60 5 0 
BEAP3 BMMO 2.0 PAn 1.54 TPPB 0.44 100 24 20 
BEAP4 BMMO 1.5 PAn 1.16 TPPB 0.33 130 24 25 
BEAP5 BMMO 2.0 PAn 1.54 TBAB 0.33 60 5 0 
BEAP6 BMMO 1.5 PAn 1.16 TBAB 0.25 100 24 10 
BEAP7 BMMO 1.0 PAn 0.77 TBPB 0.17 130 24 10 
BEAP8a BMMO  0.77 PAn 0.59 TPPB 0.17 60 6 0 
BEAP9a BMMO  1.0 PAn 0.77 TBPB 0.17 60 6 0 
BEAP9a BMMO 1.3 PAn 1.00 TPPB 0.28 130 24 60 
BEAP10a BMMO 6.5 PAn 5.00 TPPB 1.40 140 24 83 
a Runs carried out with vacuum–dried oxetane and phthalic anhdride. 
4.3.4. Polymerization of bis(3–methyl–3–oxetanemethyl) terephthalate) with 
dicarboxylic acids 
 
Copolymerization experiments of bis((3–methyloxetan–3–yl)methyl) terephthalate) 
(BOMT) with dicarboxylic acid, were performed according to common procedures. Data 
BENEDETTA CERBAI – PHD THESIS 
 96 
relevant to the different runs are summarized in Tables 4.4, whereas a few typical 
experiments are described by following. 
 
Table 4.4. Anionic polymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) 
(BOMT) with dicarboxylic acid. 
Run a BOMT Dicarboxylic acid TPPB  TMU Yield 
 (g) (Type) (mg) (mg)  (mL) (%) 
BOPSU 2.33 SucAc 530 188 2.5 25 
BOPPA 1.32 AdpAc 576 165 3.0 25 
BOPPS 1.04 SebAc 40.1884 84 1.0 30 
BOPITA 3.11 ItcAc 780 250 3.3 30 
BOPCI 2.48 ChxAc 770 188 2.5 30 
BOPATP b 1.56 AdpAc/tPTAc 350 1250 2.5 42 
BOPAIP c 1.56 AdpAc/iPTAc 350 1250 2.5 25 
a At 140 °C for 24 h. b 0.10 g of terephthalic acid were also present in the reaction mixture. c 0.10 g of 
isophthalic acid were also present in the reaction mixture. 
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Figure 4.50.  FT–IR spectrum of the polymerization product of 2–(benzyloxymethyl)–3–
methyloxetane with phthalic anhydride. 
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Figure 4.51. 1H–NMR spectrum of the polymerization product of 2–(benzyloxymethyl)–
3–methyloxetane with phthalic anhydride in CDCl3. 
4.3.4.1. Copolymerization of bis(((3–methyloxetan–3–yl)methyl) terephthalate) with 
sebacic acid 
Run BOPPS: Starting from a solution of 1.04 g (2.0 mmoles) of bis(((3–methyloxetan–
3–yl)methyl) terephthalate) (BOMT), 404 mg (2.0 mmoles) of sebacic acid, and 84 mg 
(0.20 mmoles) of tetraphenylphosphonium bromide in 1.0 mL tetramethylurea, the above 
procedure afforded 0.433 g (30% yield) of colourless product that was characterized by 
FT–IR and 1H–NMR (Figs. 4.52 and 4.53) spectroscopy.  
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Figure 4.52. FT–IR spectrum of the polymerization product of (3–methyloxetan–3–
yl)methyl terephthalate with sebacic acid. 
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Figure 4.53. 1H–NMR spectrum of the polymerization product of (3–methyloxetan–3–
yl)methyl terephthalate with sebacic acid in DMSO–d6. 
FT–IR (cast film): ?  = 3437 (? OH), 3000–2850 (? aliphatic CH), 1722 (? ester C=O), 
1505 (? aromatic C=C) and 1270 cm–1 (? ester C–O–C). 
1H–NMR (200 MHz, DMSO–d6): ? = 0.60–1.80 (m, 18 H; CH3 and CH2–CH2–CH2), 
2.20 (s, 4 H; CO–CH2–CH2), 3.40 (s, 4 H; C–CH2–OH), 3.46–5.20 (m, 10H ;O– CH2–C 
and CH2–OH) and 8,10 ppm (s, 4 H; Ph–H). 
4.3.4.2. Copolymerization of bis(((3–methyloxetan–3–yl)methyl) terephthalate) with 
itaconic acid 
Run BOPITA: Starting from a solution of 3.11 g (9.3 mmoles) of bis(((3–methyloxetan–
3–yl)methyl) terephthalate), 1.22 g (9.3 mmoles) of itaconic acid, and 390 mg (0.90 
mmoles) of tetraphenylphosphonium bromide in 6.6 mL tetramethylurea, the above 
procedure afforded 2.17 g (30% yield) of colourless product that was characterized by 
FT–IR and 1H–NMR spectroscopy (Figs. 4.54 and 4.55). 
FT–IR (cast film): ?  = 3423 (? OH), 2964–2880 (? aliphatic CH), 1722 (? ester C=O), 
1505 (? aromatic C=C) and 1270 cm–1 (? ester C–O–C). 
1H–NMR (200 MHz, DMSO–d6): ? = 0.60–1.80 (m, 6 H; CH3), 3.26 (s, 6 H; CH2–OH 
and CH2–COO), 3.80–4.80 (m, 10H; O– CH2–C and CH2–OH), 5.8–6.2 (s C=CH2) and 
8,06 ppm (s, 4 H; Ph–H). 
4.3.4.3. Copolymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) with 
succinic acid 
Run BOPSU: A solution of 1.50 g (4.49 mmoles) of ((3–methyloxetan–3–yl)methyl) 
terephthalate), 530 mg (4.49 mmoles) of succinic acid, and 188 mg (0.449 mmoles) of 
tetraphenylphosphonium bromide in 2.5 mL tetramethylurea was placed under dry argon 
atmosphere in a glass vial, equipped with magnetic stirrer and connected to a condenser 
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trap,. The vial was cooled, degassed under vacuum, and sealed; the reaction mixture was 
stirred at 130 °C for 24 hours. After cooling at room temperature, the crude product was 
dissolved in 3 mL THF, coagulated in water, reprecipitated from THF into diethyl ether, 
and finally dried to constant weigh to give 0.715 g (25% yield) that was characterized by 
FT–IR and
 1H–NMR spectroscopy (Figs. 4.56 and 4.57). 
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Figure 4.54.  FT–IR spectrum of the polymerization product of (3–methyloxetan–3–
yl)methyl terephthalate with itaconic acid. 
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Figure 4.55. 1H–NMR spectrum of the polymerization product of (3–methyloxetan–3–
yl)methyl terephthalate with itaconic acid in DMSO–d6. 
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Figure 4.56.  FT–IR spectrum of the polymerization product of bis((3–methyloxetan–3–
yl)methyl) terephthalate with succinic acid. 
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Figure 4.57. 1H–NMR spectrum of the polymerization product of bis((3–methyloxetan–
3–yl)methyl) terephthalate with succinic acid in DMSO–d6. 
 
 
 
FT–IR (cast film): ?  = 3440 (? OH), 2964–2880 (? aliphatic CH), 1722 (? ester C=O), 
1505 (? aromatic C=C) and 1270 cm–1 (? ester C–O–C). 
1H–NMR (200 MHz, DMSO–d6): ? = 0.60–1.80 (m, 6 H; CH3 and CH2–CH2–CH2), 
2.26 (s, 4 H; CO–CH2–CH2), 3.40 (s, 4 H; C–CH2–OH), 3.72–5.20 (m, 10H; O– CH2–C 
and CH2–OH) and 8,06 ppm (s, 4 H; Ph–H). 
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4.3.4.4. Copolymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) with 
adipic acid 
Run BOPPA: Starting from a solution of 1.30 g (3.95 mmoles) of bis((3–methyloxetan–
3–yl)methyl) terephthalate (BOMT), 0.576 g (3.95 mmoles) of adipic acid, and 0.165 g 
(0.395 mmoles) of tetraphenylphosphonium bromide in 3.0 mL tetramethylurea, the 
above procedure afforded 0.66 g (25% yield) of colourless product that was characterized 
by FT–IR and 1H–NMR spectroscopy (Figs. 4.58 and 4.59). 
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Figure 4.58.  FT–IR spectrum of the polymerization product of bis((3–methyloxetan–3–
yl)methyl) terephthalate with adipic acid. 
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Figure 4.59. 1H–NMR spectrum of the polymerization product of (3–methyloxetan–3–
yl)methyl terephthalate with adipic acid in DMSO–d6. 
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FT–IR (cast film): ?  = 3437 (? OH), 3000–2850 (? aliphatic CH), 1722 (? ester C=O), 
1505 (? aromatic C=C) and 1270 cm–1 (? ester C–O–C). 
1H–NMR (200 MHz, DMSO–d6): ? = 0.60–1.80 (m, 10 H; CH3 and CH2–CH2–CH2), 
2.26 (s, 4 H; CO–CH2–CH2), 3.40 (s, 4 H; C–CH2–OH), 3.72–5.20 (m, 10H; O– CH2–C 
and CH2–OH) and 8,06 ppm (s, 4 H; Ph–H). 
4.3.4.5. Copolymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) with 
1,4–cyclohexanedicarboxylic acid 
Run BOPCI: Starting from a solution of 1.5 g (4.78 mmoles) of bis((3–methyloxetan–3–
yl)methyl) terephthalate) (BOMT), 770 mg (4.78 mmoles) of adipic acid, and 188 mg 
(0.45 mmoles) of tetraphenylphosphonium bromide in 3.3 mL tetramethylurea, the above 
procedure afforded 0.87 g (30% yield) of colourless product that was characterized by 
FT–IR and 1H–NMR spectroscopy (Figs. 4.60 and 4.61). 
FT–IR (cast film): ?  = 3432 (? OH), 2944–2880 (? aliphatic CH), 1723 (? ester C=O), 
1505 (? aromatic C=C) and 1269 cm–1 (? ester C–O–C). 
1H–NMR (200 MHz, DMSO–d6): ? = 0.80–2.20 (m, 17H; CH3 and CH3 ciclo ), 3.26 (s, 4 
H; CH2–OH), 3.80–4.80 (m, 10H; O–CH2–C and CH2–OH) and 8,06 ppm (s, 4 H; Ph–H). 
 
 
 
 
100
80
60
40
20
Tr
an
sm
itt
an
ce
 (%
)
4000 3600 3200 2800 2400 2000 1600 1200 800 400
Wavenumber (cm-1)  
Figure 4.60.  FT–IR spectrum of the polymerization product of bis((3–methyloxetan–3–
yl)methyl) terephthalat with 1,4–cyclohexanedicarboxylic acid. 
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Figure 4.61. 1H–NMR spectrum of poly(bis((3–methyloxetan–3–yl)methyl) 
terephthalate)–co–1,4–cyclohexanedicarboxylic acid) in DMSO–d6. 
4.3.4.6. Copolymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) with 
80:20 adipic acid/terephthalic acid mixture 
Run BOPATP: A solution of 1.0 g (3.0 mmoles) of bis((3–methyloxetan–3–yl)methyl) 
terephthalate), 0.350 g (2.4 mmoles) of adipic acid, 0.10 g (0.6 mmoles) of terephthalic 
acid, and 1.250 g (0.3 mmoles) tetraphenylphosphonium bromide in 2.5 mL 
tetramethylurea was placed under dry nitrogen atmosphere in a glass vials, equipped with 
magnetic stirrer and connected to a condenser trap. The vial was cooled, degassed, and 
sealed; the resulting mixture was stirred at 140 °C for 24 hours. After cooling at room 
temperature, the crude product was dissolved in 2 mL THF, coagulated in water, 
reprecipitated from THF into diethyl ether, and finally dried to constant weigh to give 
0.84 g (42% yield) of colorless solid that was characterized by FT–IR and
 1H–NMR (Fig. 
4.62) spectroscopy. 
4.3.4.7. Copolymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate with 
80:20 adipic acid/isophthalic acid mixture  
Run BOPAIP: A solution of 1.0 g (3.0 mmoles) of bis((3–methyloxetan–3–yl)methyl) 
terephthalate), 0.350 g (2.4 mmoles) of adipic acid, 0.10 g (0.6 mmoles) of terephthalic 
acid, and 1.250 g (0.3 mmoles) tetraphenylphosphonium bromide in 2.5 mL 
tetramethylurea was placed under dry nitrogen atmosphere in a glass vials, equipped with 
magnetic stirrer and connected to a condenser trap. The vial was cooled, degassed, and 
sealed; the resulting mixture was stirred at 140 °C for 24 hours. After cooling at room 
temperature, the crude product was dissolved in 2 mL THF, coagulated in water, 
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reprecipitated from THF into diethyl ether, and finally dried to constant weigh to give 
0.498 g (25% yield) that was characterized by FT–IR and 1H–NMR spectroscopy (Figs. 
4.63 and 4.64). 
12 10 8 6 4 2 0 PPM -2  
Figure 4.62. 1H–NMR spectrum of the copolymerization product of bis((3–
methyloxetan–3–yl)methyl) terephthalate) with 80:20 adipic 
acid/terephthalic acid mixture in DMSO–d6. 
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Figure 4.63. FT–IR spectrum of the copolymerization product of bis((3–methyloxetan–
3–yl)methyl) terephthalate) with 80:20 adipic acid/isophthalic acid 
mixture. 
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Figure 4.64. 1H–NMR spectrum of the copolymerization product of bis((3–
methyloxetan–3–yl)methyl) terephthalate) with 80:20 adipic 
acid/isophthalic acid mixture in DMSO–d6. 
BENEDETTA CERBAI – PHD THESIS 
 106
4.4. MODIFICATION OF POLYESTERS 
 
4.4.1. Hydrogenation of poly(benzyl (R,S)–3,3–dimethylmalate) 
 
A solution of 390 mg (1.66 mmoles) poly(benzyl (R,S)–3,3–dimethylmalate) in 28 mL of 
freshly distilled acetone was placed under dry nitrogen atmosphere in 100 mL two–
necked round–bottom flask, equipped with magnetic stirrer and reflux condenser. 
Palladium/C (78 mg, 20%) was added, the nitrogen atmosphere was replaced by 
hydrogen, and the mixture was left overnight at room temperature. The organic layer was 
filtered on celite and concentrated under vacuum to give 233 mg (97% yield) of a white 
product that was characterized by FT–IR,
 1H–NMR, and
 13C–NMR spectroscopy (Figs. 
4.65–4.67).  
FT–IR (cast film): ?  = 3700–2300 (? COOH), 3000–2850 (? aliphatic CH), 1740 (? 
C=O), 1469 (? CH2), 1391 and 1376 (? CH2) and 1254–1052 cm–1 (? C–O–C). 
1H–NMR (200 MHz, acetone–d6): ? = 1.3–1.4 (CH3), 5,35 (CH) and 5–6 ppm (OH). 
13C–NMR (200 MHz, acetone–d6): ? = 19.48–20.85 (CH3–C), 44.12 (C–CH3), 75.26 
(CH2–O), 77.53 (CH–O), 167.59 and 167.70 (C=O ester main chain), 172.18 and 172.36 
ppm (C=O ester side chain). 
 
 
 
Figure 4.65. FT–IR spectrum of poly((R,S)–3,3–dimethylmalic acid). 
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Figure 4.66. 1H–NMR spectrum of poly((R,S)–3,3–dimethylmalic acid) in acetone–d6. 
 
Figure 4.67. 13C–NMR spectrum of poly((R,S)–3,3–dimethylmalic acid) in acetone–d6. 
4.4.2. Hydrogenation of poly(allyl (R,S)–3,3–dimethylmalate) 
 
A solution of 310 mg (1.63 mmoles) poly(allyl (R,S)–3,3–dimethylmalate), 47 mg (40.7 
μmoles) of palladium tetrakistriphenylphosphine, and 21 mg (81.1 μmoles) of 
triphenylphosphine in 6 mL of dry dichloromethane was placed under dry nitrogen 
atmosphere in 25 mL flask, equipped with mechanical stirrer, reflux condenser, and 
dropping funnel. The solution was cooled at 0 °C, then a solution of 143 μL (0.122 g, 
1.71 μmoli) pyrrolidine in 1.0 mL of anhydrous dichloromethane was added. The mixture 
was stirred at room temperature for 30 min, then the crude product was washed with 50 
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ml of 5% NaHCO3 and two 500 ml portions of ethyl acetate. The aqueous phases was 
acidified to pH 2 with 5% hydrochloric acid. The solid product was filtrered, dissolved in 
acetone and purified by double precipitation in dichloromethane. The coagulated polymer 
was dried under vacuum to give 186 mg (77 % yield) of a white polymer that was 
characterized by FT–IR and 1H–NMR spectroscopy (Figs. 4.68 and 4.69). 
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Figure 4.68. FT–IR spectrum of poly((R,S)–3,3–dimethylmalic acid). 
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Figure 4.69. 1H–NMR spectrum of poly((R,S)–3,3–dimethylmalic acid) in acetone–d6. 
FT–IR (cast film): ?  = 3700–2300 (? COOH), 3000–2850 (? aliphatic CH), 1740 (? 
C=O), 1469 (? CH2), 1391 and 1376 (? CH2) and 1254–1052 cm–1 (? C–O–C). 
1H–NMR (200 MHz, acetone–d6): ? = 1.3–1.4 (CH3), 5,35 (CH) and 5–6 ppm (OH). 
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13C–NMR (200 MHz, acetone–d6): ? = 19.48–20.85 (CH3–C), 44.12 (C–CH3), 75.26 
(CH2–O), 77.53 (CH–O), 167.59 and 167.70 (C=O ester main chain), 172.18 and 172.36 
ppm (C=O ester side chain). 
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5. RESULTS AND DISCUSSION 
 
 
In the last decades, biomaterial science experienced an enormous expansion, due to its 
peculiar connections with others scientific, medical, and engineering disciplines, 
including molecular and cell biology, human physiology, and material science.  
As a part of a long standing research activity ongoing on the synthesis, characterization, 
and applications of polymeric materials in the biomedical and pharmaceutical fields 
[Chiellini 1995], the present work was aimed at the development of bioactive polymeric 
materials, whose characteristics are potentially useful for drug delivery and tissue 
engineering applications. Indeed, careful design of polymeric structures can afford highly 
tailored encapsulation and release properties of bioactive agents, and can also constitute a 
suitable starting point for the development of targeted drug delivery systems. The adopted 
strategy is based on the design of special polymer classes, whose structures can be easily 
modified by optimized synthetic procedures, thus allowing for the fine control over 
material properties, such us hydrophilic–hydrophobic balance. Polyesters containing 
pendant hydroxyl groups were chosen as promising materials for targeted drug delivery 
applications. In this perspective, oxetane polymers are of interest, and indeed many 
examples of cationic ring–opening polymerization of oxetanes, oxiranes, and oxolanes 
were reported [Kameyama 2002, Nishikubo 1998]. One of the effective approaches to 
improve the thermal and mechanical properties of aliphatic polyesters is incorporation of 
aromatic ester moieties in the polyester chain [Okada 2002]. Lee et al. [Lee 1999] 
synthesized a series of aliphatic/aromatic copolyesters by polycondensation of succinic 
acid, dimethyl terephthalate and 1,4–butandiol, and evaluated their material 
characteristics and biodegradability. The tensile strength is relatively unaffected, while 
the elongation at break increases remarkably with increasing butylene terephthalate 
content. In particular, the sample with 40 mol% butylene terephthalate content shows 
550% elongation at break. At high butylene terephthalate content where the crystallinity 
of the copolyesters is suppressed, the tangent modulus of the copolyesters is relatively 
low. However, the butylene terephthalate segments contribute largely to increase the 
elongation at break, leading to good tensile strength of the copolyesters. 
As expected, the rate of biodegradation decreases with increasing butylene terephthalate 
content in the copolyesters. Although it is well known that the degree of crystallinity is an 
important factor in determining microbial degradability, the effect of the degree of 
crystallinity on the biodegradation rate was not observed, probably because the influence 
of the chemical structure on biological resistance overrides the biodegradability of the 
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copolyesters. In soil burial tests, the mechanical properties of the copolyester films 
decreased rapidly, and the films with a butylene terephthalate content of less than 20 
mol% could not be recovered after four weeks. 
Maeda et al. [Maeda 2000] synthesized random copolyesters by transesterification of 
poly(ethylene terephthalate) (PET) and poly(succinic anhydride–co–ethylene oxide) using 
titanium tetrabutoxide as a catalyst. The tensile strength and elongation at break of the 
copolymer films increased compared to the chain–extended poly(ethylene succinate) 
films due to the introduction of phthalate units. The enzymatic hydrolyzability of the 
copolymers by a lipase from Rhizopus arrhizus and biodegradability by activated sludge 
decreased with an increase in PET content. When the length of succinate unit in the 
copolymer was below 2, the hydrolyzability of the copolymers decreased considerably. 
Recently, Kint et al. [Kint 1999] reviewed the potential biodegradability of poly(ethylene 
terephthalate). They propose the following three factors for increasing the hydrolytic 
biodegradability of PET, i.e. the presence of hydrolyzable linkages along the polymer 
chains, balancing between amorphous and crystalline morphology, and lowering the glass 
temperature. In addition, they state that transesterification caused by reactive blending 
appears to be the most efficient method for incorporating suitable hydrolyzable and 
hydophilic segments in the polymer backbone. However, the high temperature required 
for this reaction to take place in high melting PET restricts the choice of the degradable 
aliphatic polymer. Kint et al. pointed out that the impact of the modification on the 
overall behavior of PET, specifically on the thermal and mechanical properties, should be 
controlled, a point that has not been considered in most of the work carried out so far. 
Aliphatic polyesters with aromatic side groups should have properties and 
biodegradability different from those with aromatic groups in the main chain. Jin et al. 
[Jin 2000] investigated mechanical and thermal properties of poly(ethylene adipate) and 
poly(butylene succinate) when phenyl side branches were introduced by copolymerizing 
styrene glycol with the respective diacids and diols. Elongation at break and tear strength 
of both polyesters declined as the styrene glycol content increased, which could be partly 
ascribed to the decrease in molecular weight and to the decrease in crystallinity as well. 
However, tensile modulus was relatively unaffected, possibly due to the increase in Tg. 
In sharp contrast to polyesters containing aromatic diacids or diols in the backbone chain 
of aliphatic polyesters, the copolyesters with pendant phenyl groups based on 
poly(butylene succinate) and poly(ethylene adipate) were biodegraded in an activated 
sludge more easily as the styrene glycol content increased. Presumably, the decreasing 
crystallinity and molecular weight played a more important role in the enhancement of 
the biodegradability compared to the change in the hydrophobicity. 
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Cyclic ethers such as epoxides (three–membered ring), oxetanes (four–membered ring), 
tetrahydrofuran (five–membered ring), and tetrahydropyran (sixmembered ring), are 
useful materials in synthetic organic chemistry, polymer chemistry, and chemical 
industry. In particular, oxiranes are most widely used as starting materials in the field of 
synthetic organic chemistry, and regioselective addition reactions of nucleophiles to 
oxiranes have been studied. The ring strain and polar properties of a four–membered 
oxygen–containing ring cause significant susceptibility to thermal cleavage, as well as to 
reaction with a wide variety of electrophilic and nucleophilic reagents. The relatively high 
basicity of oxetanes makes them quite susceptible to electrophilic reagents and to 
combinations of nucleophilic and electrophilic reagents.  
The polymerization of epoxide with both cationic– and anionic–initiators proceeds 
smoothly to afford the corresponding polyethers in high yields [Inoue 1984]. 
Oxetanes are known to polymerize with cationic initiators to provide the corresponding 
polyethers. Oxetane with 4–membered ring are polymerized exclusively with cationic 
initiators, due to high basicity [Inoue 1984]. It was reported that cationic ring–opening 
polymerization of 3–ethyl–3–(hydroxymethyl)–oxetane in the presence of aluminum 
complexes as cationic initiators produced linear polymers with high crystallinity and no 
glass transition [Vandenberg 1989]. Hyperbranched polymers were prepared by cationic 
ring opening polymerization of 3–ethyl–3–(hydroxymethyl)–oxetane using sulfonium 
salts as cationic initiators [Bendnarek 1999]. 
More recently, the anionic polymerization of 3–ethyl–3–(hydroxymethyl)–oxetane (EHO) 
and 3–methyl–3–(hydroxymethyl)–oxetane (MHO) was reported by using potassium ter–
butoxide (t–BuOK) as an initiator in the presence of 18–crown–6–ether (18–C–6). By this 
route, the hyperbranched polyether containing an oxetanyl group and many hydroxyl 
groups at the end was obtained (Scheme 5.1) [Kudo 2003]. A possible mechanism of the 
anionic polymerization of EHO is illustated in Scheme 5.2. In the first step, the proton 
exchange reaction between t–BuOK and the oxetane hydroxyl group occurred, producing 
oxetane alkoxy anion as initiator. In the second step, the reaction of the initiator with 
EHO proceeded to form a dimer alkoxy anion. Eventually, monomer–activated anionic 
ring–opening polymerization of EHO proceeded to afford a hetero telechelic 
hyperbranched polyether with an oxetanyl group at one chain end and several hydroxyl 
groups at the other ends of the polymer chain. 
Lewis acid–promoted anionic polymerizations of oxetanes were studied, and polyether 
with controlled molecular weight and molecular weight distribution was successfully 
synthesized. Copolymerization of oxetanes was also investigated: the copolymerization of 
oxetane with carbon dioxide using Lewis acids gave a copolymer, though not the 
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expected alternating copolymer. The latter, that is polycarbonate, was obtained by using 
organotin halide–lewis base system. Copolymers containing both alternating sequences 
and oxetane homopolymer were obtained by copolymerization of oxetane with cyclic 
carboxylic anhydrides using bulky titanium bisphenolates as catalysts. Following the 
same concept, reactions of oxetanes with carboxylic acids, phenols, and thiophenols 
proceeded successfully in presence of quaternary onium halides or crown ether 
complexes.  
Scheme 5.1. Anionic ring–opening polymerization of EHO, MHO and BHO. 
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Scheme 5.2. Proposed mechanism of the anionic ring–opening polymerization of EHO. 
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5.1. COPOLYMERS OF OXETANES WITH CYCLIC CARBOXYLIC ANHYDRIDES 
 
 
Initially, the synthesis of polyesters containing side chain reactive moieties was 
investigated by ring opening polymerization of oxetanes and cyclic carboxylic anhydrides 
(Scheme 5.3), catalyzed by quaternary onium halides at different temperatures. 
 
Scheme 5.3. Chemical structure of the monomers utilized for the synthesis of polyesters 
containing side chain reactive moieties. 
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Polymerization experiments were performed by reacting equimolar amounts of the 
commercially available (3–methyloxetan–3–yl)methanol (MOM) with either succinic 
anhydride (SAn) or phthalic anhydride (PAn) under dry nitrogen atmosphere by using 
tetraphenylphosphonium bromide (TPPB) as catalyst. The reactions were carried out in 
bulk for 24 h at 130 °C by using monomer/catalyst molar ratio = 20 (Table 5.1). 
Polymerization of MOM and SAn (Scheme 5.4) afforded an orange–brown product (Run 
AS1) that was insoluble in water and in common organic solvents, suggesting that 
crosslinked products are formed by the reaction of MOM free hydroxyl groups with 
reactive anhydride moieties. 
On the other hand, the orange–brown polymerization product of MOM and PAn (run 
AP1) was soluble in THF, indicating that in this case crosslinking reactions were limited 
if any. 
The FT–IR spectrum of AP1 (Fig. 5.1) was in agreement with the contemporary presence 
of units derived from both monomeric constituents. In particular, the spectrum presented 
a broad absorption band at 3400 cm–1, attributable to hydroxyl moieties and a strong 
absorption band in the 1720 cm–1 that was attributed to the stretching of the carbonyl 
groups present along the polymer backbone. Two bands of medium–strong intensity at 
1270 cm–1 were assigned to the C–(C=O)–O and OC–C coupled asymmetric stretching 
vibrations. The absorption peaks of medium intensity centered at about 700 and 750 cm–1 
were attributed to the out–of–plane bending vibrations of the phenyl C–H. 
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Table 5.1. Copolymerization of oxetanes with cyclic anhydrides.a 
Run Oxetane Anhydride Catalyst Temp. Duration Yield 
 (Type) (Type) (Type) (°C) (h) (%) 
AS1 MOM SAn TPPB 130 24 95 b 
AP1 MOM PAn TPPB 130 24 42 
BEAS2 BMMO SAn TBPB 60 6 0 
BEAS3 BMMO SAn TBPB 100 24 0 
BEAS4 BMMO SAn TPPB 130 24 0 
BEAP5 BMMO PAn TBAB 60 5 0 
BEAP6 BMMO PAn TPPB 60 6 0 
BEAP7 c BMMO PAn TBPB 60 6 0 
BEAP8 c BMMO PAn TPPB 60 6 0 
BEAP9 BMMO PAn TBAB 100 20 10 
BEAP10 BMMO PAn TBPB 130 24 10 
BEAP11 BMMO PAn TPPB 100 24 20 
BEAP12 BMMO PAn TPPB 130 24 25 
BEAP13 c BMMO PAn TPPB 130 24 60 
BEAP14 c BMMO PAn TPPB 140 24 83 
a Oxetane/anhydride molar ratio = 1; monomer/catalyst molar ratio = 20. b Product insoluble in water and in 
common organic solvents. c Runs carried out by using vacuum–dried oxetane and phthalic anhydride. 
 
Scheme 5.4. Polymerization of MOM with SAn in the presence of tetraphenyl-
phosphonium bromide (TPPB). 
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Number and position of the peaks present in the 1H–NMR spectrum of AP1 (Fig. 5.2) 
were consistent with the proposed polymer structure. However, the relative intensities of 
the signals centered at about 3.3 (side chain methylene protons) and 7.5 ppm (aromatic 
protons) were too small and too large, respectively. The peak intensities suggest that 
about 50% of the side chain hydroxyl groups reacted with phthalic anhydride (Scheme 
5.5). 
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Figure 5.1. FT–IR spectrum of the polymeric product obtained by reacting MOM with 
PAn. 
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Figure 5.2. 1H–NMR spectrum of the polymeric product obtained by reacting MOM with 
PAn. 
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Scheme 5.5. Polymerization of MOM with PAn. 
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SEC analysis (Fig. 5.3) showed that the polymerization product was mainly constituted 
by low oligomers (DPn ~ 1–3). This result is in agreement the proposed occurrence of 
side–chain esterification reactions. Indeed, PAn consumption by side reactions lowers the 
PAn/MOM molar ratio to about 0.5 thus giving rise to the formation of a mixture of low 
molar mass oligomers [Fred 1984]. 
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Figure 5.3. SEC of the polymeric product obtained by reacting MOM with PAn. 
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The different behavior observed in the reaction of succinic and phthalic anhydride with 
MOM can be tentatively attributed to the different reactivity of aliphatic anhydrides as 
compared with aromatic ones. 
In order to avoid crosslinking reactions because of the presence of MOM free hydroxyl 
group, the hydroxyl functionality was protected with a benzyl group by a modified 
Williamson reaction. Accordingly, (3–methyloxetan–3–yl)methanol (MOM) was reacted 
with benzyl chloride under phase transfer conditions (Scheme 5.6). The adopted 
etherification methodology allowed for the use of potassium hydroxide in water solution, 
instead of more reactive bases in anhydrous organic solvents. By this procedure, pure 3–
(benzyloxymethyl)–3–methyloxetane was recovered in high yields (99%). 
Scheme 5.6. Preparation of 3–(benzyloxymethyl)–3–methyloxetane. 
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All subsequent polymerization experiments were performed by reacting equimolar 
amounts of either succinic anhydride or phthalic anhydride with 3–methyl–3–
benzyloxymethyloxetane with under dry nitrogen atmosphere by using quaternary onium 
salts, such as tetrabutylammonium bromide (TBAB), tetrabutylphosphonium bromide 
(TBPB), and tetraphenylphosphonium bromide (TPPB) as catalyst. The reactions were 
carried out in bulk for 6–24 hours at 60–140 °C by using monomer/catalyst molar ratio = 
20 (Table 5.1). The polymerization products were purified by double coagulation in a 
large excess of 1:10 EtOH/n–hexane, and dried under vacuum to constant weight. 
SAn did not react at all with BMMO (Scheme 5.7), independent of the catalyst, reaction 
temperature and time (Runs BEAS2–BEAS4). At present, no sound explanation can be 
put forward to explain such a behavior. 
Scheme 5.7. Ring opening polymerization of BMMO with SAn. 
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The polymerization of BMMO/PAn mixtures (Scheme 5.8) was also investigated in order 
to evaluate their reactivity in carboxylate–initiated ROP (Table 5.1, runs BEAP5–
BEAP8). The reaction did not proceed at low temperature. In agreement, 1H–NMR 
analysis indicated that only monomers were present in the reaction product. As expected, 
the reaction yield increased on increasing the reaction temperature from 60 to 140 °C 
affording colorless polymeric materials in 20–80% yield (runs BEAP9–BEAP14). Within 
the limits of the small number of experiments, the investigated catalysts did not show any 
significant activity difference. The highest yield (83%) was recorded at 140 °C in the 
presence of TPPB, although slight discoloration of the polymer was observed. 
Scheme 5.8. Ring opening polymerization of BMMO with PAn. 
O
O
+
OO O O O
O O
O
 
In all cases, the FT–IR and 1H–NMR spectra (Figs. 5.4 and 5.5) of the reaction products 
were in agreement with the proposed polymer structure. 
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Figure 5.4. FT–IR spectrum of BMMO/PAn polymerization product (Run BEAP14). 
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Figure 5.5. 1H–NMR spectrum of BMMO/PAn polymerization product (Run BEAP14). 
On the other hand, the rather low molecular weight (Mn = 4.3 kDa) of the polymer 
obtained in run BEAP14 can be tentatively attributed to the not–high–enough monomer 
conversion. Indeed, it is well known that the larger molecular weight increase occurs at 
very high conversions in step polymerization processes [Fred 1984 ]. Additionally, the 
polydispersity index appreciably larger than unit (Mw/Mn = 1.21) indicated that the 
polymerization does not occur by a living process. 
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5.2. COPOLYMERS OF BISOXETANES WITH DICARBOXYLIC ACIDS 
 
 
Addition reactions of acyl chlorides or active esters to oxetanes proceed very smoothly by 
using quaternary onium salts as catalysts [Kameyana 1995]. It was also found recently 
that the polyaddition of bisepoxides with dicarboxylic acids affords soluble polyester with 
pendant hydroxyl groups [Nishikubo 1999]. Additionally, reaction of pendant oxetane 
groups in poly[(3–methyl–3–oxetanyl)methyl methacrylate] with benzoyl chloride or 
phenyl thioacetate produced the corresponding modified polymers with high conversion. 
That is, the pendant oxetane ring in the polymer can be used as reactive group for 
chemical modification of polymers. 
Accordingly, the synthesis of polyesters containing side chain reactive moieties was 
investigated by ring opening polymerization of bis((3–methyloxetan–3–yl)methyl) 
terephthalate) (BOMT) and dicarboxylic acids catalyzed by tetraphenylphosphonium 
bromide (TPPB) as catalyst (Scheme 5.9). 
 
 
 
Scheme 5.9. Structures of the monomers used in the polymerization of dicarboxylic acids 
with bisoxetanes. 
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Polymerization experiments were performed by reacting equimolar amounts of the 
bis((3–methyloxetan–3–yl)methyl) terephthalate with different dicarboxylic acids, such 
as succinic acid (SucAc), adipic acid (AdpAc), sebacic acid (SebAc), itaconic acid 
(ItcAc), 1,4–cyclohexane–dicarboxylic acid (cHxAc), isophthalic acid (iPTAc), and 
terephthalic acid (tPTAc). 
5.2.1. Preparation of bis((3–methyloxetan–3–yl)methyl) terephthalate) (BOMT) 
 
The commercially available 3–methyl–3–oxetanemethanol, a low cost chemical endowed 
with high solubility in common organic solvent, was reacted with terephthaloyl chloride 
under basic conditions (Scheme 5.10). This reaction was performed in THF anhydrous at 
0 °C for 3h by using of triethylamine as HCl acceptor. By this route, bis((3–
methyloxetan–3–yl)methyl) terephthalate) was obtained in 45% yield as white crystals 
having m.p 123–124 °C that were characterized by 1H–NMR. 
Scheme 5.10. Preparation of bis((3–methyloxetan–3–yl)methyl) terephthalate) (BOMT). 
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5.2.2. Polymerization experiments 
 
Polymerization experiments (Scheme 5.11) were performed under dry nitrogen 
atmosphere in concentrated (30–50% by weight) tetramethylurea solution at 140 °C for 
24 h by using tetraphenylphosphonium bromide (TPPB) as catalyst and monomer/catalyst 
molar ratio = 10 (Table 5.2). The reaction products were reprecipitated from THF 
solution into diethyl ether, and the coagulated polymers were dried under vacuum to 
constant weight. Independent of the dicarboxylic acid structure, medium–to–low 
conversions (25–40%) to polymeric products were recorded in all cases. 
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Scheme 5.11. Polymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) 
(BOMT) with dicarboxylic acids. 
O
OO
O
OO + R
O
HO OH
O
TMU, TPPB
140 °C, 24 h
O
O
O
O
HO
O
O
HO O R
O  
Table 5.2. Anionic polymerization of bis((3–methyloxetan–3–yl)methyl) terephthalate) 
(BOMT) with dicarboxylic acids.a 
 Run a Dicarboxylic acid Yield 
  (Type)  (%) 
 BOPSU SucAc 25 
 BOPPA AdpAc 25 
 BOPPS SebAc 30 
 BOPITA ItcAc 30 
 BOPCI ChxAc 30 
 BOPATP  5:1 AdpAc/tPTAc 42 
 BOPAIP  5:1 AdpAc/iPTAc 25 
a In tetramethylurea solution (30–50% by weight) at 140 °C for 24 h by using 
tetraphenylphosphonium bromide (TPPB) as catalyst; BOMT/diacid molar ratio = 1; 
BOMT/TPPB molar ratio = 10.  
5.2.2.1. FT–IR characterization 
The FT–IR spectra of all the polymer samples evidenced a broad absorption band at 3500 
cm–1, attributable to hydroxyl moieties and a strong absorption band in the 1720 cm–1 
(Figure 5.6) that was attributed to the stretching of the carbonyl groups present along the 
polymer backbone. Another distinctive feature of polymer FT–IR spectra was the 
presence of two bands of medium–strong intensity at 1270 cm–1 that were assigned to the 
C–(C=O)–O and OC–C coupled asymmetric stretching vibrations. Other typical 
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absorption peaks of medium intensity centered at about 700 and 750 cm–1 that were 
attributed to the out–of–plane bending vibrations of the phenyl C–H.  
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Figure 5.6. FT–IR spectrum of the polymer obtained by reacting BOMT with sebacic 
acid (Run BOPPS). 
5.2.2.2. 1H–NMR characterization 
Number, position, and intensity of the peaks present in the 1H–NMR spectra of all 
polymer samples were consistent with the expected structure. As a typical example, the 
1H–NMR spectrum of BOPITA in DMSO–d6, is reported in Figure 5.7.  
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Figure 5.7. 1H–NMR spectrum of BOMT/ItcAc polymerization product (Run BOPITA). 
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Comparison of the 1H–NMR spectra of homopolymer samples and of their parent 
monomeric precursors highlighted that the peaks relevant to oxetane ring protons 
underwent well–definite shift as a result of the incorporation into the macromolecular 
backbone. The relative intensity of 1H–NMR signals ruled out the occurrence of a 
significant enrichment in one of the two diacids used in copolymerization experiments 
(Runs BOPATP and BOPAIP). 
5.2.2.3. Size exclusion chromatography 
The molecular weight distribution of polymer samples was determined by size exclusion 
chromatography (SEC); monodisperse polystyrene samples were used as molecular 
weight calibration standards, and chloroform was selected as eluent. The weight average 
molecular weights (Mw) of the synthesized polymers ranged between 3 and 6 kDa (Table 
5.3). However, the experimental number average molecular weights are 2–4 times lower 
than those evaluated from the monomer/catalyst molar ratio. The reported data 
demonstrate that the anionic ring opening polymerization of bisoxetane–diacid mixtures 
did not occur by a living polymerization process, at least under the adopted experimental 
conditions. Very likely, chain transfer and chain termination reactions took place because 
of the presence of impurities in the polymerization mixture. 
Polydispersity indexes (Mw/Mn) in the 1.8– 3.2 range further confirmed the occurrence of 
chain transfer reactions, since PI of controlled living polymerizations are expected to be 
only slightly larger than unity. 
Table 5.3. Molecular weights and polydispersity index (PI) of the investigated polymer 
samples.a 
 Polymer Mn  Mw Mw/Mn
 
  (calc.) b (exp.) 
 BOPSU 4820 2600 6000 2.3 
 BOPPA 5100 1250 4000 3.2 
 BOPITA 4940 1700 3000 1.8 
 BOPCI 5360 2100 3900 1.9 
a Determined by SEC in chloroform, polystyrene standards. b Calculated from the monomer/catalyst molar 
ratio. 
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5.3. SYNTHESIS OF ?–LACTONE POLYMERS 
 
 
A series of ?–substituted ?–lactones were synthesized starting from racemic and optically 
active malic and alkylmalic acids. These monomers are indeed suitable precursors for the 
preparation of racemic and optically active polyesters. On the basis of their structural 
features, the resulting polymeric materials are expected to be bioerodible, bioassimilable, 
and biocompatible. They might be used in temporary therapeutic applications such as 
drug delivery systems and tissue engineering scaffolds. 
Since the physical–chemical characteristics of poly(alkyl malolactonate)s can be 
modulated by changing the chemical structure of the side chain, the first objective of the 
undertaken research work focused on the development of simple and effective synthetic 
procedures for the preparation of ?–substituted ?–lactones monomers carrying different 
substituents at the lateral ester moiety. In this perspective, a series of suitable side groups 
were chosen as a way to: 
• tune the polymeric hydrophilic–hydrophobic balance; 
• provide sites for further functionalization; 
• elicit specific biological effects, when polymeric materials are exposed to a 
bioenvironment. 
Only readily available starting materials were considered for the preparation of the 
lactone monomers, in order to avoid cumbersome and expensive synthetic procedures. 
5.3.1. Synthesis of ? ,?’,?– trisubstituted ?–lactones 
 
The synthesis of ?,??,?–trisubstituted ?–lactones was realized in five steps from 
precursor diethyl oxalpropionate (Scheme 5.12), where R can be benzyl, butyl, allyl, and 
cholesteryl groups. 
The benzyl group was used as protecting agent of the carboxylic moiety. After catalytic 
hydrogenolysis of either the lactone or the polyester, the free carboxylic groups obtained 
were reacted with bioactive or targeting molecules. The allyl group can be modified after 
polymerization to give epoxides, diols or even free carboxylic acid. The butyl group was 
used for its hydrophobic properties. Finally, a malic ?–lactone with a pendant polycyclic 
structure was synthesized starting from cholesterol, a complex terpene largely diffused in 
the cellular membrane where it is known to play structural as well noteworthy regulatory 
roles. The presence of two geminal methyl groups on the lactone monomers should 
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increase the hydrophobicity of the derived polymer. All synthesized compounds were 
extensively characterized by FT–IR and 1H–NMR, showing spectroscopic features in 
agreement with their expected structures. 
Scheme 5.12. Synthesis of ?,?’,?–trisubstituted ?–lactones. 
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5.3.1.1.  Preparation of diethyl 3,3–dimethyl–2–ketosuccinate [Oxam]  
The commercially available racemic diethyl oxalpropionate, a low cost chemical 
endowed with high solubility in common organic solvent, was alkylated with 
iodomethane under basic conditions. This reaction was performed in order to avoid the 
easy elimination of the hydrogen in 3–position during anionic polymerization. In the 
literature, preparation of diethyl 3,3–dimethyl–2–ketosuccinate monomer was performed 
at room temperature by using potassium t–butoxide in anhydrous benzene in the presence 
of 18–crown–6 ether as phase–transfer catalyst [Dowd 1988]. By taking into account the 
need for environmentally friendly processes and for fast large scale production, the 
alkylation reaction was performed by using potassium t–butoxide in anhydrous acetone at 
reflux (Scheme 5.13). The alkylation proceeds according to a SN2 mechanism (Scheme 
5.14). The reaction was relatively fast because of the acidity of the proton flanked by 
ketone and ester groups. Diethyl 3,3–dimethyl–2–ketosuccinate was obtained in 90% 
yield after distillation of the crude reaction product under reduced pressure. The presence 
of a single peak at 1.39 ppm integrating to six protons in the 1H NMR spectrum 
confirmed the presence of the two equivalent methyl groups in 3–position. 
RESULTS AND DISCUSSION 
 129
Scheme 5.13. Preparation of diethyl 3,3–dimethyl–2–ketosuccinate. 
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Scheme 5.14. Alkylation of ?–keto–diesters 
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5.3.1.2.  Preparation of 3,3–dimethylmalic acid [Oxa] 
A two–step synthetic procedure was adopted for the preparation of 3,3–dimethylmalic 
acid (Oxa). Initially the carbonyl function of the keto–diesters was reduced with aqueous 
NaBH4 in tetrahydrofuran (Scheme 5.15). The final product, diethyl 3,3–dimethylmalate 
(Oxamo) was isolated in 62% yield after distillation under vacuum. Glc analysis 
displayed only one peak corresponding to a racemic mixture of diethyl 3,3–
dimethylmalate enantiomers. 
Scheme 5.15. Preparation of diethyl 3,3–dimethylmalate. 
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The corresponding 3,3–dimethylmalic acid was obtained by treatment of diethyl 3,3–
dimethylmalate with 20% potassium hydroxide in water solution (Scheme 5.16). 
Scheme 5.16. Preparation of 3,3–dimethylmalic acid. 
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The reaction mixture was refluxed for 16 hours, then cooled down at room temperature, 
and eluted with water over Amberlyst–15 (SO3H). The resulting aqueous solution was 
then evaporated under reduced pressure to give the crude diacid that was recrystallized in 
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CH3CN/CHCl3 to give 75% yield of pure product [Chiba 1999]. The disappearance of 
peaks corresponding to ethyl ester groups in the 1H–NMR spectrum of this product 
confirmed that diethyl 3,3–dimethylmalate was fully hydrolyzed. In most cases, the crude 
diacid was used without any further purification. 
5.3.1.3.  Preparation of 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride [Oxamc]  
3,3–Dimethylmalic acid was converted into its cyclic anhydride (Oxamc) by the strong 
dehydrating action of trifluoroacetic anhydride (TFAA) (Scheme 5.17). The reaction was 
carried out in bulk by using excess TFFA. Crude 2–O–trifluoroacetyl–3,3–dimethylmalic 
anhydride was recovered by removal under vacuum of excess TFA and the formed 
trifluoroacetic acid. 1H–NMR spectra of the crude anhydride showed that the content of 
unreacted diacid was always lower than 1% mol. 
Scheme 5.17. Preparation of 2–O–trifluoroacetyl–3,3–dimethylmalic anhydride. 
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5.3.1.4.  Preparation of ?–hydroxyacids 
Alcoholysis of carboxy–anhydrides to give ester derivatives is a widely used general 
method for ester synthesis. Kinetic data suggest that alcoholysis occurs by the general 
addition–elimination mechanism (Scheme 5.18). This mechanism implies the initial 
nucleophilic addition of the alcohol hydroxyl group to one of the carbonyl residues of the 
anhydride, to give a tetrahedral intermediate. This intermediate can release either the 
hydroxyl moiety, to give the starting reagents, or the carboxylic residue, thus forming the 
hemiester. 
The latter process is thermodynamically favored for conventional aliphatic anhydrides, 
because the basicity of the carboxyl leaving group (pKa = 2–5) is much lower than that of 
alkoxy group (pKa =15–17). 
Scheme 5.18. Addition–elimination mechanism proposed for the alcoholysis of 
carboxylic anhydrides. 
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Polar solvents stabilize the tetrahedral zwitterionic intermediate, therefore favoring the 
reaction. Alcoholysis of anhydrides is sensitive to both acid and base catalysts, even if the 
latter ones are more effective [March1992]. The general mechanism of base catalysis 
suggests that proton removal from the hydroxy group occurs during the addition step 
[Jencks 1987]. Since polyacids and polybases do not show any additional catalytic effect, 
it was proposed that proton donation from the protonated basic catalyst to the polarized 
oxygen of the carboxyl group does not occur. Pyridine and 4–(N,N–dimethylamino-
pyridine) are the most used basic catalysts. Generally, excess base is used to avoid 
progressive protonation of the catalyst and loss of its activity. The mechanism of acid 
catalysis is less known. Very likely, the acid interacts with the oxygen of the carbonyl 
group and polarizes the carbonyl double bond, thus promoting the formation of the 
tetrahedral intermediate. However, it is unlikely that an adduct is formed, due to the low 
basicity of the carboxyl group (pKa ~ 7) [Jencks 1987]. Both organic and inorganic acids 
are generally used as catalysts. 
In the present investigation, ?–hydroxyacids were prepared by regioselective opening of 
the anhydride ring with a variety of alcohols: benzyl, butyl, allyl, and cholesteryl alcohols 
(Scheme 5.19). 
Scheme 5.19. Alcohols utilized for the synthesis of ?–hydroxyacids. 
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The anhydride was stirred with the alcohol at room temperature for 12 hours, by using 7:1 
alcohol/anhydride molar ratio (Scheme 5.20). The reaction mixture was dissolved into 
several volumes of ethyl acetate and extracted with portions of aqueous 1M NaHCO3. 
The combined aqueous solutions were washed with ethyl acetate and then acidified to pH 
2 with 1.2 N HCl. The aqueous layer was extracted with several portions of ethyl acetate. 
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The combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated to give the crude monoester. Chromatography on silica gel gave benzyl, allyl, 
and butyl monoester in 80, 83, and 90% yield, respectively. 
Scheme 5.20. Preparation of ?–hydroxyacids. 
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Prior to large–scale experiments, a pilot solvolysis reaction was carried out by using a 
stoichiometric amount of cholesterol. The corresponding cholesterol monoester was 
recovered in 63% yield. 
5.3.1.5.  Preparation of ?–lactones 
Lactonization of the prepared ?–hydroxyacids represented the last step of the selected 
synthetic pathway. Conceptually, ?–lactones can be prepared by activation of either the 
carboxyl or the hydroxyl group. In the present case, ?,?’,?–trisubstituted ?–lactones were 
synthesized by reaction with diisopropylazodicarboxylate (DIAD) and triphenyl-
phosphine (PPh3) according to the Mitsunobu procedure (Scheme 5.21). 
Very likely the reaction proceeds through four consecutive steps: 
a) addition of triphenylphosphine to diisopropylazodicarboxylate to give a quaternary 
phosphonium salt; 
b) salt protonation; 
c) formation of an alkoxyphosphonium salt; 
d) SN2 type displacement of the triphenylphosphine.  
The reaction of diethyl azodicarboxylate with triphenylphosphine is a redox reaction, in 
which triphenylphosphine is oxidized to triphenylphosphine oxide, whereas diethyl 
azodicarboxylate is reduced to diethyl hydrazinedicarboxylate. The condensation of 
alcohols with acids by the use of organic dehydrating reagents such as carbodiimides 
involves generally the initial activation of the latter components. Thus, only relatively 
strong acids such as phosphoric or carboxylic acid can be utilized as acidic components. 
On the other hand, the diethyl azodicarboxylate/triphenylphosphine system activates the 
alcohol by formation of the corresponding alkoxyphosphonium salt, which then alkylates 
the carboxylic acid. Acidic components that have been alkylated by this method include 
phosphoric monoesters and diesters, carboxylic acids, phenols, imides, N–hydroxyimides, 
oximes, and active methylene compounds. The reaction has been used in the synthesis 
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and trasformation of various kinds of natural products because it proceeds under mild 
neutral conditions (at or below room temperature) and exhibits stereospecificity, 
functional selectivity, and regioselectivity [Mitsunobu 1981]. 
Scheme 5.21. Proposed mechanism of Mitsunobu reaction. 
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In the present investigation, the ?–lactones were obtained via hydroxyl group activation 
with configuration inversion at the asymmetric carbon atom according to the mechanism 
previously described for optically active lactones. 
The reaction was carried out in anhydrous aprotic solvent such as tetrahydrofuran in 
presence of 1–1.5 molar equivalents each of triphenylphosphine and diisopropylazo-
dicarboxylate at 0 °C (Scheme 5.22). 
Scheme 5.22. Cyclization of malic acid hemiester by Mitsunobu reaction. 
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The resulting solution was stirred at this temperature for 0.5 h and then at room 
temperature for 12 hours. After removal of by–products (H2DIAD and Ph3PO) by 
precipitation in diethyl ether, the reaction products were then eluted over silica gel with 
ethyl acetate/cyclohexane mixture. 4–Benzyloxycarbonyl–3,3–dimethyl–2–oxetanone 
(BzDML), 4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone (AllDML), 4–butyloxy-
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carbonyl–3,3–dimethyl–2–oxetanone (BuDML), and (R,S)–4–cholesteryl–oxycarbonyl–
3,3–dimethyl–2–oxetanone (ChDML) were obtained in 50–60 yield by this route (Table 
5.4).  
Table 5.4. Recorded yields in the preparation of ?–lactones 
 Lactone Yield  Lactone Yield 
  (%)   (%) 
 BzDML 57 BuDML 47 
 AllDML 53 ChDML 63 
 
The synthesis of these ?,?’,?–trisubstituted ?–lactones will allow for the preparation of a 
large family of new polyesters with tunable physical, chemical, and biological properties 
by copolymerization reactions and/or by chemical modification of side–chain substituents 
[Barbaud 1999, Cammas–Marion 2000a]. 
5.3.2. Spectroscopic characterization of ??lactones  
 
FT–IR and 1H–NMR analysis of the synthesized monomers confirmed the proposed 
structures. In all cases, the FT–IR spectra displayed two diagnostic strong bands at about 
1840 and 1750 cm?1 that were attributed to the stretching of the carbonyl groups of 
lactone and ester carbonyl groups, respectively. A partially unresolved couplet at about 
1380 cm–1 confirmed the presence of gem–dimethyl groups. Depending on the structure of 
the ester substituent, typical bands were detected also in the C–H stretching and 
fingerprint regions. The FT–IR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–
2–oxetanone (BzDML) is reported in Figure 5.8 as a typical example. 
The 1H NMR spectra of all lactones presented a singlet at about 5 ppm and two singlets at 
about 1.1 and 1.5 ppm with 1:3:3 relative intensity. These signals were attributed to the 
proton in 4–position and to the two methyl groups in 3–position, respectively. It is worth 
noting that one of the two lactone methyl groups is downfield shifted by about 0.30 ppm 
because of the chirality of C–4. Also in this case, typical signals of the ester group were 
also present. The 1H NMR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone in acetone–d6 is reported in Figure 5.9 as a typical example. 
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Figure 5.8. FT–IR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone 
(BzDML). 
 
Figure 5.9. 1H–NMR spectrum of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone (BzDML). 
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5.4. PREPARATION OF ?–LACTONE POLYMERS 
 
 
5.4.1. Ring opening polymerization 
 
Aliphatic polyesters can be prepared by ring opening polymerization (ROP) of cyclic 
monomers, such as lactones, lactides and glycolides [Albertsson 2003]. This chain–
growth process displays more advantageous features than for example the 
polycondensation step growth process. Nowadays, ROP allows for the synthesis of 
polyesters with controlled architecture and tailor–made properties, which makes them 
suitable candidates for biomedical and pharmaceutical applications. Indeed, polyester 
display good mechanical properties and are hydrolysable and biocompatible. The 
polymerization of lactones is generally carried out in bulk or in solution (THF, dioxane, 
toluene, etc.), emulsion, or dispersion. The temperature of bulk polymerization is 
generally in the range of 100–150 °C, whereas lower temperatures (0–25 °C) have been 
used in solution to minimize side reactions (inter– and intramolecular transesterfication). 
The polyesters of biomedical importance are derived from glycolide (GA), lactide (LA), 
?–butyrolactone (?–BL), ??caprolactone (? –CL), and 1,5–dioxepan–2–one (DXO). The 
random copolyesters such as poly(lactic acid–co–glycolic acid) (PLGA) and block 
copolymers of lactic acid with ethylene oxide (PLA–PEG) have been widely investigated 
for their degradation behavior and drug delivery applications. 
A few lactones polymerize spontaneously on standing or on heating. Most do so in the 
presence of catalysts or initiators. Many organometallic compounds, such as oxides, 
carboxylates, and alkoxides are effective initiators for the controlled synthesis of 
polyesters using ROP of lactones. 
The needs for developing environmentally friendly processes and products and growing 
capabilities in biotechnology have culminated in synthesis of polyesters by in vitro 
enzyme catalysis. Enzymatic polymerization is an ecofriendly process of polymer 
synthesis and is based on using easily renewable resources as starting material. The state–
of–the–art organometallic catalysts used for ROP of lactones are based on derivatives of 
heavy metals, which are toxic in nature. The remnants of these catalysts have to be 
removed before use, particularly in the case of biomedical and pharmaceutical 
applications. Enzymes are nontoxic natural catalysts and, therefore, a better candidate for 
ROP of lactones. In the past decade, considerable research effort has been expended in 
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vitro enzyme catalyzed ring opening polymerization of lactones. Enzyme catalyzed 
polymerizations have several advantages over conventional chemical methods. These 
include (a) mild reaction conditions, i.e., temperature, pressure, pH, and absence of 
organic solvents, (b) high enantio and regioselectivity, and (c) recyclability of catalyst. 
Enzymatic reactions are reversible reactions, and therefore, selecting appropriate reaction 
conditions can control the equilibrium. The enzyme which catalyses a bond cleavage by 
hydrolysis can also catalyze the reverse reaction of bond formation. Hydrolysis of fatty 
acid esters in an aqueous medium is catalyzed by lipase. Some lipases are stable in 
organic solvent and can be used as catalysts for esterification and transesterification. The 
polymers produced by the in vitro enzymatic route generally have low molecular masses. 
Only in a few cases, such as poly(L–lactide) and poly(1,4–dioxan–2–one), polyesters 
with molecular mass larger than 10000 could be obtained. 
Three major reaction mechanism can be involved in ROP of lactones: carbocationic, 
anionic and coordination–insertion, the last two being the most suitable for the 
obtainment of high molecular weight products. Typically, these polymerizations have 
been carried out by using organometallic compounds as catalysts, often based on 
derivatives of heavy metals, which are obviously toxic and should be removed in case of 
biomedical applications. 
Anionic polymerization of lactones can proceed by living or a non–living mechanism. 
The effective initiators for anionic polymerization of lactones are alkali metals, alkali 
metal oxides, alkali metal naphthalenide complexes with crown ethers, etc. The reaction 
is initiated by the nucleophilic attack of a negatively charged initiator on the carbon of the 
carbonyl group or on the alkyl–oxygen, resulting in formation of linear polyester. The 
polymerization of ?–lactones proceeds through alkyl–oxygen or acyl–oxygen cleavage 
giving both carboxylate and alkoxide end groups (Scheme 5.23). 
Scheme 5.23. Schematic representation of ROP lactones initiated by anionic initiators. 
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?–Lactone polymerization initiated by weak bases proceeds via alkyl oxygen scission and 
carboxylates ions are the propagating species. There was a considerable discrepancy 
regarding ?–lactone polymerization using strong bases, i.e., alkali metal alkoxides. It was 
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proposed that acyl–oxygen scission takes place and the alcoholate ion is the propagating 
moiety. It was also claimed that propagation proceeds due to both alcoholate and 
carboxylate anions formed via alkyl–oxygen and acyl–oxygen scission. Jedlinski and co–
workers have done extensive studies on polymerization of ?–lactones i.e., ?–
propiolactone and ?–butyrolactone using potassium methoxide and potassium tert–
butoxide complexes with 18–crown–6 as initiators. Their studies provided clear evidence 
that acyl–oxygen cleavage of the monomer takes place initially to yield potassium ?–
alkoxide ester, which decomposes to give potassium hydroxide and an unsaturated ester. 
Potassium hydroxide reacts with next ?–lactone molecule inducing acyl–oxygen scission 
leading to the formation of a carboxylate ion and hydroxyl end groups. The same authors 
have also reported well defined homopolymers and copolymers of high molecular mass 
by living anionic ROP of four and five membered ring lactones. In larger lactones, such 
as ?–caprolactone or lactide, the reaction proceeds by acyl–oxygen scission only thereby 
leading to the formation of an alkoxide ion as the propagating species (Scheme 5.24). 
Scheme 5.24. Anionic polymerization of lactone showing acyl oxygen scission. 
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Coordination–insertion polymerization has a living mechanism, which means the chain–
growth process takes place without irreversible chain–breaking reactions (transfer, 
termination) allowing for the obtainment of aliphatic polyesters with well–defined 
architecture, with controlled molecular weight, and narrow polydispersity. In this case, 
the most widely used initiators are aluminum and tin alkoxydes and carboxylates, which 
are covalent compounds with vacant d orbitals and therefore react as coordination 
initiators and not as anionic initiators (Scheme 5.25). However, carboxylates are weak 
nucleophiles and therefore are used together with an active hydrogen compound, such as 
on alcohol, as co–initiator. 
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The mechanism involves the acyl–oxygen cleavage of the lactone with the insertion of the 
monomer into the metal–oxygen bond of the initiator. The process is favored by the 
coordination of the exocyclic oxygen to the metal, which result in the polarization of the 
carbonyl group and makes it more susceptible for nucleophilic attack. High temperatures 
and long reaction times can lead to side reactions, such as inter– and intramolecular 
transesterification reactions, which increase the polydispersity.  
Scheme 5.25. Schematic representation of coordination–insertion mechanism of lactones 
ROP. 
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5.4.1.1. Ring opening polymerization catalyzed by SnOct2 
Among the organometallic compounds used as initiator for ROP of lactones, Sn(II)–2–
ethylhexanoate (SnOct2) is the most commonly used initiator/catalyst. Several 
mechanisms have been proposed (Scheme 5.26). 
In the activated monomer mechanism, the monomer is coordinated and activated by the 
catalyst and it is susceptible to the attack of the alcohol, being both the initiator and the 
monomer coordinated to the catalyst during the propagation. Alternatively, is has been 
proposed that an initiating complex is formed by the initiator and the catalyst prior the 
polymerization. Aluminum alkoxides, such as trialkoxides and alkyl–dialkoxides, are the 
most widely used alkoxydic catalyst in the initiation of the ROP of lactones and lactides. 
Also in this case, the polymerization proceeds through a coordination–insertion 
mechanism, and is a living polymerization, as the polymerization degree is strictly related 
to the monomer/initiator molar ratio and the polydispersity is narrow. More recently, 
lanthanide alkoxides, such as yttrium and lanthanum alkoxides, as well as Sm and Lu 
derivatives have been introduced as ROP catalysts and display a much higher reactivity, 
especially towards lactides. 
All organometallic compounds are characterized by high toxicity, and it is almost 
impossible to remove them completely from the polyesters; therefore, the use of other less 
toxic catalyst has been investigated. Zinc–based catalysts, such as zinc metal and salts 
like zinc octoate, stearate, salicylate, and lactate are now attracting much attention and are 
commonly in use, especially for the ROP of lactides. Also derivatives of metals involved 
in metabolic processes, such as Ca, Mg, and Fe have been investigated as ROP catalysts. 
ROP can be used as a chain extension technique of prepolymers (macromers) with 
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functional end–groups (telechelic polymers); in fact, when the active hydrogen compound 
acting as initiator is a hydroxyl–terminated macromer, ROP affords block copolymers. 
 
Scheme 5.26. Schematic representation of coordination–insertion ROP catalyzed by 
SnOct2. 
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Accordingly, living ROP has been widely used to obtain block copolymers with well–
defined structures, by using a macroinitiator derived from the polymerization of the first 
comonomer, to promote the polymerization of the second monomer, provided the 
characteristics of the macroinitiator are well defined. For example, it is widely reported 
that the terminal hydroxyl group of PEO can initiate successfully the polymerization of 
lactones to afford polyether–ester block copolymers with amphiphilic characteristics 
[Kissel 2002] The use of hydroxyl–terminated NVP oligomers as telechelic 
macroinitiators of ROP of lactones and lactides has been much less investigated 
[Benahmed 2001, Luo, 2004]. 
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5.4.2. Preparation of ?–lactone homopolymers and copolymers 
 
Strictly adapting structures to targeted properties is crucially important to obtain tailored 
macromolecular materials for novel specific applications. The development of multimeric 
functionalized copolymers in the field of biocompatible and hydrolysable polyesters has 
been made possible during the two last decades by the design of synthetic approaches to 
original macromolecular backbones. Novel chemical, chemoenzymatic, and biological 
routes have been established, leading to an extended family of poly(??hydroxyacid)s. In 
addition to bacterial polyesters containing diverse functionalized pendant groups, 
polyvalent polymers were obtained by copolymerization, crosslinking, and chemical 
modification of a parent compound, poly(??malic acid). These polymers were prepared 
by anionic ring–opening polymerization of malolactonate esters catalyzed by 
tetraethylammonium benzoate (TEABz) (Scheme 5.27). 
Scheme 5.27. Preparation of ?–lactonate homopolymers and copolymers. 
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These polymeric materials may contain several types of pendant groups (neutral, 
hydrophilic, reactive, etc.) that can be arranged at different compositions and in various 
distributions along the macromolecular backbone in order to modulate their solubility and 
degradation rate. The presence of stereogenic centers in the repeat units is a major 
structural factor for fine–tuning their physical and mechanical properties. The 
introduction of a second stereogenic center in the monomer becomes possible when 
starting from racemic or optically active 3–alkylaspartic acid, which can be prepared by 
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either chemical route or biotransformation. Several polystereoisomers were prepared, and 
their configurational and thermal characteristics were investigated. Degradable micelles, 
self–assembling polymers, hydrogels, macromolecular prodrugs, graft polyesters, and 
bioactive compounds were synthesized and characterized. 
However, the use of biodegradable macromolecular materials requires careful 
investigation of polymer interactions and compatibility with the human organism, to 
avoid tissue damage and immunogenic phenomena due to both whole polymeric matrix 
and its low molecular weight degradation products [Park 1992]. To date, natural and 
artificial polyesters constitute the most developed class of biomaterials because of their 
excellent mechanical properties and good biocompatibility [Lanza 1997, Vert 1986, 
Wong 1997]. Nevertheless, the strongly hydrophobic nature and the lack of available 
reactive sites of most polyesters used for biomedical applications, such as poly(lactic 
acid), poly(glycolic acid), poly(lactic acid–co–glycolic acid), and poly(?–caprolactone) 
require special synthetic methods to realize true biologically activated materials [Barrera, 
1993 and 1995]. Poly(malic acid) represents an interesting material for biomedical 
applications, since it is biocompatible and degrades to nontoxic malic acid under 
physiological conditions [Barrera 1995, Braud 1992]. The side–chain carboxylic groups 
can be functionalized to obtain a large set of polymers and copolymers with different 
hydrophobic/hydrophilic balances, [Cammas–Marion 2000] which proved useful for 
realizing biocompatible devices [ Barbaud 1999]. In most cases, the experimental features 
of these polymerization procedures do not correspond to those expected for a living 
process. Discrepancies between theoretical and measured molecular weights have been 
observed, and the molecular weight distributions were larger than expected.  
A kinetic study also indicated a more complex and non–living mechanism. It can be 
hypothesized that the non–living character arises from the presence of an acidic hydrogen 
on the carbon atom directly attached to the carbonyl group of the lactone ring. Its 
elimination during the propagating ring opening reaction could lead to chain transfer 
reactions and to polymer chains terminated by carbon–carbon double bonds, as 
determined by 1H–NMR [Bizzarri 2002]. 
To overcome these side reactions, a new type of lactones, namely ?,??,??trisubstituted 
??lactonates were used as monomers. The role of the ?,?–dimethyl fragment is to 
minimize transfer reactions and obtain a better control of the molecular weight. The 
prepared ??lactonate monomers were utilized for the preparation of several 
homopolymers and copolymers. The commercially available ?–propiolactone was used 
for the preparation of homo–and co–polymer sample. Tetraethylammonium benzoate was 
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selected as the initiator for the polymerization of all monomeric precursors, since its high 
activity for promoting the ROP process of ??lactones is well established.  
5.4.3. Homopolymerization experiments 
 
Homopolymerization experiments were performed under dry nitrogen atmosphere by 
using either tetraethylammonium benzoate (TEABz) or tetrabutylammonium bromide 
(TBAB) as catalyst (monomer/catalyst molar ratio ~ 1000). TEABz was cast from ethanol 
solution on the bottom of the polymerization vial before the addition of the monomer. 
The reactions were generally carried out in bulk. Only in a few cases THF and 80:20 
THF/ethanol were used as solvents. Reactions were carried out until disappearance of the 
lactone 1850 cm–1 absorption band in the FT–IR spectrum of the reaction mixture, or 
when no further decrease of this band occurred. The overall reaction time resulted in the 
range of 3–9 days, in agreement with what reported for the polymerization of comparable 
substrates. The resulting materials were purified by double coagulation in protic non 
solvent, such as ethanol and methanol, and dried under vacuum to constant weight, to 
give white polymeric products. The adopted experimental conditions and the final yields 
in polymeric materials, calculated as 100·(weight of recovered polymer/weight of 
monomer mixture), are summarized in Table 5.5. 
Table 5.5. Homopolymerization of ?–lactones in bulk.a 
Run Lactone Solvent Catalyst Temp. Duration Yield 
(Type) (Type) (Type) (Type) (°C) (days) (%) 
pAl AllDML none TEABz 40 5 71 
pBu BuDML none TEABz 42 6 67 
pBz1 BzDML none TEABz 40 7 70 
pCOL ChDML none TEABz 40 7 0 
pPL1 PL none TEABz 42 3 90 
pPL2 PL none TEABz 25 7 15 
pPL3 PL none TEABz 40 b 7 90 
pPL4 PL none TBAB 40 6 80 
pPL5 PL THF–EtOH a TEABz 25 7 33 
pPL6 PL THF–EtOH a TEABz 40 b 3 52 
pPL7 PL THF TBAB 25 7 50 
pPL8 PL THF TBAB 40 b 7 58 
pBL ?–BL none TEABz 40 8 0 
pCL1 ?–CL none TEABz 40 7 0 
pCL2 ?–CL  none TEABz 80 4 0 
a 80:20 THF–EtOH. b Initially, the reaction mixture was stirred at 25 °C for 1 h. 
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Within the limits of the small experiment number, the reaction conversion seems to 
depend on the structure of the starting monomer. In particular, the steric hindrance of the 
alkyl group appears of special significance. In fact, the homopolymerization of the 
cholesteryl derivative failed, thus suggesting that the colesteryl lateral chain inhibited the 
ROP.  
The homopolymerization of PL was also investigated in order to evaluate the amenability 
of this monomer precursor toward carboxylate–initiated ROP process. The conversion to 
polymeric product was appreciably lower in THF or THF–ETOH solution (runs pPL 5–8) 
than in bulk. As expected, the reaction yield increased on increasing the reaction 
temperature from 25 to 40 °C. These results indicate that ?–propiolactone can be 
polymerized in the presence of quaternary onium salts. However, good yields can be 
obtained only by carefully designing the reaction conditions. On the other hand, the 
homopolymerization of ?–butyrolactone (?–BL) and ?–caprolactone (?–CL) failed 
probably because of the strain of these cyclic compounds is too small to favor the ring 
opening polymerization reaction. 
In order to evaluate the suitability of stannous 2–ethylhexanoate (SnOct2) for the 
polymerization of the investigated cyclic esters, several polymerization experiments were 
carried out at 100 and 130 °C by using a monomer/SnOct2 molar ratio of about 200. As 
summarized in Table 5.6, under the adopted experimental conditions only ?–
propiolactone afforded 60 % conversion, whereas the reaction failed in the case of the 
other cyclic monomers.  
Table 5.6. Homopolymerization of cyclic monomers by using SnOct2 as catalyst.
a 
Run Monomer Monomer/catalyst Temp. Duration Yield 
(Type) (Type) molar ratio (°C) (h) (%) 
pBL2 ?–BL 234 100 20 0 
pBL3 ?–BL 234 130 24 0 
pHBu2 ?–HBuL 245 100 20 0 
pHBu3 ?–HBuL 245 130 24 0 
pDDI2 LLact 200 100 20 0 
pDDI3 LLact 200 130 24 0 
pPL2 PL 200 100 20 60 
pBz2  BzDML 200 100 20 0 
pBz3 BzDML 200 130 24 0 
a Reaction carried out on 0.5 g of monomer. 
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5.4.4 Synthesis of malolactonate copolymers 
 
Copolymerization experiments of (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–
oxetanone (BzDML) with equimolar amounts of either (R,S)–4–butyloxycarbonyl–3,3–
dimethyl–2–oxetanone (BuDML) or ?–propiolactone (PL) were performed under the 
same experimental conditions adopted in the corresponding homopolymerization 
experiments (Table 5.7). The copolymerization of BuDML with PL was also carried out.  
Within the limits of the small number of experiment, the reported conversions indicate a 
larger reactivity of BzDML with propiolactone (runs pBzPL80 and pBzPL95) than with 
BuDML (run pBuBz). This result can be tentatively attributed to the steric hindrance of 
malolactonate side chains. It is not possible however to rule out catalyst poisoning by 
residual impurities present in the synthesized malolactonates. 
Interestingly, the copolymerization of 20:80 ?–caprolactone/propiolactone mixture failed 
[run pPLCL20] 
Table 5.7. Copolymerization of cyclic monomers by using TEABz as catalyst.a 
Run Monomer 1 Monomer 2 Catalyst Temp. Duration Yield 
(Type) (Type) (Type) (μl) (°C) (days) (%) 
pBuBz BuDML BzDML 28 40 10 28 
pBzPL80 PL BzDML 51 42 5 90 
pBzPL95 PL BzDML 89 40 3 66 
pPLCL20 PL ?–CL 13 42 7 0 
 
 
 
5.4.5. Deprotection of side–chain allyl and benzyl ester groups from (R,S)–4–
alkyloxycarbonyl–3,3–dimethyl–2–oxetanone polymers 
 
Soluble palladium complex are often used for the cleavage of the allyloxycarbonyl 
function using catalytic ?–allyl activation, generally applicable to all types of N– or O–
allyloxycarbonyl structures. The allyloxycarbonyl function is subjected to C–O scission 
by organocuprates and carbonyl nickel [Paul 1982]. Allyl ester cleavage of pAl was 
carried out by reaction with pyrrolidine in anhydrous dichloromethane at 0 °C in the 
presence of a catalytic amount of palladium tetrakistriphenylphosphine (Scheme 5.28). 
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Scheme 5.28. Catalytic hydrogenation of pAl. 
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This reaction implies the activation of the allyl group by Pd(0) followed by the 
substitution of the activated functionality by a strong nucleophile, such as pyrrolidine 
(Schema 5.29) 
Scheme 5.29. Proposed mechanism for the catalytic hydrogenation of pAl. 
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Benzyl ester cleavage of BzDML homopolymer was carried out by hydrogenolysis in 
anhydrous acetone by using 20% Pd/C as catalyst (Scheme 5.30). 
Scheme 5.30. Catalytic hydrogenation of pBz. 
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The FT–IR, 1H–NMR, and 13C–NMR spectra of the reaction products presented signals 
attributable free carboxylic acids whereas signals relevant to allyl and benzyl groups were 
not detectable thus demonstrating that the reaction conversion was close to 100%. The 
above results indicate that (R,S)–4–benzyloxycarbonyl–3,3–dimethyl–2–oxetanone is a 
better monomeric precursor of repeating units containing free carboxylic acid groups. 
Indeed, less expensive, less toxic, and more easily controllable reagents can be used to 
deprotect polymers containing benzyloxycarbonyl side chains. 
5.4.6. Characterization of polymer samples 
 
5.4.6.1. FT–IR spectroscopy 
The FT–IR spectra of all the polymer samples evidenced a strong absorption band in the 
1740–1750 cm–1 range (Figure 5.10) that was attributed to the stretching of the carbonyl 
groups present in both main and side chains. 
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Figure 5.10. FT–IR spectra of (R,S)–4–alkyloxycarbonyl–3,3–dimethyl–2–oxetanone 
homopolymers. 
Another distinctive feature of polymer FT–IR spectra was the presence of two bands of 
medium–strong intensity in the 1050–1250 cm–1 frequency region that were assigned to 
the C–(C=O)–O and OC–C coupled asymmetric stretching vibrations. When the polymer 
side chains contained alkenyl groups, a C=C stretching band was observed at about 1660–
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1670 cm–1. The intensity of this absorption band showed a close dependence on the 
polymer content of unsaturated units. The FT–IR spectra of the benzyl–substituted 
polymers showed two peaks of medium intensity centered at about 700 and 750 cm–1, 
which were attributed to the out–of–plane bending vibrations of the phenyl C–H. 
Removal of side chain ester groups gave rise to the disappearance of its signals from the 
FT–IR spectra accompanied by the appearance of free carboxylic acid bands between 
3500 e 2500 cm–1 (Figure 5.11). 
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Figure 5.11. FT–IR spectra of poly[(R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–
oxetanone] before (black) and after removal (red) of allyl groups. 
5.4.6.2. 1H– NMR spectroscopy 
Comparison of the 1H–NMR spectra of homopolymer samples and of their parent 
monomeric precursors highlighted some interesting general features. As a result of the 
incorporation into the macromolecular backbone by ring opening polymerization, the 
peaks relevant to lactone ring protons underwent well–definite shifts (Figure 5.12). 
Furthermore, polymer spectra did not display most of the fine spin–coupling structures 
present in the parent monomer spectra, since the repeating units along the 
macromolecular chains experienced slightly different microenvironments; therefore, 
extended signal averaging occurred. As expected, this effect was more marked for protons 
linked to the polymeric backbone than for those in the side chains. It is worth noting that 
weak resonances attributable to alkene protons were detected in the 6.0–7.0 ppm range 
for all homopolymer and copolymer samples. These peaks were attributed to 
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macromolecular chains terminated by ?,?–unsatured ester groups because of chain 
transfer reactions of the previously described kind (§ 1.5.2.2). 
8 7 6 5 4 3 2 1 PPM 0 
Figure 5.12. 1H–NMR spectra of (R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone 
(black) and poly[(R,S)–4–allyloxycarbonyl–3,3–dimethyl–2–oxetanone] 
(red). 
The 1H–NMR spectrum of pBuBz is reported in Figure 5.13 as general example of 
copolymer specimens. For comparison, the spectra of corresponding two homopolymers 
pBu and pBz are reported in Figures 5.14 and 5.15. 
 
Figure 5.13.  1H–NMR spectrum of poly(butyl (R,S)–3,3–dimethyl–2–oxetanone)–co–
benzyl (R,S)–3,3–dimethyl–2–oxetanone) in CDCl3 
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Figure 5.14. 1H–NMR spectrum of poly(butyl (R,S)–3,3–dimethyl–2–oxetanone) in 
CDCl3. 
 
Figure 5.15. 1H–NMR spectrum of poly(benzyl (R,S)–3,3–dimethyl–2–oxetanone) in 
acetone–d6. 
 
The copolymer spectrum corresponds to a linear combination of the relevant 
homopolymer spectra. However, the former spectrum showed broader peaks, presumably 
due to the random distribution of the two monomeric units along the macromolecular 
chain. A similar behavior was observed for the other copolymer samples. 
Integration of 1H–NMR signals in the copolymer spectrum allowed for the determination 
of their chemical composition (Table 5.8). In all cases, no significant enrichment in one 
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of the two comonomers was found. Indeed, comparison between feed and copolymer 
composition did not show differences larger than the NMR detection limits (~5%). 
Table 5.8. Chemical composition of the feed and of the prepared copolymers 
 Sample BzDML (% mol) 
  Feed Copolymer 
 pBuBz 20 23 
 pBzPL 80 20 18 
 pBzPL 95 5 3 
5.4.6.3. 13C–NMR spectroscopy 
13C–NMR spectra of all synthesized compounds, both of low and high molecular weight 
fully agree with their expected structures. In particular, the peaks of main chain carbons 
exhibited ill resolved structures. On the other hand, the geminal methyl groups in 3–
position presented two sharp singlets in the spectra of low molar mass monomers and 
synthetic intermediates whereas a structured peak resulting from the overlap of at least 
eight different signals was observed in the spectra of polymeric samples (Figure 5.16). 
 
Figure 5.16. Methyl signal region in the 13C–NMR spectrum of poly[(R,S)–4–benzyloxy-
carbonyl–3,3–dimethyl–2–oxetanone]. 
This result must be attributed to the sensitivity of this group to the man chain 
stereochemistry. It is worth mentioning that racemic monomers were used in 
polymerization experiments. The random enchainment of racemic units gave rise to the 
formation of different stereosequences. In particular, by taking into account a sequence of 
three structural units, there are four possible non–equivalent configurations, not taking 
into account their corresponding enantiomeric stereosequences (Scheme 5.31). 
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Scheme 5.31. Triad stereosequences of racemic poly(4–alkyloxycarbonyl–3,3–dimethyl–
2–oxetanone). 
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Accordingly, each one of the two methyl groups in the middle unit should give rise to 
four different signals, that is to eight signals. This prevision is in excellent agreement with 
the experimental results. If this hypothesis holds true, the polymerization process should 
occur mainly at random but with a limited degree of stereoselectivity. Indeed, the eight 
components of the gem–dimethyl peak have comparable by somewhat different 
intensities. However, it is not possible to rule out that the methyl signal is more complex 
than expected only because of its sensitivity to longer stereosequences. 
In the case of propiolactone/4–benzyloycarbonyl–3,3–dimethyl–2–oxetanone copolymer 
containing 20% of benzyl units, the carbonyl signal of propiolactone units presented a 
main peak at 170.34 ppm partially overlapping a smaller one at 170.21 ppm, attributable 
to junctions between propiolactone and BzDML units. Decomposition of these signals by 
Lorentzian fit (Figure 5.17) gave 89:11 ratio between the integrated peak area, which 
corresponds to an average sequence length of 9.1 propiolactone units. This value is much 
larger than that computed for a random copolymer of the same chemical composition, 
thus confirming the larger reactivity and hence the larger block–forming tendency of PL. 
5.4.6.4. Size Exclusion Chromatography 
The molecular weight distribution of polymer samples was determined by size exclusion 
chromatography (SEC); monodisperse polystyrene samples were used as molecular 
weight calibration standards, and chloroform was selected as eluent. The determined 
average molecular weights and polydispersity indexes of the different samples are 
collected in Table 5.9. The theoretical molecular weight values, as calculated from the 
monomer to initiator ratios, are also reported for comparison. 
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Figure 5.17. Decomposition of propiolactone carbonyl signal in the 13C–NMR spectrum 
of 80:20 poly(propiolactone–co–(R,S)–4–benzyloxycarbonyl–3,3–dimethyl–
2–oxetanone). 
Table 5.9. Number average (Mn) and weight average (Mw) molecular weight and 
polydispersity index (PI) of the investigated polymer samples. 
 Polymer Mn
a Mn
b PI b 
  (kDa) (kDa) 
 pAl 184 43 1.5 
 pAl depr. 144 26 3.3 
 pBu 200 39 1.2 
 pBz 234 28 1.6 
 pPL 72 38 1.5 
 pBuBz 207 19 1.3 
 pBzPL80 104 39 1.4 
 pBzPL95 80 2 3.6 
a Evaluated from the monomer/catalyst molar ratio. b Determined by SEC. 
The experimental molecular weights of the synthesized homopolymers and copolymers 
ranged between 2 and 40 kDa, and resulted significantly 2–10 times lower than the 
expected ones. However, molecular weights evaluated by SEC correspond to actual 
molecular weights only if calibration standards and analyzed samples have the same 
macromolecular structure or at least a closely related one. In the present analysis, 
polyesters were standardized against a polyolefin. On the other side, the observed 
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differences are so large that they must be very likely attributed to the occurrence of chain 
transfer reactions during the ROP process. Polydispersity indexes (PI) in the 1.2– 3.6 
range further confirmed the occurrence of chain transfer reactions, since PI of controlled 
living polymerizations are expected to be only slightly larger than unity. 
The reported data indicated also that the presence of a solvent enhanced the chain transfer 
reaction rate. Accordingly, polymers prepared in solution evidenced the highest PI. It is 
also worth noting that homopolymers displayed lower polydispersity indexes than 
copolymers, as expected from the theory of chain polymerization. 
The unexpected high polydispersity index of pBzPL95 was attributed to the poor 
solubility of the polymeric growing chains in the monomer/initiator mixture that gives 
rise to a heterophase polymerization process. 
Finally, it must be stressed that these polymerization experiments were performed in bulk 
at low temperature. It is therefore possible that solidification of the polymerization 
products and hence the reduced diffusion rates limited the further growth of 
macromolecular chains. 
5.4.6.5. Thermogravimetry 
Thermogravimetric analysis (TGA) of representative homopolymers and copolymers was 
carried out in order to assess the dependence of the polymeric thermal stability on the 
structure of the side ester groups. Each sample was heated from 25 to 700 °C at 10 
°C/min under nitrogen atmosphere. Table 5.10 reports the onset temperature (Ton), the 
decomposition temperature (Td), the percent weight loss (?w), and the weight residue at 
700 °C (R700) for all thermal degradation processes displayed by the examined samples, 
whereas Figure 5.18 shows a few typical thermogravimetric plots. 
All poly(4–alkyloxyicarbonyl–3,3–dimethyl–2–oxetanone)s were thermally stable up to 
190–240 °C and showed a single degradation step with maximum at 350–370 °C. On the 
other hand, the decomposition temperature of poly(4–carboxyl–3,3–dimethyl–2–
oxetanone), obtained by deprotection of pAl was about 100 °C lower, most likely because 
od degradation processes catalyzed by side chain carboxylic acid. 
Propiolactone copolymers decomposed between 266 and 280 °C and the decomposition 
temperature decreased on increasing the content of propiolactone units (Figure 5.18). This 
behavior can be tentatively attributed to the presence of two hydrogen atoms on the 
carbon atom in ?–position to propiolactone ester group. This structural feature can favor 
decarboxylation process and hence the polymer backbone degradation. It is worth noting 
that 80:20 PL–BzDML copolymer presented two degradation steps. The respective peak 
temperatures are very close to those of the two homopolymers whereas the weight losses 
correspond to the relative content of the two monomeric units. 
RESULTS AND DISCUSSION 
 155
Table 5.10. Thermal characteristics of the synthesized polymers.a 
Sample Tg ?Cp  Ton Td ?w R700 
 (°C) (J/g K)  (°C) (°C) (%–w) (%–w) 
pAl 26.9 0.31 288 360 97.8 2.2 
pBu 7.3 0.22 334 374 98.2 1.8 
pBz 43.4 0.37 300 353 98.1 1.9 
pBu–Bz 27.0 0.31 nd nd nd nd 
pBzPL80 –4.3 0.41 249 280 b 79.3 1.8 
pBzPL95 c –10.0 0.46 235 269  98.0 2.0 
p(PL) d –10.3 0.21 229 266 98.6 1.4 
PAl depr. 159.4 0.51 170 262 86.2 13.8 
PBz depr. 138.9  0.24 nd nd nd nd 
a nd = not determined. b A further decomposition peak is present with Td 349 °C and ?W 18.9%. c Two 
melting peaks are present at 62.3 and 77.3 °C with ?H 42.7 and 3.6 J/g, respectively. d Two melting peaks 
are present at 85.0 and 93.9 °C with ?H 55.1 and 13.7 J/g, respectively. 
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Figure 5.18. TGA traces of some of the investigated polymers. 
4.6.5.6. Differential Scanning Calorimetry 
Differential Scanning Calorimetry (DSC) analysis was performed by submitting polymer 
samples to heating–cooling–heating cycle at 10 °C/min. Data reported in Table 5.10 refer 
only to the second heating scan. Indeed, the starting thermal properties heavily depend 
upon the sample thermal history and purification procedure, and specimen preparation. 
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All investigated samples presented a glass transition included between–17 e 159 °C. It is 
worth noting that homopolymer Tg decreased from 43 to 7 °C (Figure 5.19) on increasing 
the ester side chain mobility, in the order benzyl < allyl < butyl. 
Analogously, the Tg of propiolactone copolymers decreased on increasing the content of 
more mobile PL units. On the other hand, removal of side chain ester residues increased 
the Tg by more than 100 °C, probably because of macromolecule stiffening caused by the 
formation of intramolecular and intermolecular hydrogen bonds among free carboxyl 
groups. 
Generally, the DSC of the examined polymers did not present first order endothermic 
transitions attributable to the melting of crystalline domains, at least in the investigated 
range between –50 and 200 °C. This behavior supports the hypothesis that the poly(?–
lactone) degree of crystallinity heavily depends on the stereoregularity of polymer 
backbone and/or side chains.130 In fact, ROP of alkyl ?–malolactonates is not 
stereoelective, although the ring opening process is characterized by a highly 
stereospecific SN2 mechanism.
101 Therefore, the use of racemic monomeric precursors can 
afford only atactic stereocopolyesters whose lack of microstructural order inhibits the 
organization of macromolecular chains in crystalline regions.  
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Figure 5.19. DSC traces of the synthesized homopolymers. 
On the contrary, polypropiolactone DSC presented two partially overlapping melting 
peaks at 85.0 and 93.9 °C, with ?H 55.1 and 13.7 J/g, respectively (Figure 5.20). This 
behavior is in agreement with the high structural order of a macromolecular chain that 
does not contain side chains. Analogously, the PL–BzDML copolymer containing more 
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than 95% of PL units exhibited two melting peaks at 62.3 and 77.3 °C, with ?H 42.7 e 3.6 
J/g, respectively. The decrease of both melting temperatures and enthalpies on decreasing 
the content of PL units must be assigned to the disruption of the propiolactone crystalline 
order by the presence of sparse racemic BzDML units. 
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Figure 5.20. DSC traces of polypropiolactone and of pBzPL95. 
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6. CONCLUSIONS 
 
 
The development of new bioactive polymeric materials suitable for biomedical 
applications represented the main objective the undertaken research project. The 
following points summarize the results achieved within the framework of the performed 
research activity. 
• Preparation of copolymers of oxetanes with cyclic carboxylic anhydrides  
The preparation of polyesters containing hydroxyl–bonding units can be carried out in 
bulk by using quaternary onium salt as initiator. The reaction conversion seems to 
depend on the structure of the starting monomer. In particular, the free hydroxyl 
group of the 3–methyl–3–hydroxymethyloxetane (MOM) appears of special 
significance. In fact, the reaction of equimolar amounts of MOM and succinic 
anhydride failed. The same behavior is observed in the reaction between MOM and 
phthalic anhydride, very likely because of the formation of crosslinked products by 
reaction of the hydroxyl group with anhydride. The reaction does not proceed 
between 60 and 100 °C and there is no significant difference in the activity of the 
investigated catalysts. On the other hand, when the polymerization is carried out by 
reacting 2–(benzyloxymethyl)–3–methyloxetane (BMMO) with phthalic anhydride, 
the corresponding copolymers can be obtained in high yields, although only at 
temperatures equal to or higher than 130 °C. The spectroscopic features of the 
obtained polymeric materials are in complete agreement with their expected chemical 
structures. However, polymer polydispersity index appreciably larger than unit 
(Mw/Mn = 1.2) indicated that the polymerization does not occur by a living process. 
• Preparation of copolymers of bis(oxetane) with dicarboxylic acids  
The synthesis of a bisoxetane, namely bis((3–methyloxetan–3–yl)methyl) 
terephthalate) (BOMT) can be easily performed in good yield by reacting the 
commercially available 3–methyl–3–oxetanemethanol with terephthaloyl chloride 
under basic conditions. Polyesters containing side chain reactive moieties are then 
obtained by ring opening polymerization of BOMT and different dicarboxylic acids 
(succinic, adipic, sebacic, itaconic, 1,4–cyclohexanedicarboxylic, isophthalic, and 
terephthalic acid) catalyzed by tetraphenylphosphonium bromide. Independent of the 
dicarboxylic acid structure, medium–to–low conversions to polymeric products are 
recorded in all cases. The spectroscopic features of the obtained polymeric materials 
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is in complete agreement with their expected chemical structures. Also in this case, 
polymer molecular weight and molecular weight distribution indicate that that the 
bisoxetane–diacid polymerization does not occur by a living process, at least under 
the adopted experimental conditions. 
• Preparation of functional ?–lactone monomers 
Readily available alcohols of different structural features are successfully employed to 
synthesize a series of alkyl malolactonate monomers displaying a wide range of 
physicochemical properties. Highly pure (>99%) benzyl malolactonate (BzDML), is 
prepared in 57% yield by a five–steps synthetic procedure starting from diethyl 
oxalpropionate. Alkyl ?–malolactonates with linear side–chains are also conveniently 
prepared by the same synthetic route. Final yields range between 63 and 90%, 
depending upon the length of the side chain. Conversion of (R,S)–4–(benzyloxy)–2–
hydroxy–3,3–dimethyl–4–oxobutanoic acid into (R,S)–4–benzyloxycarbonyl–3,3–
dimethyl–2–oxetanone can be performed either by intramolecular Mitsunobu 
cyclization or by activation of the carboxyl group with tosyl chloride and pyridine. 
However, the latter method affords low yields (16 %) of difficult to purify product. 
• Preparation of functional poly(?–lactone) homopolymers and copolymers 
The anionic ring opening homopolymerization and copolymerization of the 
synthesized ?–lactone monomers can be carried out by using either 
tetraethylammonium benzoate or tetrabutylammonium bromide as initiator. Less 
hindered monomers show higher polymerization rates than bulkier derivatives. The 
prepared poly(?–lactone) homopolymers and copolymers are recovered in fairly good 
yields (15–90%) by double precipitation in aprotic non solvents. The 
homopolymerization of the cholesteryl derivative failed, likely because of the 
bulkyness of the colesteryl lateral chain that hindered the anionic polymerization 
process. The spectroscopic features of the obtained polymeric materials are in 
complete agreement with their expected chemical structures. Moreover, NMR 
characterization of copolymer samples evidences that no significant enrichment in one 
of the two monomeric units occurred during the copolymerization. This indicates that 
the copolymerization occurred mainly by a random process. However, 13C–NMR 
spectra suggest that propiolactone copolyesters contain short block of units derived 
from this monomer, very likely because of the larger reactivity of propiolactone that 
does not contain geminal dimethyl groups in alpha position to the carbonyl moiety. 
Additionally, a moderate degree of stereoregularity was suggested by the multiplicity 
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of 13C–NMR signals. Unlike other copolymer samples, copolymers of benzyl 
malolactonate and methoxyethyl malolactonate show bimodal molecular weight 
distributions. This effect can be attributed to the preferential tendency of 
methoxyethyl malolactonate to homopolymerization. In all cases, SEC analysis of the 
prepared polymeric samples showed molecular weights one order of magnitude lower 
than the values for an ideal living anionic polymerization, and polydispersity indexes 
significantly greater than the unity. This suggests the occurrence of effective chain–
transfer reactions during the polymerization process. All poly(4–alkyloxycarbonyl–
3,3–dimethyl–2–oxetanone)s are thermally stable up to 190–240 °C and show a single 
degradation step with maximum at 350–370 °C. Generally, the DSC of the examined 
polymers does not present first order endothermic transitions attributable to the 
melting of crystalline domains, in agreement with their low degree of stereoregularity. 
On the contrary, polypropiolactone and its copolymers with BzDML present two 
partially overlapping melting peaks whose intensity decreases on increasing the 
BzDML content. This behavior is in agreement with the high structural order of 
polymer segments that do not contain side chains. 
• Deprotection of carboxyl groups present in the polyester side chains 
Deprotection of carboxyl groups present in the side chains of polyesters derived from 
benzyl and allyl malolactonates can be performed respectively by catalytic 
hydrogenation and by reaction with pyrrolidine in the presence of 
tetrakistriphenylphosphine and triphenylphosphine. Both processes affords 
quantitative conversions without appreciably affecting the degree of polymerization 
of the starting homopolymers. The decomposition temperature of the deprotected 
polyesters is about 100 °C lower than that of the starting materials, most likely 
because of the occurrence of degradation processes catalyzed by the free carboxylic 
acid groups present in the side chains. Correspondingly, the polymer Tg increases of 
more than 100 °C, possibly because of the stiffening of the macromolecules caused by 
the formation of intra and intermolecular hydrogen bonds. 
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